ANNEX 3 Linies.pdf - Fundació Institut d'Investigació en Ciències de ...
ANNEX 3 Linies.pdf - Fundació Institut d'Investigació en Ciències de ...
ANNEX 3 Linies.pdf - Fundació Institut d'Investigació en Ciències de ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>ANNEX</strong> 3<br />
Relació <strong>de</strong>tallada <strong>de</strong> la producció<br />
ci<strong>en</strong>tífica per línies prioritàries i tipus<br />
d’investigació<br />
Relación <strong>de</strong>tallada <strong>de</strong> la producción<br />
ci<strong>en</strong>tífica por líneas prioritarias y tipo<br />
<strong>de</strong> investigación<br />
Detailed list of the sci<strong>en</strong>tific<br />
production according the priorized<br />
areas and type of research
PROJECTES PUBLICACIONS<br />
FACTOR<br />
D'IMPACTE<br />
Infecto-Immuno Inflamació 62 210 962,714<br />
Bàsica 26 57 366,061<br />
Clínica 9 119 462,189<br />
Traslacional 27 34 134,464<br />
Càncer 13 102 495,044<br />
Bàsica 2 19 141,231<br />
Clínica 5 61 235,173<br />
Traslacional 6 22 118,640<br />
Epi<strong>de</strong>miologia Clínica i Molecular. Salut Pública.<br />
Salut Internacional<br />
12 47 188,357<br />
Bàsica -- 4 5,233<br />
Clínica 10 42 178,998<br />
Traslacional 2 1 4,126<br />
Tecnologia Aplicada a la Biomedicina<br />
(Biotecnologia, Bio<strong>en</strong>ginyeria i Bioinformàtica)<br />
4 37 113,95<br />
Bàsica -- 14 30,184<br />
Clínica -- 12 39,259<br />
Traslacional 4 11 44,507<br />
Innovació Clínica-Terapèutica i Serveis Sanitaris 14 135 366,436<br />
Bàsica 1 4 5,894<br />
Clínica 12 125 339,008<br />
Traslacional 1 6 21,534<br />
105 531 2126,501<br />
Pàgina 2 <strong>de</strong> 67
Pàgina 3 <strong>de</strong> 67
INFECTO-INMUNO<br />
INFLAMACIÓN<br />
Publicacions<br />
INVESTIGACIÓ BÀSICA<br />
Adams GG, Uddin A, Vives-Pi M, Pujol-Borrell R, James RFL.<br />
Characterisation of the NES2Y cell line and its use in the production of human glucose-responsive insulin producing (hGRIP) cell<br />
lines<br />
ISLETS 2009; 1:117-123<br />
Alonso N, Martínez-Arconada MJ, Granada ML, Sol<strong>de</strong>vila B, Cantón A, Mate JL, Sanmartí A, Martínez-Cáceres EM.<br />
Regulatory T cells in type 1 diabetic pati<strong>en</strong>ts with autoimmune chronic atrophic gastritis.<br />
ENDOCRINE 2009-JUN; 35 (3): 420-428<br />
IF: 1,899<br />
Alonso, N; Sol<strong>de</strong>vila, B; Sanmarti, A; Pujol-Borrell, R; Martinez-Caceres, E<br />
Regulatory T cells in diabetes and gastritis<br />
AUTOIMMUN REV 2009-JUL; 8 (8): 659-662<br />
IF: 6,368<br />
Ballana, E; Pauls, E; S<strong>en</strong>serrich, J; Clotet, B; Perron-Sierra, F; Tucker, GC; Este, JA<br />
Cell adhesion through alpha V-containing integrins is required for effici<strong>en</strong>t HIV-1 infection in macrophages<br />
BLOOD 2009-feb-05; 113 (6): 1278-1286<br />
IF: 10,555<br />
Beyer, K; Domingo-Sabat, M; Ariza, A<br />
Molecular Pathology of Lewy Body Diseases<br />
INT J MOL SCI 2009; 10:724-745<br />
IF: 1,387<br />
Bihl, F; Berger, C; Chisholm, JV; H<strong>en</strong>ry, LM; Bertisch, B; Trojan, A; Nadal, D; Speck, RF; Flepp, M; Bran<strong>de</strong>r, C; Mueller, NJ<br />
Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma<br />
AIDS 2009-SEP 10; 23 (14): 1918-1922<br />
IF: 4,909<br />
Brainard, DM; Seung, E; Frahm, N; Cariappa, A; Bailey, CC; Hart, WK; Shin, HS; Brooks, SF; Knight, HL; Eichbaum, Q; Yang, YG;<br />
Sykes, M; Walker, BD; Freeman, GJ; Pillai, S; Westmoreland, SV; Bran<strong>de</strong>r, C; Luster, AD; Tager, AM<br />
Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus-Infected<br />
Humanized BLT Mice<br />
J VIROL 2009 jul-15;83:7305-7321<br />
IF: 5,150<br />
Bran<strong>de</strong>r, C; Marincola, FM<br />
AAAS joins the Translational Medicine family<br />
J TRANSL MED 2009-MAY 7; 7<br />
IF: 3,407<br />
Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Sw<strong>en</strong>son LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM,<br />
Frahm N, Bran<strong>de</strong>r C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S.<br />
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins<br />
PLOS ONE 2009 Aug 19;4(8):e6687.<br />
IF: 4,351<br />
Caceres, N; Tapia, G; Ojangur<strong>en</strong>, I; Altare, F; Gil, O; Pinto, S; Vilaplana, C; Cardona, PJ<br />
Pàgina 4 <strong>de</strong> 67
Evolution of foamy macrophages in the pulmonary granulomas of experim<strong>en</strong>tal tuberculosis mo<strong>de</strong>ls<br />
TUBERCULOSIS 2009-MAR; 89 (2): 175-182<br />
IF: 2,536<br />
Caporuscio, F; Tafi, A; Gonzalez, E; Manetti, F; Este, JA; Botta, M<br />
A dynamic target-based pharmacophoric mo<strong>de</strong>l mapping the CD4 binding site on HIV-1 gp120 to id<strong>en</strong>tify new inhibitors of gp120-<br />
CD4 protein-protein interactions<br />
BIOORG MED CHEM LETT 2009; 19:6087-6091<br />
IF: 2,650<br />
Clotet-Codina, I; Bosch, B; S<strong>en</strong>serrich, J; Fernan<strong>de</strong>z-Figueras, MT; P<strong>en</strong>a, R; Ballana, E; Bofill, M; Clotet, B; Este, JA<br />
HIV <strong>en</strong>docytosis after d<strong>en</strong>dritic cell to T cell viral transfer leads to productive virus infection<br />
ANTIVIR RES 2009 Jul;83(1):94-8. Epub 2009 Apr 5<br />
IF: 3,612<br />
Coupling retroviral production with a selectable ev<strong>en</strong>t: selection of transcription factors that modulate γ-globin expression.<br />
Ulrich Tschul<strong>en</strong>a, K<strong>en</strong>neth R. Peterson, Beatriz Gonzalez, Halyna Fedosyuk & Carlos F. Barbas III.<br />
NAT STRUCT MOL BIOL 2009; Nov;16(11):1195-9.<br />
IF: 12,273<br />
Dalmau, J; Puertas, MC; Azuara, M; Marino, A; Frahm, N; Mothe, B; Izquierdo-Useros, N; Buzon, MJ; Pare<strong>de</strong>s, R; Matas, L; All<strong>en</strong>,<br />
TM; Bran<strong>de</strong>r, C; Rodrigo, C; Clotet, B; Martinez-Picado, J<br />
Contribution of Immunological and Virological Factors to Extremely Severe Primary HIV Type 1 Infection<br />
CLIN INFECT DIS 2009-JAN 15; 48 (2): 229-238<br />
IF: 8,195<br />
Darwich, L; Coma, G; P<strong>en</strong>a, R; Bellido, R; Blanco, EJJ; Este, JA; Borras, FE; Clotet, B; Ruiz, L; Rosell, A; Andreo, F; Parkhouse, RME;<br />
Bofill, M<br />
Secretion of interferon-gamma by human macrophages <strong>de</strong>monstrated at the single-cell level after costimulation with interleukin<br />
(IL)-12 plus IL-18<br />
IMMUNOLOGY 2009-MAR; 126 (3): 386-393<br />
IF: 3,276<br />
Davalos, A; <strong>de</strong> la P<strong>en</strong>a, G; Sanchez-Martin, CC; Guerra, MT; Bartolome, B; Lasuncion, MA<br />
Effects of red grape juice polyph<strong>en</strong>ols in NADPH oxidase subunit expression in human neutrophils and mononuclear blood cells<br />
BRIT J NUTR 2009; 102:1125-1135<br />
IF: 3,446<br />
Del Castillo JM, García-Martín MC, Arias-Díaz J, Giné E, Vara E, Cantero JL.<br />
Antiapoptotic effect of tacrolimus on cytokine-chall<strong>en</strong>ged human islets.<br />
CELL TRANSPLANT 2009;18(10):1237-46. Epub 2009 Aug 5.<br />
IF: 5,126<br />
Dominguez, J; De Souza-Galvao, M; Ruiz-Manzano, J; Latorre, I; Prat, C; Lacoma, A; Mila, C; Jim<strong>en</strong>ez, MA; Blanco, S; Maldonado, J;<br />
Altet, N; Ausina, V<br />
T-cell responses to the Mycobacterium tuberculosis-specific antig<strong>en</strong>s in active tuberculosis pati<strong>en</strong>ts at the beginning, during, and<br />
after antituberculosis treatm<strong>en</strong>t<br />
DIAGN MICR INFEC DIS 2009-JAN; 63 (1): 43-51<br />
IF: 2,451<br />
Fernàn<strong>de</strong>z-Busquets X, Ponce J, Bravo R, Arimon M, Martianyez T, Gella A, Cla<strong>de</strong>ra J, Durany N.<br />
Modulation of Amyloid beta Pepti<strong>de</strong>1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate.<br />
CURR ALZHEIMER RES 2009 Dec 31. [Epub ahead of print]<br />
IF: 4,971<br />
Fernan<strong>de</strong>z-Hernando, C; Yu, J; Suarez, Y; Rahner, C; Davalos, A; Lasuncion, MA; Sessa, WC<br />
G<strong>en</strong>etic Evid<strong>en</strong>ce Supporting a Critical Role of Endothelial Caveolin-1 during the Progression of Atherosclerosis<br />
CELL METAB 2009; 10:48-54<br />
IF: 17,350<br />
Garcia-Nunez, M; Pedro-Botet, ML; Ragull, S; Sop<strong>en</strong>a, N; Morera, J; Rey-Joly, C; Sabria, M<br />
Cytopathog<strong>en</strong>icity and molecular subtyping of Legionella pneumophila <strong>en</strong>vironm<strong>en</strong>tal isolates from 17 hospitals<br />
Pàgina 5 <strong>de</strong> 67
EPIDEMIOL INFECT 2009; 137:188-193<br />
IF: 2,365<br />
Gemma Òd<strong>en</strong>a, Eduard Cabré, Amparo Galan, Ramon Planas and Ramon Bartolí.<br />
Administration of Lactobacillus ferm<strong>en</strong>tum CECT 5716 does not prev<strong>en</strong>t intestinal bacterial translocation in ascitic cirrhotic rats<br />
EUR J CLIN NUTR 2009 (4) e265–e269<br />
IF: 3,072<br />
Gil O, Díaz I, Vilaplana C, Tapia G, Díaz J, Fort M, Cáceres N, Pinto S, Caylà J, Corner L, Domingo M, Cardona PJ.<br />
Granuloma <strong>en</strong>capsulation is a key factor for containing tuberculosis infection in minipigs.<br />
PLOS ONE 2009; 5(4): e10030. doi:10.1371/journal.pone.0010030<br />
IF: 4,351<br />
Gil V, Bichler Z, Lee JK, Seira O, Llor<strong>en</strong>s F, Bribian A, Morales R, Claverol-Tinture E, Soriano E, Sumoy L, Zh<strong>en</strong>g B, Del Río JA.<br />
Developm<strong>en</strong>tal Expression of the Oligod<strong>en</strong>drocyte Myelin Glycoprotein in the Mouse Tel<strong>en</strong>cephalon.<br />
CEREB CORTEX 2009 Nov 5. [Epub ahead of print]<br />
IF: 6,979<br />
Grau-Lopez, L; Raich, D; Ramo-Tello, C; Naranjo-Gomez, M; Davalos, A; Pujol-Borrell, R; Borras, FE; Martinez-Caceres, E<br />
Myelin pepti<strong>de</strong>s in multiple sclerosis<br />
AUTOIMMUN REV 2009-JUL; 8 (8): 650-653<br />
IF: 6,368<br />
Harrison, KD; Miao, RQ; Fernan<strong>de</strong>z-Hernando, C; Suarez, Y; Davalos, A; Sessa, WC<br />
Nogo-B Receptor Stabilizes Niemann-Pick Type C2 Protein and Regulates Intracellular Cholesterol Trafficking<br />
CELL METAB 2009; 10:208-218<br />
IF: 17,350<br />
Izquierdo-Useros, N; Naranjo-Gomez, M; Archer, J; Hatch, SC; Erkizia, I; Blanco, J; Borras, FE; Puertas, MC; Connor, JH; Fernan<strong>de</strong>z-<br />
Figueras, MT; Moore, L; Clotet, B; Gummuluru, S; Martinez-Picado, J<br />
Capture and transfer of HIV-1 particles by mature d<strong>en</strong>dritic cells converges with the exosome-dissemination pathway<br />
BLOOD 2009-març-19; 113 (12): 2732-2741<br />
IF: 10,555<br />
Kawashima, Y; Pfafferott, K; Frater, J; Matthews, P; Payne, R; Addo, M; Gatanaga, H; Fujiwara, M; Hachiya, A; Koizumi, H; Kuse, N;<br />
Oka, S; Duda, A; Pr<strong>en</strong><strong>de</strong>rgast, A; Crawford, H; Leslie, A; Brumme, Z; Brumme, C; All<strong>en</strong>, T; Bran<strong>de</strong>r, C; Kaslow, R; Tang, J; Hunter, E;<br />
All<strong>en</strong>, S; Mul<strong>en</strong>ga, J; Branch, S; Roach, T; John, M; Mallal, S; Ogwu, A; Shapiro, R; Prado, JG; Fidler, S; Weber, J; Pybus, OG;<br />
Kl<strong>en</strong>erman, P; Ndung'u, T; Phillips, R; Heckerman, D; Harrigan, PR; Walker, BD; Takiguchi, M; Goul<strong>de</strong>r, P<br />
Adaptation of HIV-1 to human leukocyte antig<strong>en</strong> class I<br />
NATURE 2009-APR 2; 458 (7238): 641-U108<br />
IF: 34,480<br />
Latorre, I; De Souza-Galvao, M; Ruiz-Manzano, J; Lacoma, A; Prat, C; Fu<strong>en</strong>zalida, L; Altet, N; Ausina, V; Dominguez, J<br />
Quantitative evaluation of T-cell response after specific antig<strong>en</strong> stimulation in active and lat<strong>en</strong>t tuberculosis infection in adults<br />
and childr<strong>en</strong><br />
DIAGN MICR INFEC DIS 2009 NOV;65:236-246<br />
IF: 2,451<br />
López-Laso E, Ochoa-Sepúlveda JJ, Ochoa-Amor JJ, Bescansa-Here<strong>de</strong>ro E, Camino-León R, Gascón-Jiménez FJ, Mateos-González<br />
ME, Pérez-Navero JL, Lao-Villadóniga JI, Ormazabal A, Artuch R, Beyer K.<br />
Segawa syndrome due to mutation Q89X in the GCH1 g<strong>en</strong>e: a possible foun<strong>de</strong>r effect in Córdoba (southern Spain).<br />
J NEUROL 2009 Nov;256(11):1816-24. Epub 2009 Jun 16.<br />
IF: 2,903<br />
Mane, J; Lor<strong>en</strong>, V; Pedrosa, E; Ojangur<strong>en</strong>, I; Xaus, J; Cabre, E; Dom<strong>en</strong>ech, E; Gassull, MA<br />
Lactobacillus ferm<strong>en</strong>tum CECT 5716 Prev<strong>en</strong>ts and Reverts Intestinal Damage on TNBS-induced Colitis in Mice<br />
INFLAMM BOWEL DIS 2009-AUG; 15 (8): 1155-1163<br />
IF: 4,643<br />
Mane, J; Pedrosa, E; Lor<strong>en</strong>, V; Ojangur<strong>en</strong>, I; Fluvia, L; Cabre, E; Rogler, G; Gassull, MA<br />
Partial Replacem<strong>en</strong>t of Dietary (n-6) Fatty Acids with Medium-Chain Triglyceri<strong>de</strong>s Decreases the Incid<strong>en</strong>ce of Spontaneous Colitis<br />
in Interleukin-10-Defici<strong>en</strong>t Mice<br />
Pàgina 6 <strong>de</strong> 67
J NUTR 2009-MAR; 139 (3): 603-610<br />
IF: 4,091<br />
Marín-Gallén S, Clem<strong>en</strong>te X, Planas R, Pujol I, Carrillo J, Carrascal J, Ampudia R, Pujol-Borrell R, Borràs FE, Vives-Pi M<br />
Prev<strong>en</strong>tion of experim<strong>en</strong>tal type 1 diabetes by immunotheraphy with syng<strong>en</strong>eic d<strong>en</strong>dritic cells pulsed with antig<strong>en</strong>specific<br />
apoptotic bodies<br />
J IMMUNOTHER 2009<br />
IF: 3,203<br />
Martínez-Hernán<strong>de</strong>z R, Soler-Botija C, Caselles L, Alias L, Also E, Bernal S, Baiget M, Tizzano EF.<br />
Analysis of the <strong>de</strong>velopm<strong>en</strong>tal pattern of human myotubes supports a pr<strong>en</strong>atal <strong>de</strong>lay of muscle maturation in spinal muscular<br />
atrophy.<br />
J NEUROPATH EXP NEUR 2009 May; 68(5):474-81<br />
IF: 4,564<br />
Massanella, M; Puigdom<strong>en</strong>ech, I; Cabrera, C; Fernan<strong>de</strong>z-Figueras, MT; Aucher, A; Gaibelet, G; Hudrisier, D; Garcia, E; Bofill, M;<br />
Clotet, B; Blanco, J<br />
Antigp41 antibodies fail to block early ev<strong>en</strong>ts of virological synapses but inhibit HIV spread betwe<strong>en</strong> T cells<br />
AIDS 2009-JAN 14; 23 (2): 183-188<br />
IF: 4,909<br />
Matilla-Dueñas A, Sánchez I, Corral-Juan M, Dávalos A, Alvarez R, Latorre P.<br />
Cellular and Molecular Pathways Triggering Neuro<strong>de</strong>g<strong>en</strong>eration in the Spinocerebellar Ataxias.<br />
CEREBELLUM 2009 Nov 5. [Epub ahead of print]<br />
IF: 3,280<br />
Minuesa, G; Volk, C; Molina-Arcas, M; Gorboulev, V; Erkizia, I; Arndt, P; Clotet, B; Pastor-Anglada, M; Koepsell, H; Martinez-<br />
Picado, J<br />
Transport of Lamivudine [(-)-beta-L-2 ',3 '-Di<strong>de</strong>oxy-3 '-thiacytidine] and High-Affinity Interaction of Nucleosi<strong>de</strong> Reverse<br />
Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3<br />
J PHARMACOL EXP THER 2009-APR; 329 (1): 252-261<br />
IF: 4,093<br />
Miura, T; Brockman, MA; Schnei<strong>de</strong>wind, A; Lobritz, M; Pereyra, F; Rathod, A; Block, BL; Brumme, ZL; Brumme, CJ; Baker, B;<br />
Rothchild, AC; Li, B; Trocha, A; Cutrell, E; Frahm, N; Bran<strong>de</strong>r, C; Toth, I; Arts, EJ; All<strong>en</strong>, TM; Walker, BD<br />
HLA-B57/B*5801 Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced<br />
Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition<br />
J VIROL 2009; 83:2743-2755<br />
IF: 5,150<br />
Murphy, RL; Autran, B; Katlama, C; Brucker, G; Debre, P; Calvez, V; Clotet, B; Clumeck, N; Costagliola, D; Deeks, SG; Dorrell, L;<br />
Gatell, J; Haase, A; Klein, M; Lazzarin, A; Mcmichael, AJ; Papagno, L; Schacker, T; Wain-Hobson, S; Walker, BD; Youle, M<br />
A Step Ahead on the HIV Collaboratory<br />
SCIENCE 2009-juny-05; 324 (5932): 1264-1265<br />
IF: 29,747<br />
Pare<strong>de</strong>s R, Sagar M, Marconi VC, Hoh R, Martin JN, Parkin NT, Petropoulos CJ, Deeks SG, Kuritzkes DR.<br />
In vivo fitness cost of the M184V mutation in multidrug-resistant human immuno<strong>de</strong>fici<strong>en</strong>cy virus type 1 in the abs<strong>en</strong>ce of<br />
lamivudine.<br />
J VIROL 2009 Feb;83(4):2038-43. Epub 2008 Nov 19<br />
IF: 5,150<br />
Parera, M; Perez-Alvarez, N; Clotet, B; Martinez, MA<br />
Epistasis among Deleterious Mutations in the HIV-1 Protease<br />
J MOL BIOL 2009-SEP 18; 392 (2): 243-250<br />
IF: 3,871<br />
Perez-Elias, MJ; Morellon, ML; Ortega, E; Hernan<strong>de</strong>z-Quero, J; Rodriguez-Torres, M; Clotet, B; Felizarta, F; Gutierrez, F; Pineda, JA;<br />
Nichols, G; Lou, Y; Wire, MB<br />
Pharmacokinetics of Fosampr<strong>en</strong>avir plus Ritonavir in Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus Type 1-Infected Adult Subjects with Hepatic<br />
Impairm<strong>en</strong>t<br />
ANTIMICROB AGENTS CH 2009 DEC;53:5185-5196<br />
Pàgina 7 <strong>de</strong> 67
IF: 4,802<br />
Peters L, Mocroft A, Soriano V, Rockstroh JK, Losso M, Valerio L, Aldins P, Reiss P, Le<strong>de</strong>rgerber B, Lundgr<strong>en</strong> JD; EuroSIDA<br />
Study Group.<br />
Hepatitis C virus coinfection does not influ<strong>en</strong>ce the CD4 cell recovery in HIV-1-infected pati<strong>en</strong>ts with maximum virologic<br />
suppression.<br />
JAIDS-J ACQ IMM DEF 2009 Apr 15;50(5):457-63.<br />
IF: 4,207<br />
Prado, JG; Honeyborne, I; Brierley, I; Puertas, MC; Martinez-Picado, J; Goul<strong>de</strong>r, PJR<br />
Functional Consequ<strong>en</strong>ces of Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus Escape from an HLA-B*13-Restricted CD8(+) T-Cell Epitope in p1 Gag<br />
Protein<br />
J VIROL 2009-JAN 15; 83 (2): 1018-1025<br />
IF: 5,150<br />
Pruvost, A; Negredo, E; Theodoro, F; Puig, J; Levi, M; Ay<strong>en</strong>, R; Grassi, J; Clotet, B<br />
Pilot Pharmacokinetic Study of Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus-Infected Pati<strong>en</strong>ts Receiving T<strong>en</strong>ofovir Disoproxil Fumarate (TDF):<br />
Investigation of Systemic and Intracellular Interactions betwe<strong>en</strong> TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir<br />
ANTIMICROB AGENTS CH 2009-MAY 1; 53 (5): 1937-1943<br />
IF: 4,802<br />
Puertas, MC; Buzon, MJ; Artese, A; Alcaro, S; M<strong>en</strong><strong>en</strong><strong>de</strong>z-Arias, L; Perno, CF; Clotet, B; Ceccherini-Silberstein, F; Martinez-<br />
Picado, J<br />
Effect of the Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication<br />
Capacity and Drug Susceptibility<br />
J VIROL 2009 AUG 1;83:7434-7439<br />
IF: 5,150<br />
Puigdom<strong>en</strong>ech, I; Massanella, M; Cabrera, C; Clotet, B; Blanco, J<br />
On the steps of cell-to-cell HIV transmission betwe<strong>en</strong> CD4 T cells<br />
RETROVIROLOGY 2009; 6:89<br />
IF: 4,105<br />
Radi M, Maga G, Alongi M, Angeli L, Samuele A, Zanoli S, Belluci L, Tafi A, Casaluce G, Giorgi G, Armand-Ugon M,<br />
Gonzalez E, Esté JA, Baltzinger M, Bec G, Dumas P, Ennifar E, Botta M<br />
Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-B<strong>en</strong>zyl-Oxopyrimidine (S-DABO) Derivatives as Pot<strong>en</strong>t HIV-1 Reverse<br />
Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants<br />
J MED CHEM 2009; 52, 840-851<br />
IF: 4,802<br />
Ramsay AJ, Quesada V, Sanchez M, Garabaya C, Sardà MP, Baiget M, Remacha A, Velasco G, López-Otín C.<br />
Matriptase-2 mutations in iron-refractory iron <strong>de</strong>fici<strong>en</strong>cy anemia pati<strong>en</strong>ts provi<strong>de</strong> new insights into protease activation<br />
mechanisms.<br />
HUM MOL GENET 2009 Oct 1;18(19):3673-83. Epub 2009 Jul 10.<br />
IF: 7,386<br />
Rousseau, CM; Lockhart, DW; Listgart<strong>en</strong>, J; Maley, SN; Kadie, C; Learn, GH; Nickle, DC; Heckerman, DE; D<strong>en</strong>g, W;<br />
Bran<strong>de</strong>r, C; Ndung'u, T; Coovadia, H; Goul<strong>de</strong>r, PJR; Korber, BT; Walker, BD; Mullins, JI<br />
Rare HLA Drive Additional HIV Evolution Compared to More Frequ<strong>en</strong>t Alleles<br />
AIDS RES HUM RETROV 2009; 25:297-303<br />
IF: 2,178<br />
Rusconi S, Lo Cicero M, Viganò O, Sirianni F, Bulgheroni E, Ferramosca S, B<strong>en</strong>cini A, Bianchi A, Ruiz L, Cabrera C, Martinez-Picado J,<br />
Supuran CT, Galli M.<br />
New macrocyclic amines showing activity as HIV <strong>en</strong>try inhibitors against wild type and multi-drug resistant viruses.<br />
Molecules 2009 May 22;14(5):1927-37<br />
IF: 2,359<br />
Russell, DG; Cardona, PJ; Kim, MJ; Allain, S; Altare, F<br />
Foamy macrophages and the progression of the human tuberculosis granuloma<br />
NAT IMMUNOL 2009; 10:943-948<br />
IF: 26,000<br />
Pàgina 8 <strong>de</strong> 67
Sabariegos R, Picazo F, Domingo B, Franco S, Martinez MA, Llopis J.<br />
Fluoresc<strong>en</strong>ce resonance <strong>en</strong>ergy transfer-based assay for characterization of hepatitis C virus NS3-4A protease activity in live cells.<br />
ANTIMICROB AGENTS CH 2009 Feb;53(2):728-34. Epub 2008 Dec 8.<br />
IF: 4,802<br />
Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, Leitner T, Gasch<strong>en</strong> B, Theiler J, Pare<strong>de</strong>s R, Su Z, Hughes MD, Gulick RM,<br />
Greaves W, Coakley E, Flexner C, Nusbaum C, Kuritzkes DR.<br />
Quantitative <strong>de</strong>ep sequ<strong>en</strong>cing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.<br />
PLOS ONE 2009 May 25;4(5):e5683.<br />
IF: 4,351<br />
Valles, X; Sarrias, MR; Casals, F; Farnos, M; Piner, R; Suarez, B; Morais, L; Mandomando, I; Sigauque, B; Roca, A; Alonso, PL; Torres,<br />
A; Thiel<strong>en</strong>s, NM; Lozano, F<br />
G<strong>en</strong>etic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African childr<strong>en</strong><br />
TISSUE ANTIGENS 2009; 74:298-307<br />
IF: 2,330<br />
Vera, J; F<strong>en</strong>utria, R; Canadas, O; Figueras, M; Mota, R; Sarrias, MR; Williams, DL; Casals, C; Yelamos, J; Lozano, F<br />
The CD5 ectodomain interacts with conserved fungal cell wall compon<strong>en</strong>ts and protects from zymosan-induced septic shock-like<br />
syndrome<br />
P NATL ACAD SCI USA 2009; 106:1506-1511<br />
IF: 9,432<br />
Walter M, Philotheou A, Bonnici F, Ziegler AG, Jim<strong>en</strong>ez R, on behalf of the NBI-6024 Study Group (Eva Aguilera).<br />
No effect of the altered pepti<strong>de</strong> ligand NBI-6024 on β-cell residual function and insulin needs in new-onset type 1 diabetes.<br />
DIABETES CARE 2009, 32: 2036-2040<br />
IF: 6,718<br />
INVESTIGACIÓ CLÍNICA<br />
Ahmed N, Wahlgr<strong>en</strong> N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators.<br />
Relationship of blood pressure, antihypert<strong>en</strong>sive therapy, and outcome in ischemic stroke treated with intrav<strong>en</strong>ous thrombolysis:<br />
retrospective analysis from Safe Implem<strong>en</strong>tation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).<br />
STROKE 2009 Jul;40(7):2442-9. Epub 2009 May 21.<br />
IF: 7,041<br />
Andres, A; Marc<strong>en</strong>, R; Val<strong>de</strong>s, F; Plumed, J; Sola, R; Errasti, P; Lauzurica, R; Pallardo, L; Bustamante, J; Am<strong>en</strong>abar, JJ; Plaza, JJ;<br />
Gomez, E; Grinyo, JM; R<strong>en</strong>gel, M; Puig, JM; Sanz, A; As<strong>en</strong>sio, C; Andres, I<br />
A randomized trial of basiliximab with three differ<strong>en</strong>t patterns of cyclosporin A initiation in r<strong>en</strong>al transplant from expan<strong>de</strong>d<br />
criteria donors and at high risk of <strong>de</strong>layed graft function.<br />
CLIN TRANSPLANT 2009-JAN-FEB; 23 (1): 23-32<br />
IF: 2,004<br />
Antonio J. Blasco AJ, Ferrándiz C, García A, Lázaro P, Liso J<br />
Efici<strong>en</strong>cia <strong>de</strong> los ag<strong>en</strong>tes biológicos <strong>en</strong> el tratami<strong>en</strong>to <strong>de</strong> la psoriaris mo<strong>de</strong>rada-grave.<br />
Actas Dermosifiliogr 2009;100:792-803 (A)<br />
Ar<strong>en</strong>illas JF, Sandoval P, Pérez <strong>de</strong> la Ossa N, Millán M, Guerrero C, Escu<strong>de</strong>ro D, Dorado L, López-Cancio E, Castillo J, Dávalos A.<br />
The metabolic syndrome is associated with a higher resistance to intrav<strong>en</strong>ous thrombolysis for acute ischemic stroke in wom<strong>en</strong><br />
than in m<strong>en</strong>.<br />
STROKE 2009 ;40(2):344-349. Epub 2008 Dec 24<br />
IF: 7,041<br />
Bassas-Vila J<br />
Patrones histológicos <strong>de</strong> los procesos inflamatorios <strong>de</strong> la piel<br />
PIEL 2009;24:380-386 (A)<br />
B<strong>en</strong>v<strong>en</strong>uti F, Carrascosa JM, Boada A, Ferrandiz C.<br />
Disseminated Strongyloi<strong>de</strong>s stercoralis infection pres<strong>en</strong>ting with cutaneous manifestations in an immunosuppressed pati<strong>en</strong>t<br />
EUR J DERMATOL 200;19(4):404-5.(A)<br />
Pàgina 9 <strong>de</strong> 67
IF: 2,251<br />
Ber<strong>en</strong>guer, J; Alvarez-Pellicer, J; Martin, PM; Lopez-Al<strong>de</strong>guer, J; Von-Wichmann, MA; Quereda, C; Mallolas, J; Sanz, J; Tural, C;<br />
Bellon, JM; Gonzalez-Garcia, J<br />
Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Pati<strong>en</strong>ts<br />
Coinfected with Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus and Hepatitis C Virus<br />
HEPATOLOGY 2009-AUG; 50 (2): 407-413<br />
IF: 10,840<br />
Ber<strong>en</strong>guer, J; Gonzalez-Garcia, J; Lopez-Al<strong>de</strong>guer, J; Von-Wichmann, MA; Quereda, C; Hernando, A; Sanz, J; Tural, C; Ortega, E;<br />
Mallolas, J; Santos, I; Miralles, P; Montes, ML; Bellon, JM; Esteban, H<br />
Pegylated interferon alpha 2a plus ribavirin versus pegylated interferon alpha 2b plus ribavirin for the treatm<strong>en</strong>t of chronic<br />
hepatitis C in HIV-infected pati<strong>en</strong>ts<br />
J ANTIMICROB CHEMOTH 2009-JUN; 63 (6): 1256-1263<br />
IF: 4,352<br />
Bielsa I.<br />
Nuevos anticuerpos <strong>en</strong> la <strong>de</strong>rmatomiositis<br />
Actas Dermosifiliogr 2009;100;182-189 (R)<br />
Bielsa I.<br />
Dermatomiositis.<br />
DERMATOL CLIN 2009; doi: 10.1016<br />
IF: 1,294<br />
Bluhmki, E; Chamorro, A; Davalos, A; Machnig, T; Sauce, C; Wahlgr<strong>en</strong>, N; Wardlaw, J; Hacke, W<br />
Stroke treatm<strong>en</strong>t with alteplase giv<strong>en</strong> 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and<br />
subgroup analysis of a randomised controlled trial<br />
LANCET NEUROL 2009 DEC;8:1095-1102<br />
IF: 18,126<br />
Bonjoch A, Buzon MJ, Llibre JM, Negredo E, Puig J, Pérez-Alvarez N, Vi<strong>de</strong>la S, Martinez-Picado J, Clotet B.<br />
Transi<strong>en</strong>t Treatm<strong>en</strong>t Exclusively Containing Nucleosi<strong>de</strong> Analogue Reverse Transcriptase Inhibitors in Highly Antiretroviral-<br />
Experi<strong>en</strong>ced Pati<strong>en</strong>ts Preserves Viral B<strong>en</strong>efit Wh<strong>en</strong> a Fully Active Therapy Was Initiated<br />
HIV CLIN TRIALS 2008 Nov-Dec;9(6):387-98.<br />
IF: 1,626<br />
Brea, D; Sobrino, T; Blanco, M; Fraga, M; Agulla, J; Rodriguez-Yanez, M; Rodriguez-Gonzalez, R; <strong>de</strong> la Ossa, NP; Leira, R; Forteza, J;<br />
Davalos, A; Castillo, J<br />
Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis<br />
confirmation<br />
ATHEROSCLEROSIS 2009-AUG; 205 (2): 561-567<br />
IF: 4,522<br />
Cabré E.<br />
Probióticos y prebióticos <strong>en</strong> la Enfermedad Inflamatoria Intestinal: Una revisión crítica<br />
Nutr Clin Med 2009; 3:31-39.<br />
Carrascosa JM<br />
Realida<strong>de</strong>s, perspectivas e incertidumbres <strong>de</strong> la terapia UVB <strong>de</strong> banda estrecha <strong>en</strong> la psoriasis<br />
Actas Dermosifiliogr 2009; 100;3-6 (a)<br />
Carrascosa JM, B<strong>en</strong>v<strong>en</strong>uti F, Rodríguez C, Ferrándiz C<br />
Perfil <strong>de</strong> los paci<strong>en</strong>tes con <strong>de</strong>rmatosis <strong>en</strong> las manos remitidos a la unidad <strong>de</strong> contacto <strong>de</strong> un hospital terciario e impacto <strong>de</strong> las<br />
pruebas epicutáneas <strong>en</strong> el diagnóstico.<br />
Actas Dermosifiliogr 2009;100:445-55 (A)<br />
Carrascosa JM, F Vanaclocha. L Borrego. E Fernán<strong>de</strong>z-López. A Fuertes. L Rodríguez-Fernán<strong>de</strong>z-Freire. A Zulaica. A Tuneu.G<br />
Caballé. E Colomé. X Bordas. JM Hernanz. C Brufau. E Herrera.<br />
Revisión actualizada <strong>de</strong>l tratami<strong>en</strong>to tópico <strong>de</strong> la psoriasis.<br />
Actas Dermosifiliogr 2009;100:190-200<br />
Pàgina 10 <strong>de</strong> 67
Carrascosa JM, Ferránidz C<br />
Tratami<strong>en</strong>to <strong>de</strong> la psoriasis: esperanzas y realida<strong>de</strong>s <strong>en</strong> la era biológica<br />
PIEL 2009;24:61-63 (a)<br />
Carrion, S; Dom<strong>en</strong>ech, E; Romeu, J; Dom<strong>en</strong>ech, E<br />
Pulmonary and nodal tuberculosis in a pati<strong>en</strong>t with inflammatory bowel disease and HIV infection treated with infliximab<br />
J CROHNS COLITIS 2009-SEP; 3 (3): 220-221<br />
IF: 1,729<br />
Casanova JM, Sanmartín V, Soria X, Ferrer M, Pujol RM, Ribera M<br />
Tratami<strong>en</strong>to tópico <strong>de</strong> la psoriasis (R)<br />
PIEL 2009;24:556-567<br />
Castroagudin, JF; Molina, E; Romero, R; Otero, E; Tome, S; Varo, E<br />
Improvem<strong>en</strong>t of R<strong>en</strong>al Function After the Switch from a Calcineurin Inhibitor to Everolimus in Liver Transplant Recipi<strong>en</strong>ts with<br />
Chronic R<strong>en</strong>al Dysfunction<br />
LIVER TRANSPLANT 2009; 15:1792-1797<br />
IF: 3,724<br />
Caylà JA, Rodrigo T, Ruiz-Manzano J, Caminero JA, Vidal R, García JM, Blanquer R, Casals M; Working Group on Completion of<br />
Tuberculosis Treatm<strong>en</strong>t in Spain (Study ECUTTE).<br />
Tuberculosis treatm<strong>en</strong>t adher<strong>en</strong>ce and fatality in Spain.<br />
RESP RES Respir Res. 2009 Dec 1;10:121.<br />
IF: 3,127<br />
Coll R, Colomer M, Ragull S, Roldán J.<br />
Predictive factors for survival in idiopatic pulmonary fibrosis.<br />
MED CLIN-BARCELONA 2009 Dec 30. [Epub ahead of print]<br />
IF: 1,231<br />
Coll-Canti, J; Ramo, RA; Dorado, L; Guerrero, C; Serichol, M; Davalos, A; Martinez, EM<br />
Guillain-Barre syndrome and IVIg: does early initiation of treatm<strong>en</strong>t influ<strong>en</strong>ce the mean hospital stay<br />
NEUROLOGIA 2009 MAY;24:217-219<br />
IF: 0,596<br />
Cybulla M, Walter KN, Schwarting A, Divito R, Feriozzi S, Sun<strong>de</strong>r-Plassmann G; European FOS Investigators Group. (Pintos G)<br />
Kidney transplantation in pati<strong>en</strong>ts with Fabry disease.<br />
TRANSPL INT 2009 Apr;22(4):475-81. Epub 2009 Jan 22.<br />
IF: 3,254<br />
<strong>de</strong> M<strong>en</strong>doza C, Anta L, García F, Pérez-Elías MJ, Gutiérrez F, Llibre JM, M<strong>en</strong>én<strong>de</strong>z-Arias L, Dalmau D, Soriano V.<br />
HIV-1 g<strong>en</strong>otypic drug resistance interpretation rules - 2009 Spanish gui<strong>de</strong>lines.<br />
AIDS REV 2009 Jan-Mar;11(1):39-51.<br />
IF: 3,786<br />
Decramer M, Celli B, Kest<strong>en</strong> S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators. (Morera J).<br />
Effect of tiotropium on outcomes in pati<strong>en</strong>ts with mo<strong>de</strong>rate chronic obstructive pulmonary disease (UPLIFT): a prespecified<br />
subgroup analysis of a randomised controlled trial.<br />
LANCET 2009 Oct 3;374(9696):1171-8. Epub 2009 Aug 27.<br />
IF: 30,758<br />
Descamps, A; Rousset, C; Millan, M; Spedding, M; Delagrange, P; Cespuglio, R<br />
Influ<strong>en</strong>ce of the novel anti<strong>de</strong>pressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleepwake<br />
cycle architecture<br />
PSYCHOPHARMACOLOGY 2009; 205:93-106<br />
IF: 4,103<br />
Doménech E.<br />
En contra <strong>de</strong> l’ús precoç <strong>de</strong> biològics <strong>en</strong> malaltia inflamatòria intestinal.<br />
ANN MED 2009; 92 (Supl 1): S1-S12.<br />
IF: 4,246<br />
Pàgina 11 <strong>de</strong> 67
Dom<strong>en</strong>ech, E; Manosa, M; Cabre, E<br />
Top-Down Therapy: Is the Evid<strong>en</strong>ce Strong Enough<br />
DIGEST DIS 2009;27(3):306-11. Epub 2009 Sep 24.<br />
IF: 1,487<br />
Dominguez J, Latorre I, Altet N, Mateo L, De Souza-Galvao M et al<br />
IFN-y_release assays to diagnose TB infection in the immunocompromised individual<br />
Expert Rev Respir Med 2009; 3 (3): 309-327<br />
Dominguez, A; Alvarez, J; Sabria, M; Carmona, G; Torner, N; Oviedo, M; Cayla, J; Minguell, S; Barrabeig, I; Sala, M; Godoy, R;<br />
Camps, N<br />
Factors influ<strong>en</strong>cing the case-fatality rate of Legionnaires' disease<br />
INT J TUBERC LUNG D 2009-MAR; 13 (3): 407-412<br />
IF: 2,548<br />
Dorado L, Millán M, Pérez <strong>de</strong> la Ossa N, Guerrero C, Gomis M, López-Cancio E, Ricciardi AC, Dávalos A.<br />
Influ<strong>en</strong>ce of antiplatelet pre-treatm<strong>en</strong>t on the risk of intracranial haemorrhage in acute ischaemic stroke after intrav<strong>en</strong>ous<br />
thrombolysis.<br />
EUR J NEUROL 2009 Nov 12. [Epub ahead of print]<br />
IF: 2,510<br />
Dorado, L; Ar<strong>en</strong>illas, JF; Millan, M; De La Ossa, NP; Guerrero, C; Davalos, A<br />
Prognostic impact of time-point and <strong>de</strong>gree of arterial recanalization of acute middle cerebral artery occlusions after intrav<strong>en</strong>ous<br />
tPA administration<br />
MED CLIN-BARCELONA 2009-MAY 2; 132 (16): 609-615<br />
IF: 1,231<br />
Escu<strong>de</strong>ro D, E. López-Cancio, A. Olivé, E. Martínez-Cáceres, J. Capella<strong>de</strong>s.<br />
Vasculopatía cerebral fulminante <strong>en</strong> el Síndrome <strong>de</strong> Sjögr<strong>en</strong>.<br />
NEUROLOGIA 2009; 24(7); 498-510<br />
IF: 0,596<br />
Esteban-Oliva, D; Pintos-Morell, G; Konrad, M<br />
Long-term follow-up of a pati<strong>en</strong>t with primary hypomagnesaemia and secondary hypocalcaemia due to a novel TRPM6 mutation<br />
EUR J PEDIATR 2009-APR; 168 (4): 439-442<br />
IF: 1,634<br />
Ferrándiz C, Carrascosa JM<br />
Tratami<strong>en</strong>to tópico vs sistémico <strong>en</strong> la psoriasis. ¿Dilema o acuerdo<br />
PIEL 2009;24:227-229 (a)<br />
Fu<strong>en</strong>tes, B; Castillo, J; Jose, BS; Leira, R; Ser<strong>en</strong>a, J; Vivancos, J; Davalos, A; Nunez, AG; Egido, J; Diez-Tejedor, E<br />
The Prognostic Value of Capillary Glucose Levels in Acute Stroke The GLycemia in Acute Stroke (GLIAS) Study<br />
STROKE 2009-FEB; 40 (2): 562-568<br />
IF: 7,041<br />
Fumaz CR, Muñoz-Mor<strong>en</strong>o JA, Ferrer MJ, Negredo E, Pérez-Alvarez N, Tarrats A, Clotet B.<br />
Low levels of adher<strong>en</strong>ce to antiretroviral therapy in HIV-1-infected wom<strong>en</strong> with m<strong>en</strong>strual disor<strong>de</strong>rs.<br />
AIDS PATIENT CARE ST 2009 Jun;23(6):463-8.<br />
IF: 2,683<br />
Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, <strong>de</strong> Batlle J, Gim<strong>en</strong>o E, Donaire-Gonzalez D,<br />
Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí AG, Antó JM; Ph<strong>en</strong>otype and Course of COPD Study Group.<br />
Physical activity and clinical and functional status in COPD.<br />
CHEST 2009 Jul;136(1):62-70. Epub 2009 Mar 2.<br />
IF: 6,360<br />
Garcia-Aymerich, J; Agusti, A; Barbera, JA; Belda, J; Farrero, E; Ferrer, A; Ferrer, J; Galdiz, JB; Gea, J; Gomez, FP; Monso, E;<br />
Morera, J; Roca, J; Sauleda, J; Anto, JM<br />
Ph<strong>en</strong>otypic Heterog<strong>en</strong>eity of Chronic Obstructive Pulmonary Disease<br />
ARCH BRONCONEUMOL 2009-MAR; 45 (3): 129-138<br />
IF: 2,166<br />
Pàgina 12 <strong>de</strong> 67
García-Casares E, Mateo L, García-Melchor E, Mínguez S, Vall-Llobera F, Cañellas J, Holgado S.<br />
Síndrome sarcoidosis-linfoma.<br />
Reumatología Clínica 2009; 5 (1): 31-33.<br />
García-Molina A, Enseñat-Cantallops A, Sánchez-Carrión R, Roig-Rovira T.<br />
Assessm<strong>en</strong>t of <strong>de</strong>cision-making capacity in primary and secondary progressive multiple sclerosis.<br />
NEUROLOGIA 2009 Mar;24(2):94-7.<br />
IF: 0,596<br />
Gasser, O; Bihl, F; Sanghavi, S; Rinaldo, C; Rowe, D; Hess, C; Stablein, D; Roland, M; Stock, P; Bran<strong>de</strong>r, C<br />
Treatm<strong>en</strong>t-<strong>de</strong>p<strong>en</strong>d<strong>en</strong>t Loss of Polyfunctional CD8+T-cell Responses in HIV-infected Kidney Transplant Recipi<strong>en</strong>ts Is<br />
Associated with Herpesvirus Reactivation<br />
AM J TRANSPLANT 2009-APR; 9 (4): 794-803<br />
IF: 6,433<br />
Gomez, J; Modol, J; Garcia-Nunez, M; Banos, V; Lor<strong>en</strong>zo, M; Pedro-Botet, ML; Hernan<strong>de</strong>z, T; Herrero, JA; Ruiz, J; Sabria,M<br />
Low mortality rate in an outbreak of Legionnaires' disease: Correlation with the cytopathog<strong>en</strong>ity study<br />
MED CLIN-BARCELONA 2009; 133:325-329<br />
IF: 1,231<br />
Gomis M, Ois A, Rodríguez-Campello A, Cuadrado-Godia E, Jiménez-Con<strong>de</strong> J, Subirana I, Dávalos A, Roquer J.<br />
Outcome of intracerebral haemorrhage pati<strong>en</strong>ts pre-treated with statins.<br />
EUR J NEUROL 2009 Nov 12. [Epub ahead of print]<br />
IF: 2,510<br />
Gomis, M; Sobrino, T; Ois, A; Millan, M; Rodriguez-Campello, A; <strong>de</strong> la Ossa, NP; Rodriguez-Gonzalez, R; Jim<strong>en</strong>ez-Con<strong>de</strong>, J;<br />
Cuadrado-Godia, E; Roquer, J; Davalos, A<br />
Plasma beta-Amyloid 1-40 Is Associated With the Diffuse Small Vessel Disease Subtype<br />
STROKE 2009-OCT; 40 (10): 3197-3201<br />
IF: 7,041<br />
Gonzalez N, Xicoy B, Olivé A,Jové J, Ribera JM, Feliu E<br />
Systemic lupus erythematosus in a pati<strong>en</strong>t with primary MALT lymphoma of the larynx<br />
Ear Nose Throat J 2009;ID: 19688705<br />
Grados-Canovas D; Balo S; B<strong>en</strong>itez-Diaz R; Romeu J<br />
M<strong>en</strong>ingitis simultaneously due to Cryptococcus neoformans and Mycobacterium tuberculosis in a pati<strong>en</strong>t with HIV infection<br />
MED CLIN-BARCELONA 2009-SEP 12; 133 (9): 361-362<br />
IF: 1,231<br />
Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA,<br />
Schnei<strong>de</strong>r D, Schwamm LH, Leal JS, Söhng<strong>en</strong> M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S.<br />
Intrav<strong>en</strong>ous <strong>de</strong>smoteplase in pati<strong>en</strong>ts with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or<br />
perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.<br />
LANCET NEUROL 2009 Feb;8(2):141-50. Epub 2008 Dec 25<br />
IF: 18,126<br />
Heras, E; Llibre, JM; Sirera, G; Mate, JL; Boix, V; Rey-Joly, C; Clotet, B<br />
Lymphogranuloma V<strong>en</strong>erium Proctitis in the Setting of HIV: A Case Report and Differ<strong>en</strong>tial Diagnosis<br />
AIDS PATIENT CARE ST 2009-JUL; 23 (7): 493-494<br />
IF: 2,683<br />
Horne R, Kovacs C, Katlama C, Clotet B, Fumaz CR, Youle M, Kulasegaram R, Fisher M, Coh<strong>en</strong> C, Slim J, Shalit P, Cooper V, Tsoukas<br />
C.<br />
Prescribing and using self-injectable antiretrovirals: how concordant are physician and pati<strong>en</strong>t perspectives<br />
AIDS RES THER 2009 Feb 5;6:2.<br />
INSIGHT-ESPRIT Study Group; SILCAAT Sci<strong>en</strong>tific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA,<br />
Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgr<strong>en</strong> JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G,<br />
W<strong>en</strong>tworth D.<br />
Interleukin-2 therapy in pati<strong>en</strong>ts with HIV infection.<br />
Pàgina 13 <strong>de</strong> 67
NEW ENGL J MED 2009 Oct 15;361(16):1548-59.<br />
IF: 47,050<br />
Katlama C, Haubrich R, Lalezari J, Lazzarin A, Madruga JV, Molina JM, Schechter M, Peeters M, Picchio G, Vingerhoets J, Woodfall<br />
B, De Smedt G; DUET-1, DUET-2 study groups.<br />
Efficacy and safety of etravirine in treatm<strong>en</strong>t-experi<strong>en</strong>ced, HIV-1 pati<strong>en</strong>ts: pooled 48 week analysis of two randomized, controlled<br />
trials.<br />
AIDS 2009 Nov 13;23(17):2289-300<br />
IF: 4,909<br />
Kesselring AM, Wit FW, Sabin CA, Lundgr<strong>en</strong> JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, <strong>de</strong> Wolf F, Reiss P, Mocroft A; Nevirapine<br />
Toxicity Multicohort Collaboration.<br />
Risk factors for treatm<strong>en</strong>t-limiting toxicities in pati<strong>en</strong>ts starting nevirapine-containing antiretroviral therapy.<br />
AIDS 2009 Aug 24;23(13):1689-99<br />
IF: 4,909<br />
Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomass<strong>en</strong> L, Wahlgr<strong>en</strong> N; SITS investigators.<br />
Disappearing hyperd<strong>en</strong>se middle cerebral artery sign in ischaemic stroke pati<strong>en</strong>ts treated with intrav<strong>en</strong>ous thrombolysis: clinical<br />
course and prognostic significance.<br />
J NEUROL NEUROSUR PS 2009 Mar;80(3):273-8. Epub 2008 Oct 17.<br />
IF: 4,869<br />
Lacoma A., Prat C., Andreo F., Dominguez J.<br />
Biomarkers in the managem<strong>en</strong>t of COPD.<br />
EUR RESPIR J 2009; 18: 96-104<br />
IF: 5,527<br />
Laguno, M; Cifu<strong>en</strong>tes, C; Murillas, J; Veloso, S; Larrousse, M; Payeras, A; Bonet, L; Vidal, F; Milinkovic, A; Bassa, A; Villalonga, C;<br />
Perez, I; Tural, C; Martinez-Rebollar, M; Calvo, M; Blanco, JL; Martinez, E; Sanchez-Tapias, JM; Gatell, JM; Mallolas, J<br />
Randomized Trial Comparing Pegylated Interferon alpha-2b Versus Pegylated Interferon alpha-2a, Both Plus Ribavirin, to Treat<br />
Chronic Hepatitis C in Human Immuno<strong>de</strong>fici<strong>en</strong>cy Virus Pati<strong>en</strong>ts<br />
HEPATOLOGY 2009-JAN; 49 (1): 22-31<br />
IF: 10,840<br />
Leal L, Carrascosa JM, Boada A, Ferrándiz C.<br />
Mucous membrane ulcers in an immunocompromised pati<strong>en</strong>t. Cutaneous cytomegalovirus infection.<br />
ARCH DERMATOL 2009;145:931-6.<br />
IF: 4,760<br />
Leira, R; Millan, M; Diez-Tejedor, E; Blanco, M; Ser<strong>en</strong>a, J; Fu<strong>en</strong>tes, B; Rodriguez-Yanez, M; Castellanos, M; Lago, A; Davalos, A;<br />
Castillo, J<br />
Age <strong>de</strong>termines the prognosis of the modifications of the arterial blood pressure Turing the acute phase of ischemic stroke (TICA<br />
study).<br />
HYPERTENSION 2009; 54:769-774<br />
IF: 6,614<br />
Llibre, JM<br />
First-Line Boosted Protease Inhibitor-Based Regim<strong>en</strong>s in Treatm<strong>en</strong>t-Naive HIV-1-Infected Pati<strong>en</strong>ts - Making a Good Thing Better<br />
AIDS REV 2009 OCT-DEC;11:215-222<br />
IF: 3,786<br />
Llibre, JM; Falco, V; Tural, C; Negredo, E; Pineda, JA; Munoz, J; Ortega, E; Vi<strong>de</strong>la, S; Sirera, G; Martinez, E; Miralles, C;<br />
Iribarr<strong>en</strong>, J; Galindo, MJ; Domingo, P; d'Arminio-Monforte, A; Miro, JM; Clotet, B<br />
The Changing Face of HIV/AIDS in Treated Pati<strong>en</strong>ts<br />
CURR HIV RES 2009-JUL; 7 (4): 365-377<br />
IF: 1,978<br />
Loscos J, Tapia G, <strong>de</strong> la Cámara J.<br />
Queratoconjuntivitis límbica superior (Sd. Theodore): estudio clinicopatológico.<br />
ANN OPHTHALMOL 2009;17(3):158-161.<br />
IF: 0,157<br />
Pàgina 14 <strong>de</strong> 67
M Batlle, Quesada MD, Mor<strong>en</strong>o M, JM Ribera.<br />
Brote <strong>de</strong> infección por Blastoschizomyces spp <strong>en</strong> una unidad <strong>de</strong> hematologia. Estúdio <strong>de</strong> 6 casos y hallazgo <strong>de</strong> la fu<strong>en</strong>te <strong>de</strong><br />
infección<br />
MED CLIN-BARCELONA 2009; 10 JUNIO<br />
IF: 1,231<br />
Mack, U; Migliori, GB; Sester, M; Rie<strong>de</strong>r, HL; Ehlers, S; Goletti, D; Bossink, A; Magdorf, K; Holscher, C; Kampmann, B; Ar<strong>en</strong>d, SM;<br />
Detj<strong>en</strong>, A; Bothamley, G; Zellweger, JP; Milburn, H; Diel, R; Ravn, P; Cobel<strong>en</strong>s, F; Cardona, PJ; Kan, B; Solovic, I; Duarte, R; Cirillo,<br />
DM; Lange, C<br />
LTBI: lat<strong>en</strong>t tuberculosis infection or lasting immune responses to M. tuberculosis A TBNET cons<strong>en</strong>sus statem<strong>en</strong>t<br />
EUR RESPIR J 2009; 33:956-973<br />
IF: 5,527<br />
Mallolas, J; Podzamczer, D; Milinkovic, A; Domingo, P; Clotet, B; Ribera, E; Gutierrez, F; Knobel, H; Cosin, J; Ferrer, E; Arranz, JA;<br />
Roca, V; Vidal, F; Murillas, J; Pich, J; Pedrol, E; Llibre, JM; Dalmau, D; Garcia, I; Aranda, M; Cruceta, A; Martinez, E; Blanco, JL; <strong>de</strong><br />
Lazzari, E; Gatell, JM<br />
Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Pati<strong>en</strong>ts With Virological Suppression Receiving<br />
a LPV/r-Containing HAART: The ATAZIP Study<br />
JAIDS-J ACQ IMM DEF 2009; 51:29-36<br />
IF: 4,207<br />
Mañosa M, López San Román A, Garcia-Planella E, Bastida G, Hinojosa J, Gonzalez-Lama Y, Masnou H, Domènech E.<br />
Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.<br />
DIGESTION 2009;80(1):30-5. Epub 2009 May 14.<br />
IF: 1,770<br />
Marin, I; Serra, I; Manosa, M; Cabre, E; Dom<strong>en</strong>ech, E<br />
Psoas abscess as a complication of Crohn's disease: report of three cases and literature review<br />
Gastro<strong>en</strong>terol Hepatol 2009 Oct;32(8):557-61. Epub 2009 Jun 17.<br />
Martínez E, Arranz JA, Podzamczer D, Loncá M, Sanz J, Barragán P, Ribera E, Knobel H, Roca V, Gutiérrez F, Blanco JL, Mallolas J,<br />
Llibre JM, Clotet B, Dalmau D, Segura F, Arribas JR, Cosín J, Barrufet P, Casas E, Ferrer E, Curran A, González A, Pich J, Cruceta A,<br />
Arnaiz JA, Miró JM, Gatell JM; BICOMBO Study Team.<br />
A simplification trial switching from nucleosi<strong>de</strong> reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or<br />
t<strong>en</strong>ofovir/emtricitabine in HIV-1-infected pati<strong>en</strong>ts with virological suppression.<br />
JAIDS-J ACQ IMM DEF 2009 Jul 1;51(3):290-297<br />
IF: 4,207<br />
Michetti, P; Stelle, M; Juillerat, P; Gassull, M; Heil, FJ; Stange, E; Mottet, C; Gonvers, JJ; Pittet, V; Va<strong>de</strong>r, JP; Froehlich, F; Felley, C<br />
Appropriat<strong>en</strong>ess of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II<br />
J CROHNS COLITIS 2009; 3:232-240<br />
IF: 1,729<br />
Miravitlles, M; Marin, A; Monso, E; Vila, S; <strong>de</strong> la Roza, C; Hervas, R; Esquinas, C; Garcia, M; Millares, L; Morera, J; Torres,A<br />
Efficacy of moxifloxacin in the treatm<strong>en</strong>t of bronchial colonisation in COPD<br />
EUR RESPIR J 2009 NOV;34:1066-1071<br />
IF: 5,527<br />
Moltó A, Olivé A<br />
Anti-IL-1 molecules: New comers and new indications<br />
JOINT BONE SPINE 2009 Dec 30. PMID: 20045371<br />
IF: 2,250<br />
Molto, J; Llibre, JM; Ribera, E; Minguez, C; <strong>de</strong>l Rio, JS; Pedrol, E; Vallecillo, G; Ced<strong>en</strong>o, S; Valle, M; Miranda, C; Negredo, E; Clotet,<br />
B<br />
Saquinavir exposure in HIV-infected pati<strong>en</strong>ts with chronic viral hepatitis.<br />
J ANTIMICROB CHEMOTH 2009-MAY; 63 (5): 992-997<br />
IF: 4,352<br />
Morales-Indiano C, Lauzurica R, Pastor MC, Bayés B, Sancho A, Troya M, Romero R.<br />
Pàgina 15 <strong>de</strong> 67
Greater posttransplant inflammation and oxidation are associated with wors<strong>en</strong>ing kidney function in pati<strong>en</strong>ts with pretransplant<br />
diabetes mellitus.<br />
TRANSPL P 2009 Jul-Aug;41(6):2126-8.<br />
IF: 0,994<br />
Mor<strong>en</strong>o, S; Miralles, C; Negredo, E; Domingo, P; Estrada, V; Gutierrez, F; Lozano, F; Martinez, E<br />
Disor<strong>de</strong>rs of Body Fat Distribution in HIV-1-Infected Pati<strong>en</strong>ts<br />
AIDS REV 2009-JUL-SEP; 11 (3): 126-134<br />
IF: 3,786<br />
Munoz-Mor<strong>en</strong>o, JA; Fumaz, CR; Ferrer, MJ; Gonzalez-Garcia, M; Molto, J; Negredo, E; Clotet, B<br />
Neuropsychiatric Symptoms Associated with Efavir<strong>en</strong>z: Preval<strong>en</strong>ce, Correlates, and Managem<strong>en</strong>t. A Neurobehavioral Review<br />
AIDS REV 2009-APR-JUN; 11 (2): 103-109<br />
IF: 3,786<br />
N Gonzalez, B Xicoy, A Olivé, J Jové, JM Ribera.<br />
Systemic lupus eritematosus in a pati<strong>en</strong>t with primary MALT lymphoma of the larinx.<br />
Ear Nose Throat J 2009; 88: E4-E5.<br />
Navarro-Llavat, M; Dom<strong>en</strong>ech, E; Bernal, I; Sanchez-Delgado, J; Manterola, JM; Garcia-Planella, E; Manosa, M; Cabre, E; Gassull,<br />
MA<br />
Prospective, Observational, Cross-Sectional Study of Intestinal Infections among Acutely Active Inflammatory Bowel Disease<br />
Pati<strong>en</strong>ts<br />
DIGESTION 2009;80(1):25-9. Epub 2009 May 14.<br />
IF: 1,770<br />
Nos P; Dom<strong>en</strong>ech E<br />
Apheresis in inflammatory bowel disease<br />
Gastro<strong>en</strong>terol Hepatol 2009 Aug-Sep;32(7):509-18. Epub 2009 Jul 15.<br />
Optimising the Analysis of Stroke Trials (OAST) Collaboration, Gray LJ, Bath PM, Collier T.<br />
Should stroke trials adjust functional outcome for baseline prognostic factors<br />
STROKE 2009 Mar;40(3):888-94. Epub 2009 Jan 22.<br />
IF: 7,041<br />
Ostrowski, M; Lauzurica, R; Morales, J; van Hooff, J<br />
R<strong>en</strong>al function and safety are well-maintained after conversion from twice-daily prograf (r) to once-daily advagraf (r) in stable<br />
kidney transplant pati<strong>en</strong>ts: A phase III study.<br />
TRANSPL INT 2009-AUG; 22: 196-196<br />
IF: 3,254<br />
Pauls, E; Ballana, E; Moncunill, G; Bofill, M; Clotet, B; Ramo-Tello, C; Este, JA<br />
Evaluation of the anti-HIV activity of natalizumab, an antibody against integrin alpha4<br />
AIDS 2009-JAN 14; 23 (2): 266-268<br />
IF: 4,909<br />
Pedro-Botet ML, Yu VL.<br />
Treatm<strong>en</strong>t strategies for Legionella infection.<br />
EXPERT OPIN PHARMACO 2009 May;10(7):1109-21.<br />
IF: 2,018<br />
Pérez <strong>de</strong> la Ossa, N; Millan, M; Ar<strong>en</strong>illas, JF; Sanchez-Ojangur<strong>en</strong>, J; Palomeras, E; Dorado, L; Guerrero, C; Davalos, A<br />
Influ<strong>en</strong>ce of direct admission to Compreh<strong>en</strong>sive Stroke C<strong>en</strong>ters on the outcome of acute stroke pati<strong>en</strong>ts treated with intrav<strong>en</strong>ous<br />
thrombolysis<br />
J NEUROL 2009 AUG;256:1270-1276<br />
IF: 2,903<br />
Pérez-Elias MJ, Sánchez-Con<strong>de</strong> M, Soriano V, Mallolas J, Luque I, Rodríguez-Alcántara F; Fosampr<strong>en</strong>avir Expan<strong>de</strong>d Access Program<br />
Group.<br />
Fosampr<strong>en</strong>avir (GW433908)/ritonavir in HIV-infected pati<strong>en</strong>ts: efficacy and safety results from the Spanish Expan<strong>de</strong>d Access<br />
Program.<br />
Pàgina 16 <strong>de</strong> 67
ENFERM INFEC MICR CL 2009 Jan;27(1):28-32. Epub 2009 Jan 9.<br />
IF: 1,393<br />
Perez-Elias, MJ; Gatell, JM; Flores, J; Santos, J; Vera-Me<strong>de</strong>z, F; Clotet, B; Mor<strong>en</strong>o, A; Perez-Molina, JA; V<strong>en</strong>drell, B; Serrano, O<br />
Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatm<strong>en</strong>t-Experi<strong>en</strong>ced HIV Pati<strong>en</strong>ts<br />
HIV CLIN TRIALS 2009-JUL-AUG; 10 (4): 269-275<br />
IF: 1,626<br />
Podzamczer, D; Ferrer, E; Martinez, E; <strong>de</strong>l Rio, L; Rosales, J; Curto, J; Ribera, E; Barrufet, P; Llibre, JM; Aranda, M<br />
How Much Fat Loss Is Nee<strong>de</strong>d for Lipoatrophy to Become Clinically Evid<strong>en</strong>t<br />
AIDS RES HUM RETROV 2009-JUN; 25 (6): 563-567<br />
IF: 2,178<br />
Podzamczer, D; Soriano, V; Andra<strong>de</strong>-Villanueva, J, Clotet B, Taylor S, Rockstroh J, Domingo P, Reiss P, Gellermann HJ, Cairns V, <strong>de</strong><br />
Rossi L.<br />
Comparison of lipid profile with nevirapine versus atazanavir/ritonavir, both combined with t<strong>en</strong>ofovir DF and emtricitabine<br />
(TDF/FTC), in treatm<strong>en</strong>tnaive HIV-1-infected pati<strong>en</strong>ts: ARTEN study week 48 results.<br />
ANTIVIR THER 2009; 7: A51-A51<br />
IF: 4,322<br />
Porrini, E; Bayes, B; Diaz, JM; Ibernon, M; B<strong>en</strong>itez, R; Dominguez, R; Mor<strong>en</strong>o, JM; Delgado, P; Lauzurica, R; Silva, I; Moreso, F;<br />
Lampreabe, I; Arias, M; Osuna, A; Torres, A<br />
Hyperinsulinemia and Hyperfiltration in R<strong>en</strong>al Transplantation<br />
TRANSPLANTATION 2009-JAN 27; 87 (2): 274-279<br />
IF: 3,498<br />
Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Mor<strong>en</strong>o-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote<br />
EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study<br />
Group.<br />
Peginterferon alfa-2b and ribavirin: effective in pati<strong>en</strong>ts with hepatitis C who failed interferon alfa/ribavirin therapy.<br />
GASTROENTEROLOGY 2009 May;136(5):1618-28.e2. Epub 2009 Jan 22.<br />
IF: 12,899<br />
Puig ll, Carrascosa JM, Daudén E, Sánchez Carazo JL, Ferrándiz C, Sanchez-Regaña M et al.<br />
Docum<strong>en</strong>to <strong>de</strong> cons<strong>en</strong>so sobre evaluación y tratami<strong>en</strong>to <strong>de</strong> la psoriasis mo<strong>de</strong>rada/grave <strong>de</strong>l Grupo <strong>de</strong> Psoriasis <strong>de</strong> la<br />
Aca<strong>de</strong>mia Española <strong>de</strong> Dermatología y V<strong>en</strong>ereología<br />
Actas Dermosifiliogr 2009;100:277-86 (a)<br />
Puig ll, Carrascosa JM, Daudén E, Sánchez Carazo JL, Ferrándiz C, Sanchez-Regaña M et al.<br />
Directrices españolas basadas <strong>en</strong> la evid<strong>en</strong>cia para el tratami<strong>en</strong>to <strong>de</strong> la psoriasis mo<strong>de</strong>rada a grave con ag<strong>en</strong>tes biológicos<br />
Actas Dermosifiliogr 2009;100:386-413 (a)<br />
Pulido, F; Perez-Valero, I; Delgado, R; Arranz, A; Pasquau, J; Portilla, J; Rubio, R; Gonzalez-Garcia, J; Miralles, P; Perez-Elias, MJ;<br />
Ocampo, A; Hernando, A; Estrada, V; Clotet, B; Podzamczer, D; Arribas, JR<br />
Risk factors for loss of virological suppression in pati<strong>en</strong>ts receiving lopinavir/ritonavir monotherapy for maint<strong>en</strong>ance of HIV<br />
suppression<br />
ANTIVIR THER 2009; 14 (2): 195-201<br />
IF: 4,322<br />
Rahier, JF; B<strong>en</strong>-Horin, S; Chowers, Y; Conlon, C; De Munter, P; D'Ha<strong>en</strong>s, G; Dom<strong>en</strong>ech, E; Eliakim, R; Eser, A; Frater, J; Gassull, M;<br />
Giladi, M; Kaser, A; Lemann, M; Moreels, T; Mosch<strong>en</strong>, A; Pollok, R; Reinisch, W; Schunter, M; Stange, EF; Tilg, H; Van Assche, G;<br />
Viget, N; Vucelic, B; Walsh, A; Weiss, G; Yazdanpanah, Y; Zabana, Y; Travis, SPL; Colombel, JF<br />
European evid<strong>en</strong>ce-based Cons<strong>en</strong>sus on the prev<strong>en</strong>tion, diagnosis and managem<strong>en</strong>t of opportunistic infections in inflammatory<br />
bowel disease<br />
J CROHNS COLITIS 2009-JUN; 3 (2): 47-91<br />
IF: 1,729<br />
Rodriguez-Arrondo, F; Aguirreb<strong>en</strong>goa, K; Portu, J; Munoz, J; Garcia, MA; Goikoetxea, J; Martinez, E; Iribarr<strong>en</strong>, JA; Perez-Alvarez, N;<br />
Negredo, E; Clotet, B<br />
Long-Term Effectiv<strong>en</strong>ess and Safety Outcomes in HIV-1-Infected Pati<strong>en</strong>ts After a Median Time of 6 Years on Nevirapine<br />
CURR HIV RES 2009 SEP;7:526-532<br />
IF: 1,978<br />
Pàgina 17 <strong>de</strong> 67
Rodriguez-Yanez, M; Alvarez-Sabin, J; Davalos, A; Diez-Tejedor, E; Castillo, J<br />
Thrombolytic therapy for acute ischemic stroke. Experi<strong>en</strong>ce of SITS (Safe Implem<strong>en</strong>tation of Thrombolysis in Stroke) register<br />
NEUROLOGIA 2009; 24:288-291<br />
IF: 0,596<br />
Rodríguez-Yáñez M, Sobrino T, Blanco M, <strong>de</strong> la Ossa NP, Brea D, Rodríguez-González R, Leira R, Dávalos A, Castillo J.<br />
High serum levels of pro-brain natriuretic pepti<strong>de</strong> (pro BNP) id<strong>en</strong>tify cardioembolic origin in un<strong>de</strong>termined stroke.<br />
DIS MARKERS 2009;26(4):189-95<br />
IF: 2,026<br />
Romero-Gómez M, Diago M, Andra<strong>de</strong> RJ, Calleja JL, Salmerón J, Fernán<strong>de</strong>z-Rodríguez CM, Solà R, García-Samaniego J, Herrerías<br />
JM, De la Mata M, Mor<strong>en</strong>o-Otero R, Nuñez O, Olveira A, Durán S, Planas R; Spanish Treatm<strong>en</strong>t of Resistance to Insulin in Hepatitis<br />
C G<strong>en</strong>otype 1 Group.<br />
Treatm<strong>en</strong>t of insulin resistance with metformin in naïve g<strong>en</strong>otype 1 chronic hepatitis C pati<strong>en</strong>ts receiving peginterferon alfa-2a<br />
plus ribavirin.<br />
HEPATOLOGY 2009 Dec;50(6):1702-8.<br />
IF: 10,840<br />
Roset-Llobell, J; García-Elías, M; Montero, J; Valls-Solé, J; Pascual-Leone, A.<br />
Syndrome, Can It Cause Focal Dystonia<br />
MOVEMENT DISORD 2009; Vol. 24, No. 11<br />
IF: 4,014<br />
Ruiz-Manzano J., Prat C., García-Oliver I., Domínguez J.<br />
Diagnosis and treatm<strong>en</strong>t of pneumococcal pneumonia.<br />
J INFECT DIS 2009; 3: 86-89<br />
IF: 5,865<br />
Saag M, Goodrich J, Fätk<strong>en</strong>heuer G, Clotet B, Clumeck N, Sullivan J, Westby M, van <strong>de</strong>r Ryst E, Mayer H; A4001029 Study Group.<br />
A double-blind, placebo-controlled trial of maraviroc in treatm<strong>en</strong>t-experi<strong>en</strong>ced pati<strong>en</strong>ts infected with non-R5 HIV-1.<br />
J INFECT DIS 2009 Jun 1;199(11):1638-47.<br />
IF: 5,865<br />
Sala M, Morillas RM, Planas R.<br />
Virus <strong>de</strong> la hepatitis C y carcinoma hepatocelular.<br />
Hepatitis Hoy 2009;5:15-23<br />
Sanclem<strong>en</strong>te C., Suárez C., Escu<strong>de</strong>ro D., Pie<strong>de</strong>causa M., Romero J.M., Ceballos A., Ga<strong>de</strong>lha T., Monreal M and the FRENA<br />
Investigators.<br />
G<strong>en</strong><strong>de</strong>r and Outcome in Pati<strong>en</strong>ts with Coronary Cerebrovascular or Peripheral Artery Disease. Findings from the FRENA Registry.<br />
The Op<strong>en</strong> Atherosclerosis & Thrombosis Journal 2009; 2: 45-50<br />
Sancho A, Pastor MC, Troya M, Bonal J, Bayés B, Morales-Indiano C, Lauzurica R, Romero R.<br />
Hepcidin and iron <strong>de</strong>fici<strong>en</strong>cy in pre-kidney transplant pati<strong>en</strong>ts.<br />
TRANSPL P Jul-Aug;41(6):2079-81.<br />
IF: 0,994<br />
Santin, S; Ars, E; Rossetti, S; Salido, E; Silva, I; Garcia-Maset, R; Gim<strong>en</strong>ez, I; Ruiz, P; M<strong>en</strong>dizabal, S; Nieto, JL; P<strong>en</strong>a, A; Camacho, JA;<br />
Fraga, G; Cobo, MA; Bernis, C; Ortiz, A; <strong>de</strong> Pablos, AL; Sanchez-Mor<strong>en</strong>o, A; Pintos, G; Mirapeix, E; Fernan<strong>de</strong>z-Llama, P; Ballarin, J;<br />
Torra, RFSGS Study Grp<br />
TRPC6 mutational analysis in a large cohort of pati<strong>en</strong>ts with focal segm<strong>en</strong>tal glomerulosclerosis<br />
NEPHROL DIAL TRANSPL 2009 OCT;24:3089-3096<br />
IF: 3,306<br />
Santos, JR; Molto, J; Llibre, JM; Perez, N; Capitan, MC; Miranda, C; Clotet, B<br />
Unboosted Atazanavir Plus Co-formulated Lamivudine/Abacavir as a Ritonavir-Sparing Simplification Strategy in Routine<br />
Clinical Practice<br />
HIV CLIN TRIALS 2009-MAY-JUN; 10 (3): 129-134<br />
IF: 1,626<br />
Schusselé Filliettaz S, Juillerat P, Burnand B, Arditi C, Windsor A, Beglinger C, Dubois RW, Peytremann-Bri<strong>de</strong>vaux I, Pittet V,<br />
Pàgina 18 <strong>de</strong> 67
Gonvers JJ, Froehlich F, Va<strong>de</strong>r JP; EPAGE II Study Group.<br />
Appropriat<strong>en</strong>ess of colonoscopy in Europe (EPAGE II). Chronic diarrhea and known inflammatory bowel disease.<br />
ENDOSCOPY 2009 Mar;41(3):218-26. Epub 2009 Mar 11.<br />
IF: 5,545<br />
Serra A, Romero R r<br />
La obesidad como causa <strong>de</strong> <strong>en</strong>fermedad r<strong>en</strong>al<br />
REV ESP OBESIDAD 2009. Vol 7 núm 4. Julio-Agosto: 192-199<br />
Soler-Cataluna, JJ; Calle, M; Cosio, BG; Marin, JM; Monso, E; Alfageme, I<br />
Welfare quality standards in the EPOC<br />
ARCH BRONCONEUMOL 2009-JUL; 45 (7): 361-362 IF: 2,166<br />
Soler-Cataluna, JJ; Calle, M; Cosio, BG; Marin, JM; Monso, E; Alfageme, I<br />
Health-Care Quality Standards in Chronic Obstructive Pulmonary Disease<br />
ARCH BRONCONEUMOL 2009-APR; 45 (4): 196-203<br />
IF: 2,166<br />
Sterry W, Bagot M, Ferrandiz C, Kragballe K, Papp K, Stingl G.<br />
Immunosuppressive therapy in <strong>de</strong>rmatology and PML.<br />
J DTSCH DERMATOL GES 2009 Jan;7(1):5. (a)<br />
IF: 1,403<br />
Teal P, Davis S, Hacke W, Kaste M, Lyd<strong>en</strong> PD; Modified Randomized Exposure Controlled Trial Study Investigators, Fierus M; Bayer<br />
HealthCare AG.<br />
A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and<br />
pharmacokinetic/pharmacodynamic effects of a targeted exposure of intrav<strong>en</strong>ous repinotan in pati<strong>en</strong>ts with acute ischemic<br />
stroke: modified Randomized Exposure Controlled Trial (mRECT).<br />
STROKE 2009 Nov;40(11):3518-25. Epub 2009 Sep 10.<br />
IF: 7,041<br />
Thijs, VNS; Peeters, A; Vosko, M; Aichner, F; Schellinger, PD; Schnei<strong>de</strong>r, D; Neumann-Haefelin, T; Rother, J; Davalos, A; Wahlgr<strong>en</strong>,<br />
N; Verhamme, P<br />
Randomized, Placebo-Controlled, Dose-Ranging Clinical Trial of Intrav<strong>en</strong>ous Microplasmin in Pati<strong>en</strong>ts With Acute Ischemic Stroke<br />
STROKE 2009; 40:3789-3795<br />
IF: 7,041<br />
Toro C, Soriano V; Grupo Español <strong>de</strong> Estudio <strong>de</strong>l VIH-2 y HTLV-1/2.<br />
Human immuno<strong>de</strong>fici<strong>en</strong>cy virus type 2 and human T-cell lymphotropic virus type 1 and type 2 infections in Spain: an update.<br />
ENFERM INFEC MICR CL 2009 Aug-Sep;27(7):377-9. Epub 2009 Apr 9.<br />
IF: 1,393<br />
Tsibris, AMN; Pare<strong>de</strong>s, R; Chadburn, A; Su, ZH; H<strong>en</strong>rich, TJ; Krambrink, A; Hughes, MD; Aberg, JA; Currier, JS; Tashima, K; Godfrey,<br />
C; Greaves, W; Flexner, C; Skolnik, PR; Wilkin, TJ; Gulick, RM; Kuritzkes, DR<br />
Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group<br />
A5211<br />
CLIN INFECT DIS 2009 març-01;48:642-649<br />
IF: 8,195<br />
Vick-Fragoso R, Hernán<strong>de</strong>z-Oliva G, Cruz-Alcázar J, Amábile-Cuevas CF, Arvis P, Reimnitz P, Bogner JR; STIC Study Group.<br />
Efficacy and safety of sequ<strong>en</strong>tial intrav<strong>en</strong>ous/oral moxifloxacin vs intrav<strong>en</strong>ous/oral amoxicillin/clavulanate for complicated skin<br />
and skin structure infections.<br />
INFECTION 2009 Oct;37(5):407-17.<br />
IF: 2,051<br />
Vilas, D; <strong>de</strong> la Ossa, NP; Millan, M; Capella<strong>de</strong>s, J; Davalos, A<br />
Brainstem lesions in diffusion sequ<strong>en</strong>ces of baseline MRI can be reversible after arterial recanalization.<br />
NEUROLOGY 2009-SEP 8; 73 (10): 813-815<br />
IF: 8,172<br />
Y<strong>en</strong>i P, Lamarca A, Berger D, Cimoch P, Lazzarin A, Salvato P, Smaill FM, Teofilo E, Madison SJ, Nichols WG, Adkison KK, Bonny T,<br />
Pàgina 19 <strong>de</strong> 67
Millard J, McCarty D; EPIC (CCR100136) study team.<br />
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve<br />
pati<strong>en</strong>ts: results of the EPIC study (CCR100136).<br />
HIV MED 2009 Feb;10(2):116-24<br />
IF: 2,878<br />
Zabana Y, Barreiro M, Mañosa M, Lor<strong>en</strong>zo A, Cabré E, Domènech E<br />
Cervical dysplasia in immunosupressed IBD wom<strong>en</strong><br />
INFLAMM BOWEL DIS 2009 Jan 14. Epub ahead of print<br />
IF: 4,643<br />
INVESTIGACIÓ TRASLACIONAL<br />
Brumme Z, Wang B, Nair K, Brumme C, <strong>de</strong> Pierres C, Reddy S, Julg B, Moodley E, Thobakgale C, Lu Z, van <strong>de</strong>r Stok M, Bishop K,<br />
Mncube Z, Chonco F, Yuki Y, Frahm N, Bran<strong>de</strong>r C, Carrington M, Freedberg K, Kiepiela P, Goul<strong>de</strong>r P, Walker B, Ndung'u T, Losina E.<br />
Impact of select immunologic and virologic biomarkers on CD4 cell count <strong>de</strong>crease in pati<strong>en</strong>ts with chronic HIV-1 subtype C<br />
infection: results from Sinikithemba Cohort, Durban, South Africa.<br />
CLIN INFECT DIS 2009 Sep 15;49(6):956-964<br />
IF: 8,195<br />
Cardona, PJ<br />
A Dynamic Reinfection Hypothesis of Lat<strong>en</strong>t Tuberculosis Infection<br />
INFECTION 2009; 37:80-86<br />
IF: 2,051<br />
Colobran R, Casamitjana N, Roman A, Faner R, Pedrosa E, Arostegui JI, Pujol-Borrell R, Juan M, Palou E.<br />
Copy number variation in the CCL4L g<strong>en</strong>e is associated with susceptibility to acute rejection in lung transplantation.<br />
GENES IMMUN 2009 Apr;10(3):254-9. Epub 2009 Jan 15.<br />
IF: 4,222<br />
Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hans<strong>en</strong> AB, Horban A, Bruun J, Clotet B, Lundgr<strong>en</strong> JD;<br />
EuroSIDA Study Group.<br />
Rate of accumulation of thymidine analogue mutations in pati<strong>en</strong>ts continuing to receive virologically failing regim<strong>en</strong>s containing<br />
zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.<br />
J INFECT DIS 2009 Sep 1;200(5):687-97.<br />
IF: 5,865<br />
Cu<strong>en</strong>ca-Leon, E; Banchs, I; Serra, SA; Latorre, P; Fernan<strong>de</strong>z-Castillo, N; Corominas, R; Valver<strong>de</strong>, MA; Volpini, V; Fernan<strong>de</strong>z-<br />
Fernan<strong>de</strong>z, JM; Macaya, A; Cormand, B<br />
Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A g<strong>en</strong>e<br />
J NEUROL SCI 2009-MAY 15; 280 (2): 10-14<br />
IF: 2,324<br />
Fellay J, Ge D, Shianna KV, Colombo S, Le<strong>de</strong>rgerber B, Cirulli ET, Urban TJ, Zhang K, Gumbs CE, Smith JP, Castagna A, Cozzi-Lepri A,<br />
De Luca A, Easterbrook P, Günthard HF, Mallal S, Mussini C, Dalmau J, Martinez-Picado J, Miro JM, Obel N, Wolinsky SM,<br />
Martinson JJ, Detels R, Margolick JB, Jacobson LP, Descombes P, Antonarakis SE, Beckmann JS, O'Bri<strong>en</strong> SJ, Letvin NL, McMichael<br />
AJ, Haynes BF, Carrington M, F<strong>en</strong>g S, Tel<strong>en</strong>ti A, Goldstein DB; NIAID C<strong>en</strong>ter for HIV/AIDS Vaccine Immunology (CHAVI).<br />
Common g<strong>en</strong>etic variation and the control of HIV-1 in humans.<br />
PLOS GENET 2009 Dec;5(12):e1000791. Epub 2009 Dec 24.<br />
IF: 9,532<br />
Fumaz CR, Gonzalez-Garcia M, Borras X, Ferrer MJ, Muñoz-Mor<strong>en</strong>o JA, Peña R, Perez-Alvarez N, Puig J, Pare<strong>de</strong>s R, Fernan<strong>de</strong>z-<br />
Castro J, Clotet B.<br />
Increased peripheral proinflammatory cytokines in HIV-1-infected pati<strong>en</strong>ts with prolonged viral suppression suffering from high<br />
psychological stress.<br />
JAIDS-J ACQ IMM DEF 2009 Nov 1;52(3):427-8.<br />
IF: 4,207<br />
Garrabou, G; Mor<strong>en</strong>, C; Gallego-Escuredo, JM; Milinkovic, A; Villarroya, F; Negredo, E; Giralt, M; Vidal, F; Pedrol, E; Martinez, E;<br />
Car<strong>de</strong>llach, F; Gatell, JM; Miro, O<br />
G<strong>en</strong>etic and Functional Mitochondrial Assessm<strong>en</strong>t of HIV-Infected Pati<strong>en</strong>ts Developing HAART-Related Hyperlactatemia<br />
Pàgina 20 <strong>de</strong> 67
JAIDS-J ACQ IMM DEF 2009 DEC 1;52:443-451<br />
IF: 4,207<br />
Gassull, MA<br />
Can nutritional therapy replace pharmacologic therapy in pediatric Crohn's disease<br />
NAT CLIN PRACT GASTR 2009-FEB; 6 (2): 80-81<br />
IF: 4,502<br />
Grifols, JR; Serrano, A; Ester, A; Junca, J; Muniz, E<br />
Vital transfusion in pati<strong>en</strong>ts with multiple antibodies against common erythrocyte antig<strong>en</strong>s<br />
TRANSFUS APHER SCI 2009-APR; 40 (2): 105-107<br />
IF: 0,938<br />
Harris, M; Cote, H; Ochoa, C; Allav<strong>en</strong>a, C; Negredo, E; Thorne, A; Cahn, P; Zala, C; Raffi, F; Clotet, B; Singer, J; Montaner, J<br />
A Randomized, Op<strong>en</strong>-Label Study of a Nucleosi<strong>de</strong> Analogue Reverse Transcriptase Inhibitor-Sparing Regim<strong>en</strong> in Antiretroviral-<br />
Naive HIV-Infected Pati<strong>en</strong>ts<br />
JAIDS-J ACQ IMM DEF 2009-març-01; 50 (3): 335-337<br />
IF: 4,207<br />
Ibarrondo, J; Bran<strong>de</strong>r, C<br />
Profiles of cytotoxic granules in memory CD8 T cells correlate with function, differ<strong>en</strong>tiation stage and antig<strong>en</strong> exposure<br />
FUTURE VIROL 2009; 4:325-328<br />
IF: 0,713<br />
Ibernon, M; Moreso, F; Mor<strong>en</strong>o, JM; Bestard, O; Cruzado, JM; Grinyo, JM; Ricart, W; Fernan<strong>de</strong>z-Real, JM; Seron, D<br />
Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After R<strong>en</strong>al Transplantation<br />
TRANSPLANTATION 2009-jul-27; 88 (2): 272-278<br />
IF: 3,498<br />
Le<strong>de</strong>rman MM, Este J.<br />
Targeting a host elem<strong>en</strong>t as a strategy to block HIV replication: is it nice to fool with Mother Nature<br />
Curr Opin HIV AIDS 2009 Mar;4(2):79-81.<br />
Loggi E, Bihl F, Chisholm JV, Biselli M, Bontadini A, Vitale G, Ercolani G, Grazi GL, D’Pinna A, Bernardi M, Bran<strong>de</strong>r C, Andreone, P<br />
Anti-HBs re-seroconversion after liver transplantation in a pati<strong>en</strong>t with past HBV infection receiving a HBsAg positive graft.<br />
J HEPATOL 2009; 50:625-630<br />
IF: 7,818<br />
López-Hoyos M, Pascual-Salcedo D, Mozo L, Juliá MR, Rodríguez-Mahou M, Almeida D, Alsina M, Vargas ML, Sequí J, Sáez R,<br />
Rodrigo MJ, Carrasco A, Palomino P, Bas J, Plaza A, Barrios Y, Prada A, Castro R, Pastor RM, Marcos J, Fernán<strong>de</strong>z-Pereira L,<br />
Sánchez-Ibarrola A, Rodríguez C, Nocito M, Am<strong>en</strong>gual MJ, Alarcón I, Figueredo MA, Jaímez L, Jim<strong>en</strong>ez J, Serrano A, Ocaña E,<br />
Martínez-Cáceres E, Santamaría M, Villegas N<br />
Large evaluation of anti-cardiolipin and anti-b2 glycoprotein I assays: results from the Autoimmunity workshop of the Spanish<br />
society of Immunology<br />
Inmunología 2009; Vol. 28 / Núm 2/ Abril-Junio 2009: 74-78<br />
Luc<strong>en</strong>a, MI; Martinez, C; Ulzurrun, E; Garcia-Martin, E; Pelaez, G; Romero-Gomez, M; Castiella, A; Planas, R; Guarner, C; Salmeron,<br />
JF; Borraz, Y; Andra<strong>de</strong>, RJ; Agun<strong>de</strong>z, JA<br />
Manganese superoxi<strong>de</strong> dismutase functional polymorphism (sod2 v16a) is a major <strong>de</strong>terminant of idiosyncratic drug-induced liver<br />
injury<br />
BASIC CLIN PHARMACOL 2009-AUG; 105: 77-77<br />
IF: 2,308<br />
Marin-Gall<strong>en</strong> S, Clem<strong>en</strong>te-Casares X, Planas R, Pujol-Autonell I, Carrascal J, Carrillo J, Ampudia R, Verdaguer J, Pujol-Borrell R,<br />
Borràs FE, Vives-Pi M.<br />
D<strong>en</strong>dritic cells pulsed with antig<strong>en</strong>-specific apoptotic bodies prev<strong>en</strong>t experim<strong>en</strong>tal type 1 diabetes.<br />
CLIN EXP IMMUNOL 2009 Dec 17<br />
IF: 3,009<br />
Martínez MA<br />
Progress in the therapeutic applications of siRNAs against HIV-1.<br />
Methods Mol Biol 2009;487:343-68<br />
Pàgina 21 <strong>de</strong> 67
Matamoros, T; Nevot, M; Martinez, MA; M<strong>en</strong><strong>en</strong><strong>de</strong>z-Arias, L<br />
Thymidine analogue resistance suppression by V75I of HIV-1 reverse transcriptase: effects of substituting valine 75 on stavudine<br />
excision and discrimination.<br />
J BIOL CHEM 2009 Nov 20;284(47):32792-802. Epub 2009 Sep 29.<br />
IF: 5,328<br />
Mikhail Popkov , Beatriz Gonzalez , Subhash Sinha , Carlos Barbas, III<br />
Instant immunity through chemically programmable Instant immunity through chemically programmable vaccination and<br />
coval<strong>en</strong>t self-assembly.<br />
P NATL ACAD SCI USA 2009; Mar 17;106(11):4378-83.<br />
IF: 9,432<br />
Mor<strong>en</strong>o, Clotet, Sarría, Ortega, Leal, Rodriguez-Arrondo, Sánchez-<strong>de</strong> la Rosa, Allegro Study Group.<br />
Preval<strong>en</strong>ce of CCR5-tropic HIV-1 among treatm<strong>en</strong>t-experi<strong>en</strong>ced individuals in Spain.<br />
HIV CLIN TRIALS 2009 Nov-Dec;10(6):394-402.<br />
IF: 1,626<br />
Mothe, B; Ibarrondo, J; Llano, A; Bran<strong>de</strong>r, C<br />
Virological, immune and host g<strong>en</strong>etics markers in the control of HIV infection<br />
DIS MARKERS 2009; 27:105-120<br />
IF: 2,026<br />
Navarro-Muñoz M, Pérez V, Ara J, Ibernon M, Bonet J, Bayés B, Pastor MC, Casado J, Serra A, Fluvià L, Núñez A, López D, Romero<br />
R.<br />
Urinary pepti<strong>de</strong> profiling as a possible non-invasive tool for the differ<strong>en</strong>tial diagnosis of glomerular disease.<br />
CLIN J AM SOC NEPHRO 2009;<br />
IF: 4,844<br />
Negredo, E; Miro, O; Rodriguez-Santiago, B; Garrabou, G; Estany, C; Masabeu, A; Force, L; Barrufet, P; Cucurull, J; Domingo, P;<br />
Alonso-Villaver<strong>de</strong>, C; Bonjoch, A; Mor<strong>en</strong>, C; Perez-Alvarez, N; Clotet, B<br />
Improvem<strong>en</strong>t of Mitochondrial Toxicity in Pati<strong>en</strong>ts Receiving a Nucleosi<strong>de</strong> Reverse-Transcriptase Inhibitor-Sparing Strategy:<br />
Results from the Multic<strong>en</strong>ter Study with Nevirapine and Kaletra (MULTINEKA)<br />
CLIN INFECT DIS 2009; 49:892-900<br />
IF: 8,195<br />
Pellitero S, Reverter J-L, Granada ML, Pizarro E, Pastor MC, Tàssies D, Reverter JC, Salinas I, Sanmarti A.<br />
Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the pres<strong>en</strong>ce and the<br />
morphology of carotid plaques in type 2 diabetes mellitus pati<strong>en</strong>ts with stable glycaemic control<br />
EUR J ENDOCRINOL 2009; 160: 925-932.<br />
IF: 3,539<br />
Pujol-Borrell, R; Herrero-Mata, MJ; Palou, E; Arm<strong>en</strong>gol, MP<br />
Immunological S<strong>en</strong>esc<strong>en</strong>ce and Thymic Function in Transplantation<br />
TRANSPLANTATION 2009-AUG 15; 88 (3): S8-S13<br />
IF: 3,498<br />
Reverter JL, Nadal J, Fernán<strong>de</strong>z-Novell JM, Ballester J, Ramió-Lluch L, Rivera MM, Elizal<strong>de</strong> J, Ab<strong>en</strong>goechea S, Guinovart JJ,<br />
Rodríguez-Gil JE.<br />
Tyrosine phosphorylation of vitreous inflammatory and angiog<strong>en</strong>ic pepti<strong>de</strong>s and proteins in diabetic retinopathy.<br />
INVEST OPHTH VIS SCI 2009 Mar;50(3):1378-82. Epub 2008 Oct 31<br />
IF: 3,431<br />
Ricos, C; Perich, C; Minchinela, J; Alvarez, V; Simon, M; Biosca, C; Dom<strong>en</strong>ech, M; Fernan<strong>de</strong>z, P; Jim<strong>en</strong>ez, CV; Garcia-Lario, JV; Cava,<br />
F<br />
Application of biological variation - a review<br />
BIOCHEM MEDICA 2009;19:250-259<br />
IF: 0,660<br />
Sanvis<strong>en</strong>s A, Serra I, Tural C, Tor J, Ojangur<strong>en</strong> I, Barlu<strong>en</strong>ga E, Rey-Joly C, Clotet B, Muga R.<br />
Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in pati<strong>en</strong>ts with chronic hepatitis C virus and human<br />
immuno<strong>de</strong>fici<strong>en</strong>cy virus co-infection.<br />
Pàgina 22 <strong>de</strong> 67
J VIRAL HEPATITIS 2009; 16:513-518<br />
IF: 3,348<br />
Sobrino, T; Arias, S; Rodriguez-Gonzalez, R; Brea, D; Silva, Y; <strong>de</strong> la Ossa, NP; Agulla, J; Blanco, M; Pumar, JM; Ser<strong>en</strong>a, J; Davalos, A;<br />
Castillo, J<br />
High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage<br />
J CEREBR BLOOD F MET 2009; 29:1968-1974<br />
IF: 5,457<br />
Thiebaut, R; Kotti, S; Jung, C; Merlin, F; Colombel, JF; Lemann, M; Almer, S; Tysk, C; O'Morain, M; Gassull, M; Bin<strong>de</strong>r, V; Finkel, Y;<br />
Pascoe, L; Hugot, JP<br />
TNFSF15 Polymorphisms Are Associated With Susceptibility to Inflammatory Bowel Disease in a New European Cohort<br />
AM J GASTROENTEROL 2009-FEB; 104 (2): 384-391<br />
IF: 6,012<br />
van Luin, M; Bannister, WP; Mocroft, A; Reiss, P; Di Perri, G; Peytavin, G; Molto, J; Karlson, A; Castagna, A; B<strong>en</strong>iowski, M;<br />
Lundgr<strong>en</strong>, JD; Burger, DM<br />
Abs<strong>en</strong>ce of a relation betwe<strong>en</strong> efavir<strong>en</strong>z plasma conc<strong>en</strong>trations and toxicity-driv<strong>en</strong> efavir<strong>en</strong>z discontinuations in the EuroSIDA<br />
study<br />
ANTIVIR THER 2009; 14 (1): 75-83<br />
IF: 4,322<br />
Wang YE, Li B, Carlson JM, Streeck H, Gladd<strong>en</strong> AD, Goodman R, Schnei<strong>de</strong>wind A, Power KA, Toth I, Frahm N, Alter G, Bran<strong>de</strong>r C,<br />
Carrington M, Walker BD, Altfeld M, Heckerman D, All<strong>en</strong> TM.<br />
Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in<br />
highly conserved regions of human immuno<strong>de</strong>fici<strong>en</strong>cy virus type 1.<br />
J VIROL 2009 Feb;83(4):1845-55. Epub 2008 Nov 26<br />
IF: 5,150<br />
Projectes<br />
INVESTIGACIÓ BÀSICA<br />
ABAD CAPA, JORGE - PNEUMOLOGIA<br />
SEPAR - Núm. Exp.: 889<br />
Análisis <strong>de</strong> polimorfismos g<strong>en</strong>éticos <strong>en</strong> el f<strong>en</strong>otipo SAHS-Obesidad.<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 12.000 €<br />
ARENILLAS LARA, JUAN FRANCISCO – NEUROLOGIA<br />
FIS - Núm. Exp.: PI070393<br />
Mecanismos básicos implicados <strong>en</strong> el <strong>de</strong>sarrollo y la progresión <strong>de</strong> la aterosclerosis intracraneal asintomática: estudio <strong>de</strong> base<br />
poblacional.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 96.840 €<br />
AUSINA RUIZ, VICENÇ - MICROBIOLOGIA<br />
Ministerio <strong>de</strong> Ci<strong>en</strong>cia e Innovación - Núm. Exp.: TRA2009_0370_02<br />
Validación <strong>de</strong> la <strong>en</strong>capsulación <strong>de</strong> principios activos <strong>en</strong> micro- y nanopartículas y su uso para la fabricación <strong>en</strong> <strong>de</strong>sinfectantes <strong>de</strong><br />
larga duración.<br />
Durada: 3 anys - (2010-2013)<br />
Import Concedit: 68.607 €<br />
BAYES GENIS, BEATRIU - NEFROLOGIA<br />
FIS - Núm. Exp.: PI070349<br />
Papel <strong>de</strong> la autoinmunidad <strong>en</strong> el <strong>de</strong>sarrollo <strong>de</strong> la diabetes mellitus postrasplante r<strong>en</strong>al (DMPT): Marcadores humorales, g<strong>en</strong>éticos<br />
y linfocitos T reguladores.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 62.000 €<br />
Pàgina 23 <strong>de</strong> 67
BLANCO ARBUES, JULIAN MIGUEL - FUNDACIÓ IRSICAIXA<br />
FIPSE - Núm. Exp.: 36600/06<br />
Caracterización <strong>de</strong> la proteasas ejecutoras <strong>de</strong> la muerte celular inducida por VIH.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 81.400 €<br />
BLANCO ARBUES, JULIAN MIGUEL - FUNDACIÓ IRSICAIXA<br />
FIPSE - Núm. Exp.: 36750/08<br />
Evaluación <strong>de</strong> la ad<strong>en</strong>osina <strong>de</strong>saminasa como molécula coestimuladora <strong>de</strong> la actividad linfocitaria <strong>en</strong> una vacuna terapéutica <strong>de</strong>l<br />
VIH.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 27.350 €<br />
BORRAS SERRES, FRANCESC ENRIC - IMMUNOLOGIA / BST / LIRAD<br />
FIS - Núm. Exp.: PI060453<br />
Coordinación <strong>en</strong>tre las células d<strong>en</strong>dríticas mieloi<strong>de</strong>s y plasmacitoi<strong>de</strong>s <strong>en</strong> la g<strong>en</strong>eración <strong>de</strong> la respuesta inmune.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 110.110 €<br />
BRANDER , CHRISTIAN - FUNDACIÓ IRSICAIXA<br />
FIPSE - Núm. Exp.: 36-0737-09<br />
Caracterización <strong>de</strong> los factores inmunológicos, g<strong>en</strong>éticos y virales que <strong>de</strong>terminan la pérdida <strong>de</strong>l control <strong>de</strong> la infección por el VIH<br />
<strong>en</strong><br />
la población <strong>de</strong> progresores l<strong>en</strong>tos (LTNP)<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 148.700 €<br />
CABRERA NAVARRO, CECILIA - FUNDACIÓ IRSICAIXA<br />
FIPSE - Núm. Exp.: 36725/08<br />
Caracterización <strong>de</strong> los factores virales e inmunológicos que proteg<strong>en</strong> las células CD4 <strong>en</strong> paci<strong>en</strong>tes VIH+ sin tratami<strong>en</strong>to que<br />
pres<strong>en</strong>tan niveles <strong>de</strong> CD4 constantes y replicación viral elevada.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 81.455 €<br />
ESTE ARAQUE, JOSE ANDRES - FUNDACIÓ IRSICAIXA<br />
FIS - Núm. Exp.: PI060624<br />
Integrinas <strong>en</strong> la infección viral.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 89.540 €<br />
GASULL DALMAU, TERESA - NEUROLOGIA<br />
MEC - Núm. Exp.: SAF2007-62559<br />
Papel <strong>de</strong> los rafts lipídicos <strong>en</strong> la neuro<strong>de</strong>g<strong>en</strong>eración producida por la excesiva activación <strong>de</strong> los receptores glutamatérgicos:<br />
protección por estatinas.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 76.000 €<br />
GASULL DALMAU, TERESA - NEUROLOGIA<br />
Pfizer - Núm. Exp.: ---<br />
Atorvastatin and one of its specific matabolites might protect from NMDA-Induced neuronal <strong>de</strong>ath by altering the association of<br />
NMDA receptors to lipids rafts.<br />
Durada: 2 anys - (2007-2009)<br />
Import Concedit: 45.558,9 €<br />
MAÑE ALMERO, JOSEP - APARELL DIGESTIU<br />
MEC - Núm. Exp.: BFU2006-15063-C03-02-BFI<br />
Activación <strong>de</strong> TLR-2 y función barrera <strong>en</strong> el colon. Caracterización <strong>de</strong> los mecanismos moleculares y celulares implicados.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 60.500 €<br />
MARTINEZ CACERES, EVA MARIA - IMMUNOLOGIA / BST / LIRAD<br />
Fundació La Marató <strong>de</strong> TV3 - Núm. Exp.: 072410<br />
Pàgina 24 <strong>de</strong> 67
TOLERVIP-MS: inducció <strong>de</strong> tolerància <strong>en</strong> esclerosi múltiple amb cèl·lules d<strong>en</strong>drítiques tracta<strong>de</strong>s amb pèptid intestinal vasoactiu i<br />
carrega<strong>de</strong>s amb pèptids <strong>de</strong> la mielina.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 159.871 €<br />
MARTINEZ CACERES, EVA MARIA - IMMUNOLOGIA / BST / LIRAD<br />
Fundació GAEM - Núm. Exp.: 01032007<br />
Tolervip-MS: Inducció <strong>de</strong> tolerància <strong>en</strong> Esclerosi múltiple amb cèl·lules d<strong>en</strong>drítiques tracta<strong>de</strong>s amb pèptid intestinal vasoactiu i<br />
carrega<strong>de</strong>s amb pètids <strong>de</strong> la mielina.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 45.000 €<br />
MARTINEZ DE LA SIERRA, MIGUEL ANGEL - FUNDACIÓ IRSICAIXA<br />
FIS - Núm. Exp.: PI070098<br />
Mutagénesis letal <strong>de</strong>l VIH-1 como una nueva estrategia antirretroviral.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 171.000 €<br />
MARTINEZ PICADO, JAVIER - FUNDACIÓ IRSICAIXA<br />
FIPSE - Núm. Exp.: 36621/06<br />
SLC22 y SLC21: Nuevos g<strong>en</strong>es implicados <strong>en</strong> el transporte celular <strong>de</strong> fármacos antirretrovirales <strong>en</strong> linfocitos.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 87.287 €<br />
MATILLA DUEÑAS, ANTONI - NEUROLOGIA<br />
Ministerio <strong>de</strong> Educación y Ci<strong>en</strong>cia - Núm. Exp.: BFU2008-00527<br />
Id<strong>en</strong>tificación <strong>de</strong> g<strong>en</strong>es y rutas moleculares directam<strong>en</strong>te reguladas por ataxina_1.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 95.000 €<br />
MATILLA DUEÑAS, ANTONI - NEUROLOGIA<br />
COMISSIÓ EUROPEA - Núm. Exp.: LHSM-CT-2004-503304<br />
European integrated project on spinocerebellar ataxias (EUROSCA): Pathog<strong>en</strong>esis, g<strong>en</strong>etics, animal mo<strong>de</strong>ls and therapy.<br />
Durada: 5 anys - (2004-2009)<br />
Import Concedit: 50.000 €<br />
MATILLA DUEÑAS, ANTONI - NEUROLOGIA<br />
FIS - Núm. Exp.: CP08/00027<br />
Investigación <strong>de</strong> las bases moleculares neuro<strong>de</strong>g<strong>en</strong>erativas <strong>en</strong> la ataxia espinocerebelosa tipo 1 (SCA1)<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 34.516,5 €<br />
PLANAS VILA, RAMON - APARELL DIGESTIU<br />
FIS - Núm. Exp.: PI080809<br />
Bloqueo <strong>de</strong>l receptor <strong>de</strong> <strong>en</strong>docanabinoi<strong>de</strong>s CB1 por SR141716A <strong>en</strong> ratas cirróticas con ascitis. Efecto sobre la progresión a cirrosis,<br />
la hipert<strong>en</strong>sión portal, translocación bacteriana y <strong>en</strong>cefalopatía.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 32.400 €<br />
ROLDAN SANCHEZ, JUAN - PNEUMOLOGIA<br />
FIS - Núm. Exp.: PI070228<br />
Mecanismos G<strong>en</strong>éticos y Celulares <strong>en</strong> Fibrosis Pulmonar.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 79.000 €<br />
SANMARTI SALA, ANNA - ENDOCRINOLOGIA I NUTRICIÓ<br />
FIS - Núm. Exp.: PI051510<br />
Mecanismos patogénicos implicados <strong>en</strong> la aparición <strong>de</strong> <strong>en</strong>fermedad autoinmunitaria tiroi<strong>de</strong>a. Células reguladoras y señales<br />
moleculares <strong>de</strong> peligro.<br />
Durada: 4 anys - (2005-2009)<br />
Import Concedit: 43.000 €<br />
Pàgina 25 <strong>de</strong> 67
SARRIAS FORNÉS, MARIA ROSA - IMMUNOLOGIA IGTP<br />
FIS - Núm. Exp.: CP08/00124<br />
Papel <strong>de</strong> las proteínas scav<strong>en</strong>ger Spalpha/AIM <strong>en</strong> la respuesta <strong>de</strong>l huésped a la infección bacteriana.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 34.711 €<br />
SARRIAS FORNÉS, MARIA ROSA - IMMUNOLOGIA IGTP<br />
FIS - Núm. Exp.: PI070036<br />
Estudio <strong>de</strong> las propieda<strong>de</strong>s inmunoreguladoras <strong>de</strong> la proteína scav<strong>en</strong>ger Sp_ <strong>en</strong> la respuesta anti-infecciosa.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 148.000 €<br />
VIVES PI, MARTA - IMMUNOLOGIA / BST / LIRAD<br />
FIS - Núm. Exp.: PI060465<br />
Papel <strong>de</strong> Reg (Reg<strong>en</strong>erating g<strong>en</strong>e) como nuevo autoantíg<strong>en</strong>o, marcador <strong>de</strong> autoinmunidad y <strong>de</strong> reg<strong>en</strong>eración celular <strong>en</strong> la<br />
diabetes tipo 1.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 68.970 €<br />
INVESTIGACIÓ CLÍNICA<br />
CARDONA IGLESIAS, PERE JOAN - MICROBIOLOGIA<br />
BILL & MELINDA GATES FOUNDATION - Núm. Exp.: 37885<br />
Preclinical and clinical evaluation of a post-exposure TB vaccine (proposal no.82)<br />
Durada: 5 anys - (2005-2010)<br />
Import Concedit: 320.200 €<br />
CASABONA BARBARA, JORDI - CEEISCAT<br />
COMISSIÓ EUROPEA - Núm. Exp.: 20091211<br />
HIV community-based testing practices in Europe. HIV-COBATEST.<br />
Durada: 3 anys - (2010-2013)<br />
Import Concedit: 142.174 €<br />
DOMINGUEZ BENITEZ, JOSE ANTONIO - MICROBIOLOGIA<br />
FUCAP - Núm. Exp.: --<br />
Utilidad <strong>de</strong> la cuantificación <strong>de</strong> linfócitos T s<strong>en</strong>sibilizados fr<strong>en</strong>te a antíg<strong>en</strong>os específicos <strong>de</strong> mycobacterium tuberculosis pres<strong>en</strong>tes<br />
<strong>en</strong> lavado broncoalveolar para el diagnóstico <strong>de</strong> la tuberculosis pulmonar.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 12.020 €<br />
DOMINGUEZ BENITEZ, JOSE ANTONIO - MICROBIOLOGIA<br />
B•R•A•H•M•S Akti<strong>en</strong>gesellschaft - Núm. Exp.: ---<br />
Clinical Evaluation of the In Vitro Diagnostic Product BRAHMS PCT direct<br />
Durada: 2 anys - (2008-2010)<br />
Import Concedit: 2.000 €<br />
LAUZURICA VALDEMOROS, RICARDO - NEFROLOGIA<br />
FIS - Núm. Exp.: EC07/90472<br />
Estudio piloto <strong>de</strong> selección <strong>de</strong>l regim<strong>en</strong> inmunosupresor basado <strong>en</strong> anti-calcineurinico o libre <strong>de</strong> anti-calcineurinico <strong>de</strong>p<strong>en</strong>di<strong>en</strong>do<br />
<strong>de</strong> la aloreactividad celular donante-específica mediante técnica <strong>de</strong> elispot <strong>en</strong> receptores <strong>de</strong> un injerto redal <strong>de</strong> bajo riesgo.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 5.700 €<br />
MILLAN TORNE, MONICA - NEUROLOGIA<br />
FIS - Núm. Exp.: PS09/01638<br />
Efecto <strong>de</strong> la recanalización arterial y <strong>de</strong>l postcondicionami<strong>en</strong>to isquémico sobre el daño por reperfusión <strong>en</strong> paci<strong>en</strong>tes con<br />
oclusión proximal <strong>de</strong> la arteria cerebral media<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 152.500 €<br />
MONSO MOLAS, EDUARD - PNEUMOLOGIA<br />
FIS - Núm. Exp.: PI060684<br />
Pàgina 26 <strong>de</strong> 67
Caracterización y efectos <strong>de</strong> la inflamación y colonización bronquial <strong>en</strong> la <strong>en</strong>fermedad pulmonar obstructiva crónica.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 87.120 €<br />
MONSO MOLAS, EDUARD - PNEUMOLOGIA<br />
<strong>Institut</strong>o <strong>de</strong> Salud Carlos III - Núm. Exp.: GR09/0001<br />
La gripe pandémica A/H1N1 <strong>en</strong> España. Caracterización clínica y biológica. Un estudio piloto <strong>en</strong> 5 hospitales (Estudio 5H).<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 0 €<br />
ROMEU FONTANILLAS, JOAN - MEDICINA INTERNA - VIH<br />
FIS - Núm. Exp.: EC07/90672<br />
Tratami<strong>en</strong>to antirretroviral una vez al día <strong>en</strong> paci<strong>en</strong>tes con infección por el VIH-1 no tratados previam<strong>en</strong>te y con cifras <strong>de</strong><br />
linfocitos CD$+ inferioresa 100 cel/MM3. Estudio prospectivo aleatorizado, multicéntrico y abierto. Estudio ADVANZ-3.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 8.000 €<br />
INVESTIGACIÓ TRASLACIONAL<br />
ABAD ESTEVE, ALBERT - ONCOLOGIA MÈDICA<br />
FIS - Núm. Exp.: PS09/01463<br />
Implicación <strong>de</strong> los TLRS <strong>en</strong> la tumorogénesis intestinal: Determinación <strong>de</strong> biomarcadores humanos, validación <strong>de</strong>l mo<strong>de</strong>lo animal<br />
y análisis <strong>de</strong> perfiles g<strong>en</strong>éticos por micromatrices.<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 46.500 €<br />
BALIBREA DEL CASTILLO, JOSÉ MARÍA - CIRURGIA GENERAL I DIGESTIVA<br />
FIS - Núm. Exp.: PS09/00759<br />
Estudio comparativo <strong>de</strong> la respuesta inflamatoria local y sistémica tras gastrectomía abierta o laparoscópica por cáncer<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 51.000 €<br />
BEYER , KATRIN - ANATOMIA PATOLÒGICA<br />
Fundació La Marató <strong>de</strong> TV3 - Núm. Exp.: 06/1410<br />
Expressió difer<strong>en</strong>cial d’isoformes d’alfa-sinucleïna: un possible marcador <strong>en</strong> sang perifèrica <strong>de</strong> la malaltia <strong>de</strong> Parkinson.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 108.700 €<br />
BEYER , KATRIN - ANATOMIA PATOLÒGICA<br />
Ministerio <strong>de</strong> Ci<strong>en</strong>cia e Innovación - Núm. Exp.: CP09/00102<br />
Expresión difer<strong>en</strong>cial <strong>de</strong> isoformas <strong>de</strong> beta-sinucleína <strong>en</strong> cerebro y su <strong>de</strong>tección <strong>en</strong> sangre como posible biomarcador diagnóstico<br />
para la <strong>en</strong>fermedad <strong>de</strong> Parkinson<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 44.900 €<br />
BLANCO ARBUES, JULIAN MIGUEL - FUNDACIÓ IRSICAIXA<br />
FIS - Núm. Exp.: PI081306<br />
Herrami<strong>en</strong>tas para la cuantificación <strong>de</strong> la respuesta humoral protectiva contra las proteínas gp120 y gp41 <strong>de</strong>l VIH. Análisis <strong>de</strong><br />
indicadores <strong>de</strong> protección y diseño racional <strong>de</strong> inmunóg<strong>en</strong>os.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 61.200 €<br />
BOFILL SOLIGUER, MARGARITA - FUNDACIÓ IRSICAIXA<br />
FIS - Núm. Exp.: PI081308<br />
Impacto <strong>de</strong> la infección por el VIH sobre acción <strong>de</strong> la IL-12 e IL-18 sobre monocitos y macrófagos: relevancia sobre el control <strong>de</strong><br />
Mycobacterium tuberculosis y Mycobacterium avium.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 77.100 €<br />
BORRAS SERRES, FRANCESC ENRIC - IMMUNOLOGIA / BST / LIRAD<br />
FIS - Núm. Exp.: PS09/00229<br />
Estrategias para la inducción <strong>de</strong> tolerancia y prev<strong>en</strong>ción <strong>de</strong> la Nefropatía Crónica <strong>de</strong>l Transplante. SUBPROYECTO 2: Evaluación <strong>de</strong>l<br />
Pàgina 27 <strong>de</strong> 67
uso <strong>de</strong> exosomas obt<strong>en</strong>idos <strong>de</strong> fluidos biológicos como aloantíg<strong>en</strong>os para la inducción <strong>de</strong> tolerancia <strong>en</strong> trasplante<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 76.500 €<br />
CABRE GELADA, EDUARD - APARELL DIGESTIU<br />
FIS - Núm. Exp.: PS09/01294<br />
Perfil g<strong>en</strong>ético funcional <strong>en</strong> la <strong>en</strong>fermedad <strong>de</strong> CROHN. Efecto sobre el <strong>de</strong>sarrollo <strong>de</strong> recurr<strong>en</strong>cia post-quirúrgica<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 76.000 €<br />
CABRERA NAVARRO, CECILIA - FUNDACIÓ IRSICAIXA<br />
FIS - Núm. Exp.: PI070418<br />
Efecto <strong>de</strong>l tratami<strong>en</strong>to con T-20 <strong>en</strong> las funciones <strong>de</strong> la <strong>en</strong>vuelta viral: relaciones <strong>de</strong> fusog<strong>en</strong>icidad, patog<strong>en</strong>icidad e infectividad <strong>en</strong><br />
virus T-20-resist<strong>en</strong>tes.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 139.258 €<br />
CARDONA IGLESIAS, PERE JOAN - MICROBIOLOGIA<br />
COMISSIÓ EUROPEA - Núm. Exp.: 200999<br />
LATENT TUBERCULOSIS: New tools for the <strong>de</strong>tection and clearance of dormant Mycobacterium tuberculosis. (StopLATENT-TB)<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 310.160 €<br />
CARDONA IGLESIAS, PERE JOAN - MICROBIOLOGIA<br />
FIS - Núm. Exp.: PI080785<br />
Demostración <strong>de</strong> la hipótesis dinámica <strong>de</strong> la infección tuberculosa lat<strong>en</strong>te.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 157.450 €<br />
CARDONA IGLESIAS, PERE JOAN - MICROBIOLOGIA<br />
Comissió Europea - Núm. Exp.: CURE TB<br />
New Drugs to Cure TB: Pre-clinical Validation of Optimised Drug leads for the Treatm<strong>en</strong>t and Cure of Resistant and Persist<strong>en</strong>t<br />
Tuberculosis.<br />
Durada: 3 anys - (2010-2013)<br />
Import Concedit: 60.000 €<br />
DAVALOS ERRANDO, ANTONI - NEUROLOGIA<br />
FIS - Núm. Exp.: PI060788<br />
Sobrecarga <strong>de</strong> hierro y toxicidad neurovascular: Estudio clínico y experim<strong>en</strong>tal <strong>en</strong> la isquémia y reperfusión cerebral.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 141.570 €<br />
DAVALOS ERRANDO, ANTONI - NEUROLOGIA<br />
CIDEM - Núm. Exp.: RDITSCON07-4-2006<br />
Diss<strong>en</strong>y <strong>de</strong> mo<strong>de</strong>ls per al <strong>de</strong>s<strong>en</strong>volupam<strong>en</strong>t <strong>de</strong> noves Teràpies Neuro reparadores e Ictus.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 371.514 €<br />
DOMINGUEZ BENITEZ, JOSE ANTONIO - MICROBIOLOGIA<br />
SEPAR - Núm. Exp.: --<br />
Utilidad <strong>de</strong> la cuantificación <strong>de</strong> linfocitos T s<strong>en</strong>sibilizados fr<strong>en</strong>te a antíg<strong>en</strong>os específicos <strong>de</strong> Mycobacterium tuberculosis <strong>en</strong> la<br />
monitorización <strong>de</strong>l tratami<strong>en</strong>to <strong>de</strong> la tuberculosis y <strong>de</strong> la profilaxis <strong>de</strong> la infección tuberculosa.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 65.000 €<br />
DOMINGUEZ BENITEZ, JOSE ANTONIO - MICROBIOLOGIA<br />
FIS - Núm. Exp.: PI070551<br />
Detección, id<strong>en</strong>tificación <strong>de</strong> Mycobacterium tuberculosis, caracterización molecular <strong>de</strong> la resist<strong>en</strong>cia a los principales<br />
antituberculosos <strong>en</strong> muestra clínica directa mediante pirosecu<strong>en</strong>ciación. Aplicabilidad <strong>en</strong> el estudio <strong>de</strong> la clonalidad <strong>de</strong> las cepas.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 117.960 €<br />
Pàgina 28 <strong>de</strong> 67
DOMINGUEZ BENITEZ, JOSE ANTONIO - MICROBIOLOGIA<br />
SEPAR - Núm. Exp.: 47<br />
Utilidad <strong>de</strong> la pirosecu<strong>en</strong>ciación <strong>en</strong> la <strong>de</strong>tección, id<strong>en</strong>tificación <strong>de</strong> Mycobacterium tuberculosis y caracterización molecular <strong>de</strong> la<br />
resist<strong>en</strong>cia a los principales antituberculosos <strong>en</strong> muestra clínica directa.<br />
Durada: 4 anys - (2007-2011)<br />
Import Concedit: 9.000 €<br />
IBARRONDO VALLEJO, FRANCISCO JAVIER - FUNDACIÓ IRSICAIXA<br />
FIS - Núm. Exp.: PS09/00283<br />
Definition of protective immunity to HIV using Toggled pepti<strong>de</strong>s<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 106.500 €<br />
MARTINEZ BALIBREA, EVA - ONCOLOGIA MÈDICA<br />
Fundación Privada Olga Torres - Núm. Exp.: FOT 2009-2011<br />
Estudio <strong>de</strong>l papel <strong>de</strong> la isoforma M2 <strong>de</strong> Piruvato quinasa (PK-M2) <strong>en</strong> la respuesta y resist<strong>en</strong>cia a oxaliplatino <strong>en</strong> líneas celulares y<br />
paci<strong>en</strong>tes con cáncer colorrectal avanzado.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 60.000 €<br />
MARTRO CATALA, ELISA - MICROBIOLOGIA<br />
Ministerio <strong>de</strong> Ci<strong>en</strong>cia e Innovación - Núm. Exp.: CP09/00044<br />
Impacto <strong>de</strong> la variabilidad g<strong>en</strong>ética <strong>de</strong>l VHC-1 y <strong>de</strong> los cofactores <strong>de</strong>l hospedador basales <strong>en</strong> la probabilidad <strong>de</strong> respuesta a la<br />
teràpia antivírica combinada <strong>de</strong> la hepatitis C crónica.<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 44.800 €<br />
PUJOL BORRELL, RICARDO - IMMUNOLOGIA / BST / LIRAD<br />
FIS - Núm. Exp.: PI081405<br />
Fisiopatología y diagnóstico <strong>de</strong> las <strong>en</strong>fermeda<strong>de</strong>s autoinmunes: Tiroiditis, Diabetes y Esclerosis Múltiple, un abordaje inspirado <strong>en</strong><br />
la biologia <strong>de</strong> sistemas.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 62.200 €<br />
ROMERO GONZALEZ, RAMÓN - NEFROLOGIA<br />
FIS - Núm. Exp.: PI060878<br />
Aplicaciones clínico-diagnósticas <strong>de</strong> la proteómica <strong>en</strong> las nefropatías glomerulares proteinúricas.<br />
Durada: 4 anys - (2006-2010)<br />
Import Concedit: 73.205 €<br />
RUIZ MANZANO, JOAN - PNEUMOLOGIA<br />
SOCAP - Núm. Exp.:<br />
Estudi <strong>de</strong> la utilitat <strong>de</strong> la <strong>de</strong>terminació dual <strong>de</strong>l número <strong>de</strong> cèl•lules T productores d’interferó gamma i interleuquina 2 <strong>en</strong> la<br />
monitorització <strong>de</strong>l tractam<strong>en</strong>t <strong>de</strong> la tuberculosi i <strong>de</strong> la profilaxi <strong>de</strong> la infecció tuberculosa.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 19.500 €<br />
SARRIAS FORNÉS, MARIA ROSA - IMMUNOLOGIA IGTP<br />
Fundació La Marató <strong>de</strong> TV3 - Núm. Exp.: 080932<br />
Mecanismes moleculars implicats <strong>en</strong> la prev<strong>en</strong>ció <strong>de</strong> l'aterosclerosi mediada per LXR I RXR. subprojecte 3: Paper d´aim <strong>en</strong><br />
l´activació <strong>de</strong>l macròfag i <strong>de</strong>s<strong>en</strong>volupam<strong>en</strong>t <strong>de</strong> cèl.lules espumoses.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 127.205,78 €<br />
SOLDEVILA MADORELL, BERTA - ENDOCRINOLOGIA I NUTRICIÓ<br />
Societat Catalana d'Endocrinologia i Nutrició - Núm. Exp.:<br />
Mecanismes patogènics implicats <strong>en</strong> l’aparició <strong>de</strong> malaltia autoimmunitària tiroïdal <strong>en</strong> paci<strong>en</strong>ts amb melanoma maligne tractats<br />
amb interferó-alfa. Paper <strong>de</strong> les cèl·lules T reguladores.<br />
Durada: 1 anys - (2009-2010)<br />
Import Concedit: 6.000 €<br />
TOR AGUILERA, JORDI - MEDICINA INTERNA - DESINTOXICACIÓ<br />
Pàgina 29 <strong>de</strong> 67
FIS - Núm. Exp.: PI051550<br />
Evaluación no invasiva <strong>de</strong> la fibrosis hepática <strong>en</strong> paci<strong>en</strong>tes coinfectados por el VHC y VIH. Correlación <strong>de</strong>l patrón histológico con la<br />
<strong>de</strong>terminación <strong>de</strong> proteinas relacionadas con la formación <strong>de</strong> la matriz extracelular.<br />
Durada: 4 anys - (2005-2009)<br />
Import Concedit: 65.600 €<br />
VIVES PI, MARTA - IMMUNOLOGIA / BST / LIRAD<br />
FIS - Núm. Exp.: PS09/00253<br />
Prev<strong>en</strong>ción y remisión <strong>de</strong> la diabetes tipo 1 mediante inmunoterapia con células d<strong>en</strong>dríticas autólogas pulsadas con cuerpos<br />
apoptoticos antíg<strong>en</strong>o específicos<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 80.500 €<br />
Pàgina 30 <strong>de</strong> 67
CÀNCER<br />
Publicacions<br />
INVESTIGACIÓ BÀSICA<br />
Arm<strong>en</strong>gol C, Cairo S, Fabre M, Bu<strong>en</strong>dia MA.<br />
Wnt signaling and hepatocarcinog<strong>en</strong>esis: The hepatoblastoma mo<strong>de</strong>l.<br />
INT J BIOCHEM CELL B 2009 Jul 29. [Epub ahead of print]<br />
IF: 4,887<br />
Baranovskaya S, Martin Y, Alonso S, Pisarchuk KL, Falchetti M, Dai Y, Khaldoyanidi S, Krajewski S, Novikova I, Sidor<strong>en</strong>ko YS,<br />
Perucho M, Malkhosyan SR.<br />
Down-regulation of epi<strong>de</strong>rmal growth factor receptor by selective expansion of a 5'-<strong>en</strong>d regulatory dinucleoti<strong>de</strong> repeat in colon<br />
cancer with microsatellite instability.<br />
CLIN CANCER RES 2009 Jul 15;15(14):4531-7.<br />
IF: 6,747<br />
Buschbeck M, Uribesalgo I, Wibowo I, Rué P, Martin D, Gutierrez A, Morey L, Guigó R, López-Schier H, Di Croce L.<br />
The histone variant macroH2A is an epig<strong>en</strong>etic regulator of key <strong>de</strong>velopm<strong>en</strong>tal g<strong>en</strong>es.<br />
NAT STRUCT MOL BIOL 2009 Oct;16(10):1074-9. Epub 2009 Sep 6.<br />
IF: 12,273<br />
Carbajosa G, Trigo A, Val<strong>en</strong>cia A, Cases I.<br />
Bionemo: molecular information on bio<strong>de</strong>gradation metabolism.<br />
NUCLEIC ACIDS RES 2009 Jan;37(Database issue):D598-602. Epub 2008 Nov 5.<br />
IF: 7,479<br />
Mayor R, Casadomé L, Azuara D, Mor<strong>en</strong>o V, Clark SJ, Capellà G, Peinado MA.<br />
Long-range epig<strong>en</strong>etic sil<strong>en</strong>cing at 2q14.2 affects most human colorectal cancers and may have application as a non invasive<br />
biomarker of disease.<br />
BRIT J CANCER 2009 May 19;100(10):1534-9. Epub 2009 Apr 21.<br />
IF: 4,346<br />
Miller SJ, Jess<strong>en</strong> WJ, Mehta T, Hardiman A, Sites E, Kaiser S, Jegga AG, Li H, Upadhyaya M, Giovannini M, Muir D, Wallace MR,<br />
Lopez E, Serra E, Niels<strong>en</strong> GP, Lazaro C, Stemmer-Rachamimov A, Page G, Aronow BJ, Ratner N.<br />
Integrative g<strong>en</strong>omic analyses of neurofibromatosis tumours id<strong>en</strong>tify SOX9 as a biomarker and survival g<strong>en</strong>e.<br />
EMBO MOL MED 2009 Jul;1(4):236-48.<br />
IF: 0,000<br />
Morales C, García MJ, Ribas M, Miró R, Muñoz M, Caldas C, Peinado MA.<br />
DHFR amplification and s<strong>en</strong>sitization to methotrexate of methotrexate resistant colon cancer cells. Molecular Cancer<br />
Therapeutics.<br />
MOL CANCER THER 2009; 8:424-432<br />
IF: 4,953<br />
Pros E, Fernán<strong>de</strong>z-Rodríguez J, B<strong>en</strong>ito L, Ravella A, Capellá G, Blanco I, Serra E, Lázaro C.<br />
Modulation of aberrant NF1 pre-mRNA splicing by kinetin treatm<strong>en</strong>t.<br />
EUR J HUM GENET 2009 Nov 25. [Epub ahead of print]<br />
IF: 3,564<br />
Pros E, Fernán<strong>de</strong>z-Rodríguez J, Canet B, B<strong>en</strong>ito L, Sánchez A, B<strong>en</strong>avi<strong>de</strong>s A, Ramos FJ, López-Ariztegui MA, Capellá G, Blanco I, Serra<br />
E, Lázaro C.<br />
Antis<strong>en</strong>se therapeutics for neurofibromatosis type 1 caused by <strong>de</strong>ep intronic mutations.<br />
HUM MUTAT 2009 Mar; 30(3):454-62.<br />
Pàgina 31 <strong>de</strong> 67
IF: 6,887<br />
Rangel A, Madroñal N, Gruart i Massó A, Gavín R, Llor<strong>en</strong>s F, Sumoy L, Torres JM, Delgado-García JM, Del Río JA.<br />
Regulation of GABA(A) and glutamate receptor expression, synaptic facilitation and long-term pot<strong>en</strong>tiation in the hippocampus of<br />
prion mutant mice.<br />
PLOS ONE 2009 Oct 26;4(10):e7592.<br />
IF: 4,351<br />
Rosell, R<br />
BRCA1 g<strong>en</strong>e and s<strong>en</strong>sitivity to lung cancer chemotherapy<br />
J THORAC ONCOL 2009-SEP; 4 (9): S53-S54<br />
IF: 4,547<br />
Rosell, R; Moran, T; Queralt, C; Porta, R; Card<strong>en</strong>al, F; Camps, C; Majem, M; Lopez-Vivanco, G; Isla, D; Prov<strong>en</strong>cio, M; Insa, A;<br />
Massuti, B; Gonzalez-Larriba, JL; Paz-Ares, L; Bover, I; Garcia-Campelo, R; Mor<strong>en</strong>o, MA; Catot, S; Rolfo, C; Reguart, N; Palmero, R;<br />
Sanchez, JM; Bastus, R; Mayo, C; Bertran-Alamillo, J; Molina, MA; Sanchez, JJ; Taron, M<br />
Scre<strong>en</strong>ing for Epi<strong>de</strong>rmal Growth Factor Receptor Mutations in Lung Cancer.<br />
NEW ENGL J MED 2009-SEP 3; 361 (10): 958-U38<br />
IF: 47,050<br />
Rosell, R; Ramirez, JL; <strong>de</strong> Aguirre, I; B<strong>en</strong>lloch, S; Cuello, M; Cardona, AF; Moran, T; Carcer<strong>en</strong>y, E; Massuti, B; Taron, M;<br />
Gonzalez, N; Porta, R<br />
The nicotinic acetylcholine receptor (nAChR) subunit alpha3 (CHRNA3) polymorphism in advanced non-small-cell lung cancer<br />
(NSCLC) pati<strong>en</strong>ts (p) with EGFR mutations treated with erlotinib<br />
J THORAC ONCOL 2009-SEP; 4 (9): S538-S538<br />
IF: 4,547<br />
Rosell, R; Wei, J; Taron, M<br />
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer<br />
CLIN LUNG CANCER 2009-JAN; 10 (1): 8-9<br />
IF: 1,509<br />
Servitja JM, Pignatelli M, Maestro MA, Cardalda C, Boj SF, Lozano J, Blanco E, Lafu<strong>en</strong>te A, McCarthy MI, Sumoy L, Guigó R, Ferrer J.<br />
Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic<br />
islets and liver.<br />
MOL CELL BIOL 2009 Jun;29(11):2945-59. Epub 2009 Mar 16.<br />
IF: 6,057<br />
Shuda M, Arora R, Kwun HJ, F<strong>en</strong>g H, Sarid R, Fernán<strong>de</strong>z-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH,<br />
Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y.<br />
Human Merkel cell polyomavirus infection I. MCV T antig<strong>en</strong> expression in Merkel cell carcinoma, lymphoid tissues and lymphoid<br />
tumors.<br />
INT J CANCER 2009 Sep 15;125(6):1243-9.<br />
IF: 4,722<br />
Taron, M; B<strong>en</strong>lloch, S; Chaib, I; M<strong>en</strong><strong>de</strong>z, P; Rosell, R<br />
Mechanisms of drug resistance with cytotoxics<br />
J THORAC ONCOL 2009-SEP; 4 (9): S97-S97<br />
IF: 4,547<br />
Trigo A, Val<strong>en</strong>cia A, Cases I.<br />
Systemic approaches to bio<strong>de</strong>gradation.<br />
FEMS MICROBIOL REV 2009 Jan;33(1):98-108. Epub 2008 Nov 13.<br />
IF: 9,783<br />
Yamamoto F, Yamamoto M, Blancher A.<br />
G<strong>en</strong>eration of histo-blood group B transferase by replacing the N-acetyl-d-galactosamine recognition domain of human A<br />
transferase with the galactose-recognition domain of evolutionarily related murine alpha1,3-galactosyltransferase.<br />
TRANSFUSION 2009 Nov 20. [Epub ahead of print]<br />
IF: 2,982<br />
INVESTIGACIÓ CLÍNICA<br />
Pàgina 32 <strong>de</strong> 67
Alvarez, M; Lezcano, C; Ponton, JL; Bonafont, X<br />
Study of granulocyte colony-stimulating factor use in an onco-haematology unit<br />
PHARM WORLD SCI 2009-FEB; 31 (1): 126-126<br />
IF: 0,919<br />
Barnadas, A; Gil, M; Gonzalez, S; Tusquets, I; Munoz, M; Arcusa, A; Prieto, L; Margeli-Vila, M; Mor<strong>en</strong>o, A<br />
Exemestane as primary treatm<strong>en</strong>t of oestrog<strong>en</strong> receptor-positive breast cancer in postm<strong>en</strong>opausal wom<strong>en</strong>: a phase II trial<br />
BRIT J CANCER 2009-feb-03; 100 (3): 442-449<br />
IF: 4,346<br />
Bassas-Vila J,.<br />
Patrones tumorales <strong>en</strong> <strong>de</strong>rmatopatología (A)<br />
PIEL 2009;24:446-450<br />
Bosch F, Abrisqueta P, Villamor N, Terol MJ, González-Barca E, Ferra C, González Diaz M, Abella E, Delgado J, Carbonell F, García<br />
Marco JA, Escoda L, Ferrer S, Monzó E, González Y, Estany C, Jarque I, Salamero O, Muntañola A, Montserrat E.<br />
Rituximab, fludarabine, cyclophosphami<strong>de</strong>, and mitoxantrone: a new, highly active chemoimmunotherapy regim<strong>en</strong> for chronic<br />
lymphocytic leukemia.<br />
J CLIN ONCOL 2009; 27(27):4578-84.<br />
IF: 17,793<br />
Carcer<strong>en</strong>y, E; Moran, T; Felip, E; Borghaei, H; Fitzgerald, T; Clark, J; Guan, SH; Hsu, K; Beckman, R; Yan, L; Rosell, R; Johnson, DH<br />
An op<strong>en</strong> label, randomized phase I/IIA trial evaluating MK-0646, an anti-IGF-1R monoclonal antibody (MoAB), in combination with<br />
erlotinib for pati<strong>en</strong>ts with recurr<strong>en</strong>t non-small cell lung cancer (NSCLC)<br />
J THORAC ONCOL 2009-SEP; 4 (9): S445-S446<br />
IF: 4,547<br />
Card<strong>en</strong>al, F; Moran, T; Queralt, C; Porta, R; Camps, C; Majem, M; Lopez-Vivanco, G; Isla, D; Prov<strong>en</strong>cio, M; Sanchez, JJ; Taron, M;<br />
Rosell, R<br />
Multic<strong>en</strong>ter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) pati<strong>en</strong>ts with epi<strong>de</strong>rmal growth factor<br />
receptor (EGFR) mutations<br />
J THORAC ONCOL 2009-SEP; 4 (9): S324-S325<br />
IF: 4,547<br />
Cardona, AF; Reguart, N; Reveiz, L<br />
Wood-Smoke Exposure (WSE) as a Predictor of Response and Survival in Erlotinib-Treated Non-small Cell Lung Cancer (NSCLC)<br />
Pati<strong>en</strong>ts<br />
J THORAC ONCOL 2009-JAN; 4 (1): 142-143<br />
IF: 4,547<br />
De la Rubia J, Montesinos P, Martino R, Jarque I, Rovira M, Vázquez L, López J, Batlle M, <strong>de</strong> la Cámara R, Julià A, Lahuerta JJ,<br />
Debén G, Díaz J, García R, Sanz MA.<br />
Imip<strong>en</strong>m/cilastatin wtih or without glycopepti<strong>de</strong> as initial antibiotic therapy for recipi<strong>en</strong>ts of autologous stem cell transplantation:<br />
results of a Spanish multic<strong>en</strong>ter study.<br />
BIOL BLOOD MARROW TR 2009; 15: 512-516<br />
IF: 3,149<br />
Diez-Martin, JL; Balsalobre, P; Re, A; Michieli, M; Ribera, JM; Canals, C; Con<strong>de</strong>, E; Rosselet, A; Gabriel, I; Varela, R; Allione, B;<br />
Cwynarski, K; G<strong>en</strong>et, P; Espigado, I; Biron, P; Schmitz, N; Hunter, AE; Ferrant, A; Guillerm, G; H<strong>en</strong>trich, M; Jurado, M; Fernan<strong>de</strong>z, P;<br />
Serrano, D; Rossi, G; Sureda, A<br />
Comparable survival betwe<strong>en</strong> HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma pati<strong>en</strong>ts un<strong>de</strong>rgoing autologous peripheral<br />
blood stem cell transplantation<br />
BLOOD 2009-juny-04; 113 (23): 6011-6014<br />
IF: 10,555<br />
Estevez, LG; Fortes, JL; Adrover, E; Peiro, G; Margeli, M; Castella, E; Cuevas, JM; Bernet, L; Segui, MA; Andreu, X<br />
Doxorubicin and cyclophosphami<strong>de</strong> followed by weekly docetaxel as neoadjuvant treatm<strong>en</strong>t of early breast cancer: analysis of<br />
biological markers in a GEICAM phase II study<br />
CLIN TRANSL ONCOL 2009-JAN; 11 (1): 54-59<br />
IF: 1,146<br />
Pàgina 33 <strong>de</strong> 67
Felip, E; Massuti, B; Maestre, JA; Alonso, G; Paniagua, JMR; Gonzalez-Larriba, JL; Camps, C; Isla, D; Overbeck, T; Costas, E; Sanchez,<br />
JJ; Rosell, R<br />
A phase III randomized trial of surgery (S) alone, or preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy followed by S,<br />
or S followed by adjuvant (adj) PC chemotherapy in early stage non-small cell lung cancer (NSCLC): NATCH follow-up data<br />
J THORAC ONCOL 2009-SEP; 4 (9): S283-S283<br />
IF: 4,547<br />
Ferra C, Ribera JM. Unrelated<br />
Transplants for High-Risk Adult Acute Lymphoblastic Leukemia.<br />
EUR J HAEMATOL 2009; 3<br />
IF: 2,345<br />
Ferrándiz C, Fu<strong>en</strong>te MJ, Ferrándiz L, Carrascosa JM<br />
Basal cell carcinoma<br />
CANCER TREAT REV 2009;146:263-78.(R)<br />
IF: 4,980<br />
Ferrando-Martinez, S; Franco, JM; Hernan<strong>de</strong>z, A; Ordonez, A; Gutierrez, E; Abad, A; Leal, M<br />
Thymopoiesis in el<strong>de</strong>rly human is associated with systemic inflammatory status<br />
AGE 2009; 31:87-97<br />
IF: 5,839<br />
Fu<strong>en</strong>te MJ, Leal L, Ribera M<br />
Efectos secundarios cutáneos <strong>de</strong> los tratami<strong>en</strong>tos sistémicos <strong>de</strong>l cáncer (I): quimioterapia (R)<br />
PIEL 2009;24:368-379<br />
Gallardo F, García-Muret P, Servitje O, Estrach T, Bielsa I , Solar A et al<br />
Cutaneous lymphomas showing promin<strong>en</strong>te granulomatous compon<strong>en</strong>t: clinicopathological features in a series of 16 cases<br />
J EUR ACAD DERMATOL 2009;23:648-650 (A)<br />
IF: 2,787<br />
García Marco JA, Panizo C, Sánchez García E, Deb<strong>en</strong> G, Alvarez-Larran A, González Barca E, Sancho JM, Peñarrubia MJ, García-<br />
Cerecedo T, García Vela JA.<br />
Efficacy and safety of liposomal cytarabine in lymphoma pati<strong>en</strong>ts with c<strong>en</strong>tral nervous system involvem<strong>en</strong>t from lymphoma.<br />
CANCER 2009; 115: 1892-1898.<br />
Garcia-Olive, I; Monso, E; Andreo, F; Sanz, J; Castella, E; Llatjos, M; <strong>de</strong> Miguel, E; Astudillo, J<br />
S<strong>en</strong>sitivity of linear <strong>en</strong>dobronchial ultrasonography and gui<strong>de</strong>d transbronchial needle aspiration for the id<strong>en</strong>tification of nodal<br />
metastasis in lung cancer staging.<br />
ULTRASOUND MED BIOL 2009-AUG; 35 (8): 1271-1277<br />
IF: 2,021<br />
Garrido, P; Rosell, R; Massuti, B; Card<strong>en</strong>al, F; Alberola, V; Domine, M; Maeztu, I; Ramos, A; Arellano, A<br />
Predictors of Long-Term Survival in Pati<strong>en</strong>ts with Lung Cancer Inclu<strong>de</strong>d in the Randomized Spanish Lung Cancer Group 0008 Phase<br />
II Trial Using Concomitant Chemoradiation with Docetaxel and Carboplatin plus Induction or Consolidation Chemotherapy<br />
CLIN LUNG CANCER 2009-MAY; 10 (3): 180-186<br />
IF: 1,509<br />
Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N, Hoelzer D, Doubek M, Mayer J, Piatkowska-Jakubas B, Skotnicki AB,<br />
Dombret H, Ribera JM, Piccaluga PP, Czerw T, Kyrcz-Krzemi<strong>en</strong> S, Holowiecki J.<br />
Status of minimal residual disease <strong>de</strong>termines outcome of autologous hematopoietic stem cell transplantation in adult acute<br />
lymphoblastic leukemia.<br />
BONE MARROW TRANSPL 2009; OCT 308.<br />
IF: 2,998<br />
Hidalgo, M; Abad, A; Aranda, E; Diez, L; Feliu, J; Gomez, C; Irigoy<strong>en</strong>, A; Lopez, R; Rivera, F; Rubio, C; Sastre, J; Tabernero, J; Diaz-<br />
Rubio, E<br />
Cons<strong>en</strong>sus on the treatm<strong>en</strong>t of pancreatic cancer in Spain<br />
CLIN TRANSL ONCOL 2009-MAY; 11 (5): 290-301<br />
IF: 1,146<br />
JM Ribera, A Oriol, M González, B Vidriales, S Brunet, J Esteve, E <strong>de</strong>l Potro, C Rivas, MJ Mor<strong>en</strong>o, M Tormo, V Martín-Reina, J Sarrá,<br />
Pàgina 34 <strong>de</strong> 67
R Parody, J Pérez <strong>de</strong> Oteyza, E Bureo, MT Bernal on behalf of the Programa Español <strong>de</strong> Tratami<strong>en</strong>to <strong>en</strong> Hematología (PETHEMA)<br />
and Grupo Español <strong>de</strong> Trasplante Hemopoyético (GETH) Groups.<br />
Concurr<strong>en</strong>t int<strong>en</strong>sive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Phila<strong>de</strong>lphia<br />
chromosome-positive acute lymphoblastic leukemia.<br />
HAEMATOL-HEMATOL J 2009; Oct 1<br />
IF: 6,416<br />
JM Ribera, A Oriol.<br />
Acute Lymphoblastic Leukemia in Adolesc<strong>en</strong>ts and Young Adults.<br />
HEMATOL ONCOL CLIN N 2009; 23:1033-42<br />
IF: 2,054<br />
Juncà J, Mor<strong>en</strong>o M, Mate JL, Milla F.<br />
Concomitant diagnosis of acute myeloid leukaemia and a chronic lymphoproliferative disor<strong>de</strong>r with AA amyloidosis as a final<br />
ev<strong>en</strong>t.<br />
MED CLIN-BARCELONA 2009 Sep 17<br />
IF: 1,231<br />
Leal L, Fu<strong>en</strong>te MJ, Ribera M.<br />
Efectos secundarios cutáneos <strong>de</strong> los fármacos antineoplásicos(II):<br />
Inhibidores <strong>de</strong> cinasas y anticuerpos monoclonales<br />
PIEL 2009;24:427-439 (R)<br />
Margelí, M.<br />
Superviv<strong>en</strong>cia tras la primera recidiva <strong>en</strong> cáncer <strong>de</strong> mama, ¿se pue<strong>de</strong> individualizar<br />
MED CLIN-BARCELONA 2009;133:506-7.<br />
IF: 1,231<br />
Martin-Algarra, S; Espinosa, E; Rubio, J; Lopez, JJL; Manzano, JL; Carrion, LA; Plazaola, A; Tanovic, A; Paz-Ares, L<br />
Phase II study of weekly Kahalali<strong>de</strong> F in pati<strong>en</strong>ts with advanced malignant melanoma<br />
EUR J CANCER 2009-MAR; 45 (5): 732-735<br />
IF: 4,121<br />
Martin, M; Lluch, A; Ruiz-Simon, A; Ribelles, N; Ruiz-Borrego, M; Rodriguez-Lescure, A; Munoz, M; Ramos, M; Gonzalez, S;<br />
Margeli, M<br />
First safety data from a randomised phase III trial comparing adjuvant epirubicin-cyclophosphami<strong>de</strong> -> docetaxel (EC -> T) vs ET<br />
capecitabine (X) in N plus operable breast cancer (BC)<br />
BREAST 2009-MAR; 18: S55-S55<br />
IF: 2,087<br />
Martínez A, Xicoy B, Ferrà C, Ribera JM.<br />
Sustained remission following autologous recovery after non-myeloablative stem cell transplantation in a pati<strong>en</strong>t with Hodgkin's<br />
lymphoma.<br />
MED CLIN-BARCELONA 2009 May 16;132(18):723-4. Epub 2009 Mar 13<br />
IF: 1,231<br />
Martínez A, Xicoy B, Flores A, JM Ribera.<br />
Remisión completa continuada tras un trasplante alogénico con acondicionami<strong>en</strong>to <strong>de</strong> int<strong>en</strong>sidad reducida no mieloablativo con<br />
recuperación antóloga <strong>en</strong> una paci<strong>en</strong>te con linfoma <strong>de</strong> Hodgkin <strong>en</strong> recidiva precoz tras trasplante autogénico <strong>de</strong> prog<strong>en</strong>itores<br />
hematopoyéticos<br />
MED CLIN-BARCELONA 2009; Jun 10<br />
IF: 1,231<br />
Martinez C; Solano C; Ferra C; Sampol A; Valcarcel D; Perez-Simon JA<br />
Alemtuzumab as Treatm<strong>en</strong>t of Steroid-Refractory Acute Graft-versus-Host Disease: Results of a Phase II Study<br />
BIOL BLOOD MARROW TR 2009-MAY; 15 (5): 639-642<br />
IF: 3,149<br />
Martinez-Balibrea, E; Martinez-Cardus, A; Musul<strong>en</strong>, E; Gines, A; Manzano, JL; Aranda, E; Plas<strong>en</strong>cia, C; Neamati, N; Abad, A<br />
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer pati<strong>en</strong>ts receiving<br />
oxaliplatin-based chemotherapy<br />
INT J CANCER 2009-juny-15; 124 (12): 2905-2910<br />
Pàgina 35 <strong>de</strong> 67
IF: 4,722<br />
Maurel, J; Lopez-Pousa, A; <strong>de</strong> las P<strong>en</strong>as, R; Fra, J; Martin, J; Cruz, J; Casado, A; Poveda, A; Martinez-Trufero, J; Balana, C; Gomez,<br />
MA; Cubedo, R; Gallego, O; Rubio-Viqueira, B; Rubio, J; Andres, R; Sevilla, I; <strong>de</strong> la Cruz, JJ; <strong>de</strong>l Muro, XG; Buesa, JM Efficacy of<br />
Sequ<strong>en</strong>tial High-Dose Doxorubicin and Ifosfami<strong>de</strong> Compared With Standard-Dose Doxorubicin in Pati<strong>en</strong>ts With Advanced Soft<br />
Tissue Sarcoma: An Op<strong>en</strong>-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas<br />
J CLIN ONCOL 2009-APR 10; 27 (11): 1893-1898<br />
IF: 17,793<br />
Mellado, B; Font, A; Alcaraz, A; Aparicio, LA; Veiga, FJG; Areal, J; Gallardo, E; Hannaoui, N; Lor<strong>en</strong>zo, JRM; Sousa, A; Fernan<strong>de</strong>z, PL;<br />
Gascon, P<br />
Phase II trial of short-term neoadjuvant docetaxel and complete androg<strong>en</strong> blocka<strong>de</strong> in high-risk prostate cancer<br />
BRIT J CANCER 2009 oct-13;101:1248-1252<br />
IF: 4,346<br />
Millares, L; Rodriguez, N; Andreo, F; Sanz, J; Ramirez, JL; Lopez-Lisbona, R; Seto, L; Taron, M; Rosell, R; Monso, E; Rosell, A<br />
Aberrant promoter methylation in sputum and bronchial washing in pati<strong>en</strong>ts at risk for lung cancer<br />
J THORAC ONCOL 2009-SEP; 4 (9): S635-S635<br />
IF: 4,547<br />
Mohammed, S; Syro, LV; Scheithauer, BW; Abad, A; Uribe, H; Rotondo, F; Horvath, E; Cusimano, M; Kovacs, K<br />
Pituitary Ad<strong>en</strong>oma with Peliosis: A Report of Two Cases<br />
ENDOCR PATHOL 2009; 20:41-45<br />
IF: 1,417<br />
Mor<strong>en</strong>o M, Sancho JM, Gar<strong>de</strong>lla S, Coll R, García O, Gallardo D, Ribera JM.<br />
Doxorubicina liposomal no pegilada <strong>en</strong> combinación con ciclofosfamida, vincristina, prednisona y rituximab <strong>en</strong> el tratami<strong>en</strong>to <strong>de</strong><br />
linfomas no hodgkinianos: estudio <strong>de</strong> 26 paci<strong>en</strong>tes.<br />
MED CLIN-BARCELONA 2009; Nov 11<br />
IF: 1,231<br />
Motlló C, Xicoy B, Sancho JM, Ribera JM.<br />
Infiltación cutánea masiva seguida <strong>de</strong> infiltración <strong>de</strong>l sistema nervioso c<strong>en</strong>tral <strong>en</strong> un paci<strong>en</strong>te con leucemia mielomonocítica<br />
crónica.<br />
MED CLIN-BARCELONA 2009; JULIO<br />
IF: 1,231<br />
Novello, S; Scagliotti, GV; Rosell, R; Socinski, MA; Brahmer, J; Atkins, J; Pallares, C; Burgess, R; Tye, L; Selaru, P; Wang, E; Chao, R;<br />
Govindan, R<br />
Phase II study of continuous daily sunitinib dosing in pati<strong>en</strong>ts with previously treated advanced non-small cell lung cancer<br />
BRIT J CANCER 2009; 101:1543-1548<br />
IF: 4,346<br />
P Balsalobre, JL Diez-Martin, A Re, M Michieli, JM Ribera, C Canals, A Rosselet, E Con<strong>de</strong>, R Varela, K Cwynarski, I Gabriel,P G<strong>en</strong>et,<br />
G Guillerm, B Allione, A Ferrant, P Biron, I Espigado, D Serrano, A Sureda.<br />
The European experi<strong>en</strong>ce on Autologous Stem Cell Transplantation in HIV-related lymphoma pati<strong>en</strong>ts: An EBMT Lymphoma<br />
Working Party analysis.<br />
J CLIN ONCOL 2009; 27: 2192-2198.<br />
IF: 17,793<br />
P Miralles, J Ber<strong>en</strong>guer, JM Ribera.<br />
El diagnóstico, la profilaxis y el tratami<strong>en</strong>to <strong>de</strong> sistema nervioso c<strong>en</strong>tral por el linfoma no Hodgkin <strong>en</strong> paci<strong>en</strong>tes infectados por VIH<br />
MED CLIN-BARCELONA 2009; Jul 21<br />
IF: 1,231<br />
Paiva B, Vidriales MB, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García <strong>de</strong> Coca A, <strong>de</strong> las Heras N,<br />
Mateos MV, López-Berges MC, García-Boyero R, Gal<strong>en</strong><strong>de</strong> J, Hernán<strong>de</strong>z J, Palomera L, Carrera D, Martínez R, <strong>de</strong> la Rubia J, Martín<br />
A, González Y, Bladé J, Lahuerta JJ, Orfao A, San-Miguel JF; GEM (Grupo Español <strong>de</strong> MM)/PETHEMA (Programa para el Estudio <strong>de</strong><br />
la Terapéutica <strong>en</strong> Hemopatías Malignas) Cooperative Study Groups.<br />
The persist<strong>en</strong>ce of immunoph<strong>en</strong>otypically normal residual bone marrow plasma cells at diagnosis id<strong>en</strong>tifies a good prognostic<br />
Pàgina 36 <strong>de</strong> 67
subgroup of symptomatic multiple myeloma pati<strong>en</strong>ts.<br />
BLOOD 2009;114(20):4369-72<br />
IF: 10,555<br />
Prov<strong>en</strong>cio, M; Camps, C; Alberola, V; Massutti, B; Vinolas, N; Isla, D; Domine, M; Millan, I; Cobo, M; Rosell, R<br />
Lung cancer and treatm<strong>en</strong>t in el<strong>de</strong>rly pati<strong>en</strong>ts: The Achilles Study<br />
LUNG CANCER 2009; 66:103-106<br />
IF: 3,140<br />
Prov<strong>en</strong>cio, M; Sanchez, A; Gas<strong>en</strong>t, J; Gomez, P; Rosell, R<br />
Cancer Treatm<strong>en</strong>ts: Can We Find Treasures at the Bottom of the Sea<br />
CLIN LUNG CANCER 2009; 10:295-300<br />
IF: 1,509<br />
Reguart, N; Isla, D; Card<strong>en</strong>al, F; Cardona, A; Palmero, R; Moran, T; Rolfo, CD; Nadal, ES; Massuti, T; Montanes, A; Queralt, C;<br />
Taron, M; Rosell, R<br />
Phase I trial of vorinostat in combination with erlotinib for advanced non-small cell lung cancer (NSCLC) pati<strong>en</strong>ts (pts) with EGFR<br />
mutations after erlotinib progression<br />
J THORAC ONCOL 2009-SEP; 4 (9): S708-S708<br />
IF: 4,547<br />
Rex J, Para<strong>de</strong>lo C, Mangas C, Hilari JM, Fernán<strong>de</strong>z-Figueras MT, Ferrándiz C<br />
Managem<strong>en</strong>t of primary cutaneous Melanoma of the hands and feet: a clinicoprognostic study<br />
DERMATOL SURG 2009; 35(10):1505-13.(A)<br />
IF: 2,343<br />
Ribera JM, Oriol A, Sancho JM, Morga<strong>de</strong>s M, García O, Ferrá C, Xicoy B, Batlle M, Flores A, Vives S, Jiménez MJ, Juncà J,<br />
Granada I, Zamora L, Millá F, Feliu E.<br />
Tratami<strong>en</strong>to <strong>de</strong> la leucemia aguda linfoblástica <strong>de</strong>l adulto.<br />
HAEMATOL-HEMATOL J 2009; 94 (extr 1): 39-50<br />
IF: 6,416<br />
Rodríguez I, Grau J, Sancho JM, Ribera JM.<br />
Síndrome hemofagocítico asociado a linfoma B difuso <strong>de</strong> célula gran<strong>de</strong>.<br />
MED CLIN-BARCELONA 2009; DEC<br />
IF: 1,231<br />
Rosell, R; Moran, T<br />
CLINICAL TRIALS BASED ON BIOMARKERS<br />
LUNG CANCER 2009-MAY; 64: S4-S4<br />
IF: 3,140<br />
Rosinol, L; Cibeira, MT; Martinez, J; Mateos, MV; Terol, MJ; <strong>de</strong> la Rubia, J; Palomera, L; <strong>de</strong> Arriba, F; Oriol, A; Amor, AA; Besalduch,<br />
J; <strong>de</strong> Paz, R; Garcia-Larana, J; Diaz-Mediavilla, J; Sureda, A; Lahuerta, JJ; San Miguel, J; Bla<strong>de</strong>, J<br />
Thalidomi<strong>de</strong>/Dexamethasone (TD) Versus Bortezomib (Velca<strong>de</strong>)/Thalidomi<strong>de</strong>/Dexamethasone (VTD) Versus VB<br />
CLIN LYMPHOMA MYELOM 2009-FEB; 9 : S26-S26<br />
IF: 1,130<br />
Safont, MJ; Artal-Cortes, A; Sirera, R; Gomez-Codina, J; Gonzalez-Larriba, JL; Barneto, I; Carrato, A; Isla, D; Rosell, R; Camps, C<br />
Retrospective study of efficacy and toxicity on pati<strong>en</strong>ts ol<strong>de</strong>r than 70 years within a randomized clinical trial of two cisplatinbased<br />
combinations in pati<strong>en</strong>ts with small-cell lung cancer<br />
LUNG CANCER 2009-JAN; 63 (1): 83-87<br />
IF: 3,140<br />
Sanchez-Wan<strong>de</strong>lmer, J; Hernan<strong>de</strong>z-Pinto, AM; Cano, S; Davalos, A; <strong>de</strong> la P<strong>en</strong>a, G; Puebla-Jim<strong>en</strong>ez, L; Arilla-Ferreiro, E; Lasuncion,<br />
MA; Busto, R<br />
Effects of the antipsychotic drug haloperidol on the somastostatinergic system in SH-SY5Y neuroblastoma cells<br />
J NEUROCHEM 2009; 110:631-640<br />
IF: 3,999<br />
Sastre, J; Aranda, E; Massuti, B; Tabernero, J; Chaves, M; Abad, A; Carrato, A; Reina, JJ; Queralt, B; Gomez-Espana, A; Gonzalez-<br />
Flores, E; Rivera, F; Losa, F; Garcia, T; Sanchez-Rovira, P; Maestu, I; Diaz-Rubio, E<br />
Pàgina 37 <strong>de</strong> 67
El<strong>de</strong>rly pati<strong>en</strong>ts with advanced colorectal cancer <strong>de</strong>rive similar b<strong>en</strong>efit without excessive toxicity after first-line chemotherapy<br />
with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study<br />
CRIT REV ONCOL HEMAT 2009-MAY; 70 (2): 134-144<br />
IF: 5,269<br />
Sola M, Fraile M, Mariscal A, Julian FJ, Gubern JM, Culell P, Puig P, Peñalva G, Deulofeu P, Janer J, Valles A, Encinas X, Calvo E,<br />
Vallejos V, Mila M.<br />
Estudio comparativo <strong>de</strong> la técnica <strong>de</strong>l ganglio c<strong>en</strong>tinela <strong>en</strong>tre los casos <strong>de</strong> carcinoma <strong>de</strong> mama multifocal y unifocal.<br />
Radiologia 2009;51:140-7<br />
Sola M, Recaj M, Calvo E, Sune J, Robles J, Puig P, Fraile M<br />
En Gar<strong>de</strong>, S<strong>en</strong>tinel No<strong>de</strong>!<br />
REV ESP MED NUCL 2009-SEP-OCT; 28 (5): 246-248<br />
IF: 0,765<br />
Sola M., Recaj M., Calvo E., Sune J., Robles J., Puig P., Fraile M.<br />
Inverted exclamation markEn guardia, c<strong>en</strong>tinela!<br />
REV ESP MED NUCL 2009 Sep-Oct;28(5):246-8. Epub 2009 Jul 28.<br />
IF: 0,765<br />
Suarez, MS; Andres, RP; <strong>de</strong> Pablo, PP; Collsamata, PC; Bota, EC; Arroyo, VV; Fraile M<br />
Utility of bone SPECT-CT in percutaneous vertebroplasty<br />
REV ESP MED NUCL 2009 NOV-DEC;28:291-294<br />
IF: 0,765<br />
Vilanova, JC; Comet, J; Barcelo-Vidal, C; Barcelo, J; Lopez-Bonet, E; Maroto, A; Arzoz, M; Mor<strong>en</strong>o, A; Areal, J<br />
Peripheral Zone Prostate Cancer in Pati<strong>en</strong>ts with Elevated PSA Levels and Low Free-to-Total PSA Ratio: Detection with MR Imaging<br />
and MR Spectroscopy<br />
RADIOLOGY 2009 OCT;253:135-143<br />
IF: 6,341<br />
Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socié G, Rio B, Sirv<strong>en</strong>t A, R<strong>en</strong>aud M, Ma<strong>de</strong>ro L, Mohty M, Ferra C, Garnier<br />
F, Loiseau P, Garcia J, Lecchi L, Kögler G, Beguin Y, Navarrete C, Devos T, Ionescu I, Boudjedir K, Herr AL, Gluckman E, Rocha V<br />
Eurocord-Netcord and Acute Leukaemia Working Party of the EBMT. KIR-ligand incompatibility in the graft-versus-host direction<br />
improves outcomes after umbilical cord blood transplantation for acute leukemia.<br />
LEUKEMIA 2009; 23(3):630.<br />
IF: 8,296<br />
Willemze, R; Rodrigues, CA; Labopin, M; Sanz, G; Michel, G; Socie, G; Rio, B; Sirv<strong>en</strong>t, A; R<strong>en</strong>aud, M; Ma<strong>de</strong>ro, L; Mohty, M; Ferra, C;<br />
Garnier, F; Loiseau, P; Garcia, J; Lecchi, L; Kogler, G; Beguin, Y; Navarrete, C; Devos, T; Ionescu, I; Boudjedir, K; Herr, AL; Gluckman,<br />
E; Rocha, V<br />
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for<br />
acute leukemia<br />
LEUKEMIA 2009-MAR; 23 (3): 492-500<br />
IF: 8,296<br />
Xicoy B, Ribera JM, Miralles P, Ber<strong>en</strong>guer J, Rubio R, Mahillo B, Val<strong>en</strong>cia ME, Abella E, López-Guillermo A, Sureda A, Morga<strong>de</strong>s M,<br />
Navarro JT, Esteban H.<br />
Limited prognostic value of the International Prognostic Score in advanced stage human immuno<strong>de</strong>fici<strong>en</strong>cy virus infection-related<br />
Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine, and dacarbazine regim<strong>en</strong>.<br />
LEUKEMIA LYMPHOMA 2009; 50: 1718-20<br />
IF: 2,397<br />
INVESTIGACIÓ TRASLACIONAL<br />
Balague O, Mozos A, Martinez D, Hernan<strong>de</strong>z L, Colomo L, Mate JL, Teruya-Feldstein J, Lin O, Campo E, Lopez-Guillermo A,<br />
Martinez A.<br />
Activation of the <strong>en</strong>doplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of<br />
normal germinal-c<strong>en</strong>ter B cells and in aggressive B-cell lymphomas with prognostic implications.<br />
AM J PATHOL 2009 Jun;174(6):2337-46. Epub 2009 Apr 23.<br />
Pàgina 38 <strong>de</strong> 67
IF: 5,673<br />
Barba, I; Sanz, C; Barbera, A; Tapia, G; Mate, JL; Garcia-Dorado, D; Ribera, JM; Oriol, A<br />
Metabolic fingerprinting of fresh lymphoma samples used to discriminate betwe<strong>en</strong> follicular and diffuse large B-cell lymphomas<br />
EXP HEMATOL 2009 NOV;37:1259-1265<br />
IF: 3,106<br />
Bartolucci, R; Wei, J; Sanchez, JJ; Perez-Roca, L; Chaib, I; Puma, F; Farabi, R; M<strong>en</strong><strong>de</strong>z, P; Roila, F; Okamoto, T; Taron, M; Rosell, R<br />
XPG mRNA Expression Levels Modulate Prognosis in Resected Non-Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1<br />
Expression<br />
CLIN LUNG CANCER 2009-JAN; 10 (1): 47-52<br />
IF: 1,509<br />
Boix, R; Sanz, C; Mora, M; Quer, A; Beyer, K; Musul<strong>en</strong>, E; Gonzalez, C; Bayona, S; Saladie, JM; Ariza, A<br />
Primary R<strong>en</strong>al Cell Carcinoma in a Transplanted Kidney: G<strong>en</strong>etic Evid<strong>en</strong>ce of Recipi<strong>en</strong>t Origin<br />
TRANSPLANTATION 2009-APR 15; 87 (7): 1057-1061<br />
IF: 3,498<br />
Brüggemann M, Schrau<strong>de</strong>r A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, Asnafi V, Baruchel A, Bassan R, B<strong>en</strong>oit Y, Biondi A, Cavé<br />
H, Dombret H, Fielding AK, Foà R, Gökbuget N, Goldstone AH, Gould<strong>en</strong> N, H<strong>en</strong>ze G, Hoelzer D, Janka-Schaub GE, Macintyre EA,<br />
Pieters R, Rambaldi A, Ribera JM, Schmiegelow K, Spinelli O, Stary J, von Stackelberg A, Kneba M, Schrappe M, van Dong<strong>en</strong> JJ.<br />
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessm<strong>en</strong>t<br />
in Kiel, Germany, 18-20 September 2008.<br />
LEUKEMIA 2009; doi:10.1038/leu.2009.268.<br />
IF: 8,296<br />
D Gallardo, R Cámara, JB Nieto, I Espigado, A Iriondo, A Jiménez-Velasco, C Vallejo, C Martin, D Caballero, S Brunet, D Serrano, C<br />
Solano, JM Ribera, J <strong>de</strong> la Rubia, E Carreras.<br />
Is mobilized peripheral blood stem cells comparable with bone marrow as a source of hematopoietic cells for allog<strong>en</strong>eic<br />
transplantation from HLA-id<strong>en</strong>tical sibling donors. A case – control study.<br />
HAEMATOL-HEMATOL J 2009; 94:1282-8<br />
IF: 6,416<br />
Danesi, R; Altavilla, G; Giovannetti, E; Rosell, R<br />
Pharmacog<strong>en</strong>omics of gemcitabine in non-small-cell lung cancer and other solid tumors<br />
PHARMACOGENOMICS 2009-JAN; 10 (1): 69-80<br />
IF: 3,991<br />
Danesi, R; Pasqualetti, G; Giovannetti, E; Crea, F; Altavilla, G; Del Tacca, M; Rosell, R<br />
Pharmacog<strong>en</strong>omics in non-small-cell lung cancer chemotherapy<br />
ADV DRUG DELIVER REV 2009-MAY 20; 61 (5): 408-417<br />
IF: 11,957<br />
Giros A, Grzybowski M, Sohn VR, Pons E, Fernan<strong>de</strong>z-Morales J, Xicola RM, Sethi P, Grzybowski J, Goel A, Boland CR, Gassull MA,<br />
Llor X.<br />
Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexa<strong>en</strong>oic and Eicosap<strong>en</strong>ta<strong>en</strong>oic.<br />
CANCER PREV RES 2009 Aug;2(8):732-42. Epub 2009 Jul 28.<br />
IF: 4,678<br />
Hilari JM, Mangas C, Xi L, Para<strong>de</strong>lo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE.<br />
Molecular Staging of Pathologically Negative S<strong>en</strong>tinel Lymph No<strong>de</strong>s from Melanoma Pati<strong>en</strong>ts Using Multimarker, Quantitative<br />
Real-Time RT-PCR.<br />
ANN SURG ONCOL 2009 Jan;16(1):177-85. Epub 2008 Nov 4<br />
IF: 4,130<br />
Isla, D; Cobo, M; Ramirez, JL; Sanchez-Ronco, M; <strong>de</strong> Aguirre, I; Prov<strong>en</strong>cio, M; Lopez-Vivanco, G; Camps, C; Domine, M; Alberola, V;<br />
Taron, M; Rosell, R<br />
Blood-based CHRNA3 single nucleoti<strong>de</strong> polymorphisms (SNPs) and outcome in advanced non-small-cell lung cancer (NSCLC)<br />
pati<strong>en</strong>ts<br />
J THORAC ONCOL 2009-SEP; 4 (9): S536-S537<br />
IF: 4,547<br />
Pàgina 39 <strong>de</strong> 67
Martinez-Balibrea, E; Plas<strong>en</strong>cia, C; Gines, A; Martinez-Cardus, A; Musul<strong>en</strong>, E; Aguilera, R; Manzano, JL; Neamati, N; Abad,A<br />
A proteomic approach links <strong>de</strong>creased pyruvate kinase M2 expression to oxaliplatin resistance in pati<strong>en</strong>ts with colorectal cancer<br />
and in human cell lines<br />
MOL CANCER THER 2009-APR; 8 (4): 771-778<br />
IF: 4,953<br />
Martinez-Cardus, A; Martinez-Balibrea, E; Bandres, E; Malumbres, R; Gines, A; Manzano, JL; Taron, M; Garcia-Foncillas, J; Abad, A<br />
Pharmacog<strong>en</strong>omic approach for the id<strong>en</strong>tification of novel <strong>de</strong>terminants of acquired resistance to oxaliplatin in colorectal cancer<br />
MOL CANCER THER 2009-JAN; 8 (1): 194-202<br />
IF: 4,953<br />
Massuti, B; Cobo, M; Sanchez, JM; Rodriguez-Paniagua, JM; Jim<strong>en</strong>ez, U; Aguiar, D; Arrabal, R; Gonzalez-Larriba, JL; Reguart, N;<br />
Astudillo, J; Taron, M; Rosell, R<br />
The pharmacog<strong>en</strong>omic approach in adjuvant setting of NSCLC: postoperative chemotherapy customized according BRCA1 levels;<br />
docetaxel single ag<strong>en</strong>t arm compared with platinum doublets; SCAT pilot trial results<br />
J THORAC ONCOL 2009-SEP; 4 (9): S299-S299<br />
IF: 4,547<br />
Moran, T; Mayo, C; Queralt, C; Molina, MA; B<strong>en</strong>lloch, S; Quiroga, V; Rolfo, C; Cuello, M; Carcer<strong>en</strong>y, E; Cardona, AF; Taron, M;<br />
Rosell, R<br />
Mutations of EGFR (mEGFR) in tumor tissue and serum DNA from stage IV non-small-cell lung cancer (NSCLC) pati<strong>en</strong>ts (p)<br />
prospectively treated with erlotinib<br />
J THORAC ONCOL 2009-SEP; 4 (9): S503-S504<br />
IF: 4,547<br />
Musul<strong>en</strong>, E; Sanz, C; B<strong>en</strong>ito, L; Ariza, A<br />
Scre<strong>en</strong>ing for lynch syndrome in a series of 869 colorectal carcinomas<br />
VIRCHOWS ARCH 2009-AUG; 455: 87-88<br />
IF: 2,305<br />
Pérez-García A, Brunet S, Berlanga JJ, Tormo M, Nom<strong>de</strong><strong>de</strong>u J, Guardia R, Ribera JM, Heras I, Llor<strong>en</strong>te A, Hoyos M, Esteve J,<br />
Besalduch J, Bu<strong>en</strong>o J, Sierra J, Gallardo D; Grupo cooperativo para el estudio y tratami<strong>en</strong>to <strong>de</strong> las leucemias agudas.<br />
CTLA-4 g<strong>en</strong>otype and relapse incid<strong>en</strong>ce in pati<strong>en</strong>ts with acute myeloid leukemia in first complete remission after induction<br />
chemotherapy.<br />
LEUKEMIA 2009 Mar;23(3):486-91. Epub 2008 Dec 18<br />
IF: 8,296<br />
Quijano S, López A, Manuel Sancho J, Panizo C, Debén G, Castilla C, Antonio García-Vela J, Salar A, Alonso-V<strong>en</strong>ce N, González-<br />
Barca E, Peñalver FJ, Plaza-Villa J, Morado M, García-Marco J, Arias J, Briones J, Ferrer S, Capote J, Nicolás C, Orfao A; Spanish<br />
Group for the Study of CNS Disease in NHL.<br />
Id<strong>en</strong>tification of leptom<strong>en</strong>ingeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved s<strong>en</strong>sitivity of flow cytometry.<br />
J CLIN ONCOL 2009 Mar 20;27(9):1462-9. Epub 2009 Feb 17.<br />
IF: 17,793<br />
Rosell R, Bertran-Alamillo J, Molina MA, Taron M.<br />
IL-6/gp130/STAT3 signaling axis in cancer and the pres<strong>en</strong>ce of in-frame gp130 somatic <strong>de</strong>letions in inflammatory<br />
hepatocellular tumors.<br />
FUTURE ONCOL 2009 Apr;5(3):305-8.<br />
Rosell R, Perez-Roca L, Sanchez JJ, Cobo M, Moran T, Chaib I, Prov<strong>en</strong>cio M, Domine M, Sala MA, Jim<strong>en</strong>ez U, Diz P, Barneto I,<br />
Macias JA, <strong>de</strong> Las Peñas R, Catot S, Isla D, Sanchez JM, Ibeas R, Lopez-Vivanco G, Oramas J, M<strong>en</strong><strong>de</strong>z P, Reguart N, Blanco R, Taron<br />
M.<br />
Customized treatm<strong>en</strong>t in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.<br />
PLOS ONE 2009;4(5):e5133. Epub 2009 May 5.<br />
IF: 4,351<br />
Rosell, R<br />
Pharmacog<strong>en</strong>omic approaches<br />
J THORAC ONCOL 2009-SEP; 4 (9): S193-S194<br />
IF: 4,547<br />
Wei, J; Okamoto, T; Sanchez-Ronco, M; Chaib, I; Perez-Roca, L; M<strong>en</strong><strong>de</strong>z, P; Taron, M; Liu, BR; Rosell, R<br />
Pàgina 40 <strong>de</strong> 67
Bio-ANITA project: increased BRCA1 mRNA levels predict favorable outcome in non-small cell lung cancer (NSCLC) pati<strong>en</strong>ts<br />
receiving adjuvant cisplatin (cis)/vinorelbine (vrb)<br />
J THORAC ONCOL 2009-SEP; 4 (9): S298-S299<br />
IF: 4,547<br />
Projectes<br />
INVESTIGACIÓ BÀSICA<br />
MORERA PRAT, JOSEP - PNEUMOLOGIA<br />
SEPAR - Núm. Exp.: 894<br />
Estudio <strong>de</strong> la vía <strong>de</strong> señalización <strong>de</strong> la prostaglandina E2 <strong>en</strong> cáncer <strong>de</strong> pulmón y su relación con <strong>en</strong> receptor <strong>de</strong>l factor <strong>de</strong><br />
crecimi<strong>en</strong>to epidérmico.<br />
Durada: 2 anys - (2009-2011)<br />
Import Concedit: 12.000 €<br />
ROSELL COSTA, RAFAEL - ONCOLOGIA MÈDICA<br />
National Cancer <strong>Institut</strong> - Núm. Exp.: 1 U01 CA114771<br />
Firmas moleculares <strong>en</strong> cáncer <strong>de</strong> pulmon.<br />
Durada: 4 anys - (2006-2010)<br />
Import Concedit: 50.000 €<br />
INVESTIGACIÓ CLÍNICA<br />
ANDREO GARCIA, FELIPE CRISTOBAL - PNEUMOLOGIA<br />
SOCAP - Núm. Exp.:<br />
R<strong>en</strong>tabilitat diagnòstica <strong>de</strong> la ultrasonografia <strong>en</strong>dobronquial <strong>en</strong> el diagnòstic i estadificació <strong>de</strong> carcinoma <strong>de</strong> pulmó no cèl·lula<br />
petita.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 12.000 €<br />
BALAÑA QUINTERO, CARMEN - ONCOLOGIA MÈDICA<br />
FIS - Núm. Exp.: EC08/00071<br />
Estudio abierto, fase II aleatorizado <strong>de</strong> tratami<strong>en</strong>to neo-adyuvante con 3 ciclos <strong>de</strong> temozolamida a dosis ext<strong>en</strong>didas, previos al<br />
tratami<strong>en</strong>to con temozolamida más irradiación, versus mismo tratami<strong>en</strong>to con bevacizumab bisemanal <strong>en</strong> paci<strong>en</strong>tes con<br />
Glioblastoma clase V-VI <strong>de</strong> la RPA EORTC y sólo biopsia.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 838.500 €<br />
MONSO MOLAS, EDUARD - PNEUMOLOGIA<br />
FIS - Núm. Exp.: PS09/01612<br />
Estadificación nodal sistemática con ultrasonografía <strong>en</strong>dobronquial lineal <strong>en</strong> el carcinoma pulmonar no microcítico<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 102.500 €<br />
SERRANO MAESTRO, ALFONS - HEMATOLOGIA I HEMOTERÀPIA<br />
Fundación Española <strong>de</strong> Hematología y Hemoterapia - Núm. Exp.:<br />
Análisis <strong>de</strong> los ev<strong>en</strong>tos a largo plazo relacionados con el tratami<strong>en</strong>to <strong>en</strong> paci<strong>en</strong>tes adultos con leucemia aguda linfoblástica <strong>en</strong><br />
remisión completa y su comparación con la población g<strong>en</strong>eral.<br />
Durada: 1 anys - (2009-2010)<br />
Import Concedit: 15.000 €<br />
TEIXIDOR RODRIGUEZ, Ma. DEL PILAR - NEUROCIRURGIA<br />
Ministerio <strong>de</strong> Sanidad y Politica Social - Núm. Exp.: TRA-085<br />
Estudio observacional multicéntrico <strong>de</strong> seguimi<strong>en</strong>to <strong>de</strong> una cohorte <strong>de</strong> paci<strong>en</strong>tes con glioma <strong>de</strong> alto grado con resección<br />
quirúrgica guiada con ácido 5-aminolevulínico.<br />
Durada: 2 anys - (2009-2011)<br />
Import Concedit: 72.200 €<br />
Pàgina 41 <strong>de</strong> 67
INVESTIGACIÓ TRASLACIONAL<br />
ABAD ESTEVE, ALBERT - ONCOLOGIA MÈDICA<br />
FIS - Núm. Exp.: PI070321<br />
Polimorfismos g<strong>en</strong>éticos (Opmr-1, βarrestina 2, stat6 y COMT) y su influ<strong>en</strong>cia <strong>en</strong> la tolerancia al tratami<strong>en</strong>to con opiáceos<br />
mayores.Papel <strong>en</strong> la selección <strong>de</strong> rotación individualizada <strong>de</strong> opiáceos.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 25.100 €<br />
FELIU FRASNEDO, EVARIST - HEMATOLOGIA I HEMOTERÀPIA<br />
FIS - Núm. Exp.: PI051409<br />
Estudio <strong>de</strong> los perfiles <strong>de</strong> expresión génica <strong>en</strong> síndromes mielodisplásicos que ayud<strong>en</strong> a id<strong>en</strong>tificar subgrupos pronósticos y<br />
morfológicos.<br />
Durada: 4 anys - (2005-2009)<br />
Import Concedit: 65.000 €<br />
MARTINEZ BALIBREA, EVA - ONCOLOGIA MÈDICA<br />
FIS - Núm. Exp.: PS09/01334<br />
Estudio <strong>de</strong> la expresión <strong>de</strong> g<strong>en</strong>es relacionados con resist<strong>en</strong>cia a quimioterapia basada <strong>en</strong> oxaliplatino <strong>en</strong> líneas celulares y tejido<br />
<strong>de</strong> paci<strong>en</strong>tes con cáncer colorrectal avanzado<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 61.500 €<br />
MONSO MOLAS, EDUARD - PNEUMOLOGIA<br />
FUCAP - Núm. Exp.: Beca Oscar Ravà<br />
Detección <strong>de</strong> displasia bronquial y carcinoma in situ a nivel molecular y <strong>en</strong>doscópico <strong>en</strong> una población <strong>de</strong> riesgo <strong>de</strong> cáncer <strong>de</strong><br />
pulmón por <strong>en</strong>fermedad pulmonar obstructiva crónica (EPOC).<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 9.000 €<br />
ROSELL COSTA, RAFAEL - ONCOLOGIA MÈDICA<br />
FIS - Núm. Exp.: PI051621<br />
Análisis <strong>de</strong> expresión génica <strong>en</strong> paci<strong>en</strong>tes con carcinoma broncopulmonar no microcítico <strong>en</strong> estadios quirúrgicos y su papel <strong>en</strong> la<br />
predicción <strong>de</strong> metástasis.<br />
Durada: 4 anys - (2005-2009)<br />
Import Concedit: 73.000 €<br />
SALA LLINÀS, MARGARITA - APARELL DIGESTIU<br />
FIS - Núm. Exp.: PS09/00751<br />
Id<strong>en</strong>tificación <strong>de</strong> marcadores diagnóstico y pronóstico <strong>en</strong> plasma <strong>de</strong> cáncer hepático mediante análisis proteómico.<br />
Durada: 3 anys - (2009-2012)<br />
Import Concedit: 86.000 €<br />
Pàgina 42 <strong>de</strong> 67
EPIDEMIOLOGIA CLÍNICA<br />
Y MOLECULAR<br />
SALUD PÚBLICA.<br />
SALUD INTERNACIONAL<br />
Publicacions<br />
INVESTIGACIÓ BÀSICA<br />
Cueto, R; Luc<strong>en</strong>a, MI; Crespo, E; Ulzurrun, E; Ruiz-Cabello, F; Borraz, Y; Cabello, M; Fernan<strong>de</strong>z, M; Madrazo, A; Romero-Gomez, M;<br />
Costa, J; Barriocanal, A; Planas, R; Salmeron, JF; Soriano, G; Andra<strong>de</strong>, R<br />
Frequ<strong>en</strong>cy of-24 c > t polymorphism in the hepatic canalicular transporter abcc2 g<strong>en</strong>e in spanish population basic<br />
CLIN PHARMACOL 2009-AUG; 105: 78-79<br />
IF: 2,308<br />
Esteve A, Fortiana J, Boj E<br />
Interaction terms in distance-based regresion<br />
COMMUN STAT-THEOR M 2009; 38:1-12<br />
IF: 0,406<br />
Gómez-Díaz E, González-Solís J, Peinado MA.<br />
Population structure in a highly pelagic seabird, the Cory’s shearwater (Calonectris diome<strong>de</strong>a): an examination of g<strong>en</strong>etics,<br />
morphology and ecology. Marine Ecology Progress Series,<br />
MAR ECOL-PROG SER 2009; 382:197-209<br />
IF: 2,519<br />
Jordà M, Peinado MA.<br />
G<strong>en</strong>e regulation of the social behavior in the honey bee (in Spanish).<br />
Investigación y Ci<strong>en</strong>cia 2009; 395:40-43<br />
INVESTIGACIÓ CLÍNICA<br />
Antiretroviral Therapy Cohort Collaboration (ART-CC), Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, Sabin C,<br />
Fatk<strong>en</strong>heuer G, Justice A, Reiss P, d'Arminio Monforte A, Gill J, Hogg R, Bonnet F, Kitahata M, Staszewski S, Casabona J, Harris R,<br />
Saag M.<br />
Variable impact on mortality of AIDS-<strong>de</strong>fining ev<strong>en</strong>ts diagnosed during combination antiretroviral therapy: not all AIDS <strong>de</strong>fining<br />
conditions are created equal.<br />
CLIN INFECT DIS 2009 Apr 15;48(8):1138-51.<br />
IF: 8,195<br />
Bielsa I, Soria X, Esteve M, Ferrándiz C; on behalf of the Skin Cancer Study Group of Barcelonès Nord<br />
Population-based incid<strong>en</strong>ce of basal cell carcinoma in a Spanish Mediterranean area.<br />
BRIT J DERMATOL 2009;161:1341-1346 (A)<br />
IF: 4,260<br />
Brown AE, Gifford RJ, Clewley JP, Kucherer C, Masquelier B, Porter K, Balotta C, Back NK, Jorg<strong>en</strong>s<strong>en</strong> LB, <strong>de</strong> M<strong>en</strong>doza C, Bhaskaran<br />
K, Gill ON, Johnson AM, Pillay D; Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) Collaboration.<br />
Phylog<strong>en</strong>etic reconstruction of transmission ev<strong>en</strong>ts from individuals with acute HIV infection: toward more-rigorous<br />
epi<strong>de</strong>miological <strong>de</strong>finitions.<br />
J INFECT DIS 2009 Feb 1;199(3):427-31.<br />
IF: 5,865<br />
Butler LM, Dorsey G, Hladik W, Ros<strong>en</strong>thal PJ, Bran<strong>de</strong>r C, Neilands TB, Mbisa G, Whitby D, Kiepiela P, Mosam A, Mzolo S, Dollard<br />
Pàgina 43 <strong>de</strong> 67
SC, Martin JN.<br />
Kaposi sarcoma-associated herpesvirus (KSHV) seropreval<strong>en</strong>ce in population-based samples of African childr<strong>en</strong>: evid<strong>en</strong>cefor at<br />
least 2 patterns of KSHV transmission.<br />
J INFECT DIS 2009:430-438.<br />
IF: 5,865<br />
Calmet, M; Juve, R; Alberny, M; Andreu, A; Loureiro, E; Matas, L; Vilamala, A; Casabona, J<br />
Diagnostic resources for sexually-transmitted infections in laboratories in Catalonia (Spain)<br />
GACETA SANITARIA 2009-JUL-AUG; 23 (4): 348-350<br />
Caro-Murillo, AM; Gutierrez, F; Ramos, JM; Sobrino, P; Miro, JM; Lopez-Cortes, LF; Tural, C; Mor<strong>en</strong>o, A; Gil, ID; Angoiti, JM;<br />
Camino, X; Lleti, MS; Rubio, R; Mor<strong>en</strong>o, S; <strong>de</strong>l Amo, J<br />
HIV infection in immigrants in Spain: Epi<strong>de</strong>miological characteristics and clinical pres<strong>en</strong>tation in the CoRIS Cohort (2004-2006)<br />
ENFERM INFEC MICR CL 2009-AUG-SEP; 27 (7): 380-388<br />
IF: 1,393<br />
Del Pino-Montes J et al y grupo <strong>de</strong> trabajo <strong>de</strong>l registro<br />
Caracterísitcas <strong>de</strong> la <strong>en</strong>fermedad ósea <strong>de</strong> Paget <strong>en</strong> España. Datos <strong>de</strong>l Registro Nacional <strong>de</strong> Paget.<br />
Reumatología Clínica 2009; 5: 109-114.<br />
Esteve M, Casas I, Clèries R, Ribes J.<br />
Diagnostico <strong>de</strong> cancer <strong>en</strong> trabajadores <strong>de</strong> un c<strong>en</strong>tro sanitario.<br />
MED CLIN-BARCELONA 2009; 133(2):53-6.<br />
IF: 1,231<br />
Fernàn<strong>de</strong>z L, Rifà B, Pujol F, Becerra J, Pérez M, Merono M, Zaragoza,K, Rafael A, Diaz O, Avellaneda A, Casado, MJ, Giménez A,<br />
Casabona J<br />
Impact of the introduction of rapid HIV testing in the Voluntary Counseling and Testing sites network of Catalonia, Spain<br />
INT J STD AIDS 2009; [Epub ahead of print]<br />
IF: 1,050<br />
Folch C, Esteve A, Zaragoza K, Muñoz R, Casabona J.<br />
Correlates of int<strong>en</strong>sive alcohol and drug use in m<strong>en</strong> who have sex with m<strong>en</strong> in Catalonia, Spain.<br />
EUR J PUBLIC HEALTH 2009 Jun 29. [Epub ahead of print]<br />
IF: 2,313<br />
Folch C, Munoz R, Zaragoza K, Casabona J.<br />
Sexual risk behaviour and its <strong>de</strong>terminants among m<strong>en</strong> who have sex with m<strong>en</strong> in Catalonia, Spain.<br />
Euro Surveill 2009 Nov 26;14(47). pii: 19415.<br />
Folch C., Esteve A., Sanclem<strong>en</strong>te C., Martró E., Lugo R., Molinos S., Gonzalez V., Ausina V., Casabona J. (CIBERESP)<br />
Difer<strong>en</strong>cias <strong>en</strong> las características sociales, conductas <strong>de</strong> riesgo y preval<strong>en</strong>cia <strong>de</strong> VIH/infecciones <strong>de</strong> transmisión sexual<br />
<strong>en</strong>tre trabajadoras <strong>de</strong>l sexo españolas e inmigrantes <strong>en</strong> Cataluña.<br />
MED CLIN-BARCELONA 2009; 132: 385-388<br />
IF: 1,231<br />
Folch, C; Sanclem<strong>en</strong>te, C; Esteve, A; Martro, E; Molinos, S; Casabona, J<br />
Social characteristics, risk behaviours and differ<strong>en</strong>ces in the preval<strong>en</strong>ce of HIV/sexually transmitted infections betwe<strong>en</strong> Spanish<br />
and inmigrant female sex workers in Catalonia, Spain<br />
MED CLIN-BARCELONA 2009-març-21; 132 (10): 385-388<br />
IF: 1,231<br />
Ga<strong>de</strong>lha, T; Bisbe, J; Toril, J; Pedrajas, JNA; Monreal, M<br />
Major bleeding ev<strong>en</strong>ts in stable outpati<strong>en</strong>ts with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA<br />
registry(1)<br />
J THROMB HAEMOST 2009-AUG; 7 (8): 1414-1416<br />
IF: 6,069<br />
Garcia M, Morillas RM, Miquel M, Rodriguez O, Cirera I, Vergara M, Sala M, Gim<strong>en</strong>ez MD, Cañete N, Gallach M, Ardèvol M,<br />
Alvarez MA, Montoliu S, Romero M, Planas R, Solá R.<br />
Predictive factors of sustained virological response in pati<strong>en</strong>ts with complete early virological response to the treatm<strong>en</strong>t of<br />
hepatitis<br />
Pàgina 44 <strong>de</strong> 67
HEPATOLOGY 2009, 50(supll):A875<br />
IF: 10,840<br />
Garrido, P; Maj<strong>en</strong>, M; Vinolas, N; Artal, A; Isla, D; Felip, E; De Castro, J; Terrasa, J; Garcia-Campelo, R; Bover, I; Amador, ML; Rosell,<br />
R<br />
Lung cancer in wom<strong>en</strong>: the Spanish female-specific database WORLD 07<br />
J THORAC ONCOL 2009-SEP; 4 (9): S424-S424<br />
IF: 4,547<br />
Gomez, M; Valle, V; Aros, F; Sanz, G; Sala, J; Fiol, M; Bruguera, J; Elosua, R; Molina, L; Marti, H; Covas, MI; Rodriguez-Llorian, A;<br />
Fito, M; Suarez-Pinilla, MA; Amezaga, R; Marrugat, J<br />
Oxidized LDL, Lipoprotein (a) and Other Emerg<strong>en</strong>t Risk Factors in Acute Myocardial Infarction (FORTIAM study)<br />
REV ESP CARDIOL 2009-APR; 62 (4): 373-382<br />
IF: 2,746<br />
Hawkins NM, Huang Z, Pieper KS, Solomon SD, Kober L, Velazquez EJ, Swedberg K, Pfeffer MA, McMurray JJ, Maggioni AP;<br />
Valsartan in Acute Myocardial Infarction Trial Investigators. (Valle, Lupón)<br />
Chronic obstructive pulmonary disease is an in<strong>de</strong>p<strong>en</strong>d<strong>en</strong>t predictor of <strong>de</strong>ath but not atherosclerotic ev<strong>en</strong>ts in pati<strong>en</strong>ts with<br />
myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).<br />
EUR J HEART FAIL 2009 Mar;11(3):292-8. Epub 2009 Jan 27.<br />
IF: 3,706<br />
Huntington S, Folch C, González V, Meroño M, Ncube F, Casabona J.<br />
Preval<strong>en</strong>ce of human immuno<strong>de</strong>fici<strong>en</strong>cy virus and hepatitis C virus, and associated factors among injecting drug users in<br />
Catalonia.<br />
ENFERM INFEC MICR CL 2009 Aug 18. [Epub ahead of print]<br />
IF: 1,393<br />
Jordan AJ, Amguita MP, Investigafores BADAPIC (Lupón)<br />
Efecto <strong>de</strong>l tratami<strong>en</strong>to con estatinas <strong>en</strong> la mortalidad <strong>de</strong> una gran cohorte <strong>de</strong> paci<strong>en</strong>tes con insufici<strong>en</strong>cia cardiaca<br />
REV ESP CARDIOL 2009; 62:323-7.<br />
IF: 2,746<br />
Levy WC, Mozaffarian D, Linker DT, et al. COMET Investigators (Valle, Lupón)<br />
Years-nee<strong>de</strong>d-to-treat to add 1 year of life: a new metric to estimate treatm<strong>en</strong>t effects in randomized trials.<br />
EUR J HEART FAIL 2009; 11:256-63<br />
IF: 3,706<br />
Mirandola M, Folch Toda C, Krampac I, Nita I, Stanekova D, Stehlikova D, Toskin I, Gios L, Foschia JP, Breveglieri M, Furegato M,<br />
Castellani E, Bonavina MG; SIALON network.<br />
HIV bio-behavioural survey among m<strong>en</strong> who have sex with m<strong>en</strong> in Barcelona, Bratislava, Bucharest, Ljubljana, Prague and Verona,<br />
2008-2009.<br />
Euro Surveill 2009; 14(48). pii: 19427.<br />
Monreal, M; Trujillo-Santos, J<br />
Lessons from VTE registries: the RIETE experi<strong>en</strong>ce<br />
BEST PRACT RES CL HA 2009-MAR; 22 (1): 25-33<br />
IF: 3,134<br />
Mothe, B; Perez, I; Domingo, P; Podzamczer, D; Ribera, E; Curran, A; Vila<strong>de</strong>s, C; Vidal, F; Dalmau, D; Pedrol, E; Negredo, E; Molto,<br />
J; Pare<strong>de</strong>s, R; Perez-Alvarez, N; Gatell, JM; Clotet, B<br />
HIV-1 Infection in Subjects Ol<strong>de</strong>r than 70: A Multic<strong>en</strong>ter Cross-Sectional Assessm<strong>en</strong>t in Catalonia, Spain<br />
CURR HIV RES 2009; 7:597-600<br />
IF: 1,978<br />
Pérez Cachafeiro S, Del Amo J, Iribarr<strong>en</strong> JA, Salavert Lleti M, Gutiérrez F, Mor<strong>en</strong>o A, Labarga P, Pineda JA, Vidal F, Ber<strong>en</strong>guer J,<br />
Mor<strong>en</strong>o S; Cohorts of the Spanish AIDS Research Network (CoRIS and CoRIS-MD).<br />
Decrease in serial preval<strong>en</strong>ce of coinfection with hepatitis C virus among HIV-infected pati<strong>en</strong>ts in Spain, 1997-2006.<br />
CLIN INFECT DIS 2009 May 15;48(10):1467-70<br />
IF: 8,195<br />
Qamar, AA; Grace, ND; Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Burroughs, AK; Ripoll, C; Maurer, R; Planas, R; Escorsell, A; Garcia-<br />
Pàgina 45 <strong>de</strong> 67
Pagan, JC; Patch, D; Maltoff, DS; Makuch, R; R<strong>en</strong>don, G<br />
Incid<strong>en</strong>ce, Preval<strong>en</strong>ce, and Clinical Significance of Abnormal Hematologic Indices in Comp<strong>en</strong>sated Cirrhosis<br />
CLIN GASTROENTEROL H 2009-JUN; 7 (6): 689-695<br />
IF: 5,642<br />
Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Co<strong>de</strong>luppi M, Cocchi S, Prati F, Paci V, Meacci M, Meccugni B,<br />
Rumpianesi F, Roversi P, Cerri S, Luppi F, Ferrara G, Latorre I, Gerunda GE, Torelli G, Esposito R, Fabbri LM.<br />
Performance of tests for lat<strong>en</strong>t tuberculosis in differ<strong>en</strong>t groups of immunocompromised pati<strong>en</strong>ts.<br />
CHEST 2009 Jul;136(1):198-204. Epub 2009 Mar 24.<br />
IF: 6,360<br />
Rios, E; Ferrer, L; Casabona, J; Cayla, J; Avecilla, A; Prat, JGI; Edison, J; Perez, O; Garcia, S; Toran, P; Ruiz, M; Gros, T; Rodriguez, L;<br />
Arribas, D; Folch, C; Esteve, A<br />
Knowledge of HIV and sexually-transmitted diseases in Latin American and Maghrebi immigrants in Catalonia (Spain)<br />
GACETA SANITARIA 2009 NOV-DEC;23:533-538<br />
Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cu<strong>en</strong>ca M, Esteve M, Peña<br />
C, Llanos AC, Cantón R, Pascual A.<br />
Escherichia coli producing SHV-type ext<strong>en</strong><strong>de</strong>d-spectrum beta-lactamase is a significant cause of community-acquired infection.<br />
J ANTIMICROB CHEMOTH 2009; 63(4):781-4.<br />
IF: 4,352<br />
Romero, A; Gonzalez, V; Granell, M; Matas, L; Esteve, A; Martro, E; Rodrigo, I; Pumarola, T; Miro, JM; Casanova, A; Ferrer, E; Tural,<br />
C; <strong>de</strong>l Romero, J; Rodriguez, C; Caballero, E; Ribera, E; Casabona, J<br />
Rec<strong>en</strong>tly acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for rec<strong>en</strong>t HIV<br />
seroconversion<br />
SEX TRANSM INFECT 2009-APR; 85 (2): 106-110<br />
IF: 2,175<br />
Sabido, M; Giardina, F; Hernan<strong>de</strong>z, G; Fernan<strong>de</strong>z, VH; Monzon, JE; Ortiz, R; Montoliu, A; Casabona, J<br />
The UALE Project: Decline in the Incid<strong>en</strong>ce of HIV and Sexually Transmitted Infections and Increase in the Use of<br />
Condoms Among Sex Workers in Guatemala<br />
JAIDS-J ACQ IMM DEF 2009-MAY 1; 51: S35-S41<br />
IF: 4,207<br />
Sobrino-Vegas, P; Miguel, LGS; Caro-Murillo, AM; Miro, JM; Viciana, P; Tural, C; Saumoy, M; Santos, I; Sola, J; <strong>de</strong>l Amo, J;<br />
Mor<strong>en</strong>o, S<br />
Delayed Diagnosis of HIV Infection in a Multic<strong>en</strong>ter Cohort: Preval<strong>en</strong>ce, Risk Factors, Response to HAART and Impact on<br />
Mortality<br />
CURR HIV RES 2009-MAR; 7 (2): 224-230<br />
IF: 1,978<br />
Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, Kaldor J, Folch C, Op <strong>de</strong> Coul E, Marcus U, Hughes G,<br />
Archibald CP, Cazein F, McDonald A, Casabona J, van Sighem A, F<strong>en</strong>ton KA; Annecy MSM Epi<strong>de</strong>miology Study Group.<br />
Reemerg<strong>en</strong>ce of the HIV epi<strong>de</strong>mic among m<strong>en</strong> who have sex with m<strong>en</strong> in North America, Western Europe, and Australia, 1996-<br />
2005.<br />
ANN EPIDEMIOL 2009 Jun;19(6):423-31<br />
IF: 2,947<br />
Suriñach JM, Alvarez LR, Coll R, Carmona JA, Sanclem<strong>en</strong>te C, Aguilar E, Monreal M; FRENA Investigators.<br />
Differ<strong>en</strong>ces in cardiovascular mortality in smokers, past-smokers and non-smokers: findings from the FRENA registry.<br />
EUR J INTERN MED 2009 Sep;20(5):522-6. Epub 2009 Jun 12.PMID:<br />
IF: 1,385<br />
The Antiretroviral Therapy (ART) Cohort Collaboration<br />
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected pati<strong>en</strong>ts: a collaborative analysis of 18 HIV cohort studies<br />
LANCET 2009 Apr 18;373(9672):1352-63<br />
IF: 30,758<br />
Urrutia A, Santesmases J, Altimir S, Rey-Joly C.<br />
Outcome prediction in pati<strong>en</strong>ts in acute geriatric units<br />
Rev Esp Geriatr Gerontol 2009; NOV<br />
Pàgina 46 <strong>de</strong> 67
Vallès X, Murga GB, Hernán<strong>de</strong>z G, Sabidó M, Chuy A, Lloveras B, Alameda F, <strong>de</strong> San José S, Bosch FX, Pedroza I, Castellsagué X,<br />
Casabona J.<br />
High preval<strong>en</strong>ce of human papillomavirus infection in the female population of Guatemala.<br />
INT J CANCER 2009 Mar 19;125(5):1161-1167. [Epub ahead of print]<br />
IF: 4,722<br />
van Veldhuis<strong>en</strong> DJ, Coh<strong>en</strong>-Solal A, et al. SENIORS Investigators (Valle, Lupón)<br />
Beta-blocka<strong>de</strong> with nebivolol in el<strong>de</strong>rly heart failure pati<strong>en</strong>ts with impaired and preserved left v<strong>en</strong>tricular ejection fraction: Data<br />
From SENIORS (Study of Effects of Nebivolol Interv<strong>en</strong>tion on Outcomes and Rehospitalization in S<strong>en</strong>iors<br />
With Heart Failure).<br />
J AM COLL CARDIOL 2009; 53:2150-8.<br />
IF: 12,535<br />
Vercauter<strong>en</strong>, J; W<strong>en</strong>sing, AMJ; van <strong>de</strong> Vijver, DAMC; Albert, J; Balotta, C; Hamouda, O; Kucherer, C; Struck, D; Schmit, JC; Asjo, B;<br />
Bruckova, M; Camacho, RJ; Clotet, B; Coughlan, S; Grossman, Z; Horban, A; Korn, K; Kostrikis, L; Niels<strong>en</strong>, C; Paraskevis, D; Poljak,<br />
M; Puchhammer-Stockl, E; Riva, C; Ruiz, L; Salmin<strong>en</strong>, M; Schuurman, R; Sonnerborg, A; Stanekova, D; Stanojevic, M; Vandamme,<br />
AM; Boucher, CABSPREAD Programme<br />
Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe<br />
J INFECT DIS 2009 nov-15;200:1503-1508<br />
IF: 5,865<br />
Vi<strong>de</strong>la S, Darwich L, Cañadas MP, Pare<strong>de</strong>s R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group.<br />
Epi<strong>de</strong>miological data of differ<strong>en</strong>t human papillomavirus g<strong>en</strong>otypes in cervical specim<strong>en</strong>s of HIV-1-infected wom<strong>en</strong> without history<br />
of cervical pathology.<br />
JAIDS-J ACQ IMM DEF 2009 Feb 1;50(2):168-75.<br />
IF: 4,207<br />
Weller, I; Costagliola, D; Le<strong>de</strong>rgerber, B; Lundgr<strong>en</strong>, J; Ch<strong>en</strong>e, G; Touloumi, G; Warszawski, J; Meyer, L; Dabis, F; Krause, MM;<br />
Leport, C; <strong>de</strong> Wolf, F; Reiss, P; Porter, K; Dorrucci, M; Sabin, C; Gibb, D; Del Amo, J; Obel, N; Thorne, C; Mocroft, A; Kirk, O;<br />
Staszewski, S; Perez-Hoyos, S; Almeda, J; Antinori, A; Monforte, AD; <strong>de</strong> Martino, M; Brockmeyer, N; Fatk<strong>en</strong>heuer, G; Ramos, J;<br />
Battegay, M; Mussini, C; Tookey, P; Casabona, J; Miro, JM; Castagna, A; <strong>de</strong> Wit, S; Torti, C; Teira, R; Garrido, M; De<strong>de</strong>s, N; Sabin, C;<br />
Phillips, A; Furrer, H; Kirk, O; Egger, M; Dabis, F; Newell, ML; Sterne, J; Tel<strong>en</strong>ti, A - The Collaboration of Observational HIV<br />
Epi<strong>de</strong>miological Research Europe (COHERE) study group.<br />
Prognosis of HIV-associated non-Hodgkin lymphoma in pati<strong>en</strong>ts starting combination antiretroviral therapy<br />
AIDS 2009; 23:2029-2037<br />
IF: 4,909<br />
Zwahl<strong>en</strong>, M; Harris, R; May, M; Hogg, R; Costagliola, D; <strong>de</strong> Wolf, F; Gill, J; Fatk<strong>en</strong>heuer, G; Lewd<strong>en</strong>, C; Saag, M; Staszewski, S;<br />
Monforte, AD; Casabona, J; Lampe, F; Justice, A; von Wyl, V; Egger, M; Casabona, J; Ch<strong>en</strong>e, G; Costagliola, D; Dabis, F; Monforte,<br />
AD; <strong>de</strong> Wolf, F; Egger, M; Fatk<strong>en</strong>heuer, G; Gill, J; Hogg, R; Justice, A; Kitahata, M; Lampe, F; Le<strong>de</strong>rgerber, B; Leport, C; May, M;<br />
Mocroft, A; Phillips, A; Reiss, P; Saag, M; Sabin, C; Staszewski, S; Sterne, J; Harris, R; Beckthold, B; Yip, B; Dauer, B; Fusco, J;<br />
Darney, E; Rick<strong>en</strong>bach, M; Lavignolle, V; van Leth, F; Pereira, E; Pezzotti, P; Phillips, A; Sabin, C<br />
Mortality of HIV-infected pati<strong>en</strong>ts starting pot<strong>en</strong>t antiretroviral therapy: comparison with the g<strong>en</strong>eral population in nine<br />
industrialized countries<br />
INT J EPIDEMIOL 2009; 38:1624-1633<br />
IF: 5,262<br />
INVESTIGACIÓ TRASLACIONAL<br />
Sabidó M, Hernán<strong>de</strong>z G, González V, Vallès X, Montoliu A, Figuerola J, Isern V, Viñado B, Figueroa L, Casabona J. Clinic-based<br />
evaluation of a rapid point-of-care test for <strong>de</strong>tection of Chlamydia trachomatis in specim<strong>en</strong>s from sex workers in Escuintla,<br />
Guatemala. J CLIN MICROBIOL 2009 Feb;47(2):475-6. Epub 2008 Dec 3 IF: 4,126<br />
Projectes<br />
INVESTIGACIÓ CLÍNICA<br />
CASABONA BARBARA, JORDI - CEEISCAT<br />
Pàgina 47 <strong>de</strong> 67
FIPSE - Núm. Exp.: 32620/06<br />
Sinergias <strong>en</strong>tre la infección por el VIH y el virus <strong>de</strong>l papiloma humano: historia natural <strong>de</strong>l cáncer <strong>de</strong> cervix y su prev<strong>en</strong>ción <strong>en</strong><br />
mujeres infectadas por el VIH.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 70.000 €<br />
CASABONA BARBARA, JORDI - CEEISCAT<br />
Ministerio <strong>de</strong> Trabajo y Asuntos Sociales - Núm. Exp.: 81/06<br />
Sinergias <strong>en</strong>tre la infección por el VIH y el virus <strong>de</strong>l papiloma humano: historia natural <strong>de</strong>l cáncer <strong>de</strong> cérvix y su prev<strong>en</strong>ción <strong>en</strong><br />
mujeres infectadas por el VIH. (METAS)<br />
Durada: 2 anys - (2007-2009)<br />
Import Concedit: 56.294 €<br />
CASABONA BARBARA, JORDI - CEEISCAT<br />
FIPSE - Núm. Exp.: 36787/08<br />
Impacto <strong>de</strong>l diagnóstico <strong>de</strong> VIH <strong>en</strong> las conductas sexuales. Indicadores, <strong>de</strong>terminantes y evolución temporal <strong>en</strong> la cohorte PISCIS.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 183.837 €<br />
CASABONA BARBARA, JORDI - CEEISCAT<br />
AGAUR - Agència <strong>de</strong> Gestió d'Ajuts Universitaris i <strong>de</strong> Recerca - Núm. Exp.: 2008ARAF1-00012<br />
Diagnosi <strong>de</strong> situació <strong>de</strong> salut sexual i reproductiva <strong>de</strong> treballadors/res <strong>de</strong>l sexe immigrants <strong>de</strong> Catalunya.<br />
Durada: 2 anys - (2008-2010)<br />
Import Concedit: 17.500 €<br />
FOLCH TODA, CINTA - CEEISCAT<br />
COMISSIÓ EUROPEA - Núm. Exp.: 2008 12 14 EMIS<br />
European MSM Internet Survey on HIV and STI. (DG Sanco) (EMIS)<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 70.000 €<br />
FOLCH TODA, CINTA - CEEISCAT<br />
COMISSIÓ EUROPEA - Núm. Exp.: 2007309<br />
SIALON. Capacity building in HIV and Syphilis preval<strong>en</strong>ce estimation using non invasive methods among msm in countries of south<br />
and eastern Europe. (DG Sanco)<br />
Durada: 2 anys - (2007-2009)<br />
Import Concedit: 58.000 €<br />
MARTINEZ RIVERA, CARLOS - PNEUMOLOGIA<br />
FIS - Núm. Exp.: PI08/90251<br />
AUDIPOC: Auditoría Clínica Nacional sobre exacerbaciones <strong>de</strong> la EPOC <strong>en</strong> España. Proyecto Coordinado. Subproyecto AUDIPOC<br />
Cataluña.<br />
Durada: 2 anys - (2008-2010)<br />
Import Concedit: 14.200 €<br />
MUGA BUSTAMANTE, ROBERT - MEDICINA INTERNA - DESINTOXICACIÓ<br />
FIS - Núm. Exp.: PI070342<br />
Vacuna prev<strong>en</strong>tiva <strong>de</strong>l VIH: Anclaje <strong>de</strong> una cohorte <strong>de</strong> individuos a riesgo. Análisis <strong>de</strong> la aceptación y predisposición a participar<br />
<strong>en</strong> un <strong>en</strong>sayo <strong>de</strong> vacuna <strong>en</strong> fase II-III.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 18.100 €<br />
MUGA BUSTAMANTE, ROBERT - MEDICINA INTERNA - DESINTOXICACIÓ<br />
FIPSE - Núm. Exp.: 36781/08<br />
Grupo <strong>de</strong> estudio multicéntrico español <strong>de</strong> seroconvertores (GEMES): Estudio <strong>de</strong>l período <strong>de</strong> incubación <strong>de</strong>l SIDA y la<br />
superviv<strong>en</strong>cia <strong>de</strong> la infección por VIH <strong>en</strong> cohortes <strong>de</strong> seroconvertores.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 23.959 €<br />
TURAL LLACHER, CRISTINA - MEDICINA INTERNA - VIH<br />
FIPSE - Núm. Exp.: 36702/07<br />
Cohorte <strong>de</strong> GESIDA <strong>de</strong> paci<strong>en</strong>tes coinfectados por VIH y virus <strong>de</strong> Hepatitis C que recib<strong>en</strong> tratami<strong>en</strong>to para la Hepatitis C (2008-<br />
Pàgina 48 <strong>de</strong> 67
2010).<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 3.300 €<br />
INVESTIGACIÓ TRASLACIONAL<br />
MASIP MASIP, JOAN - CEEISCAT<br />
FIPSE - Núm. Exp.: 36721/08<br />
Estudio clínico-epi<strong>de</strong>miológico <strong>de</strong> las parejas madre-hijo expuestas al VIH y/o a los fármacos antirretrovirales.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 36.898 €<br />
SABRIA LEAL, MIQUEL - MEDICINA INTERNA - UMI, MALALTIES INFECCIOSES<br />
FIS - Núm. Exp.: PI080774<br />
Descripción <strong>de</strong> factores <strong>de</strong> virul<strong>en</strong>cia/compet<strong>en</strong>cia <strong>de</strong> L. pneumophila mediante técnicas <strong>de</strong> proteómica.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 56.800 €<br />
Pàgina 49 <strong>de</strong> 67
TECNOLOGÍA APLICADA<br />
A LA BIOMEDICINA<br />
(BIOTECNOLOGÍA,<br />
BIOINGENIERÍA Y BIOINFORMÁTICA)<br />
Publicacions<br />
INVESTIGACIÓ BÀSICA<br />
Bogonez-Franco P, Bragos R, Bayes-G<strong>en</strong>is A, Rosell-Ferrer J.<br />
Implantable bioimpedance monitor using ZigBee<br />
Conf Proc IEEE Eng Med Biol Soc 2009;1:4868-71.<br />
Cañadas MP, Darwich L, Sirera G, Cirigliano V, Bofill M, Clotet B, Vi<strong>de</strong>la S; on behalf of the HIV-HPV Study Group.<br />
New molecular method for the <strong>de</strong>tection of human papillomavirus type 16 integration.<br />
CLIN MICROBIOL INFEC 2009 Oct 15. [Epub ahead of print]<br />
IF: 4,014<br />
Conesa, JA; Font, R; Fullana, A; Martin-Gullon, I; Aracil, I; Galvez, A; Molto, J; Gomez-Rico, MF<br />
Comparison betwe<strong>en</strong> emissions from the pyrolysis and combustion of differ<strong>en</strong>t wastes<br />
J ANAL APPL PYROL 2009; 84:95-102<br />
IF: 2,311<br />
Diestra K., Juan C., Curiao T., Moyá B., Miró E., Oteo J., Coque TM., Pérez-Vázquez M., Campos J., Cantón R., Oliver A., Navarro F.,<br />
and Red Española <strong>de</strong> Investigación <strong>en</strong> Patología Infecciosa (REIPI) Spain<br />
Characterization of plasmids <strong>en</strong>coding bla ESBL and surrounding g<strong>en</strong>es in Sapnish clinical isolates of Escherichia coli and<br />
Klebsiella pneumoniae<br />
J ANTIMICROB CHEMOTH 2009; 63: 60-66<br />
IF: 4,352<br />
Fu<strong>en</strong>tes G, Oyarzabal J, Rojas AM.<br />
Databases of protein-protein interactions and their use in drug discovery.<br />
CURR OPIN DRUG DISC 2009 May;12(3):358-66.<br />
IF: 4,904<br />
JA.Gómez Gerique, F.Izquierdo, A.Galán, P Laporta, N.Garnacho, y Nikos Ekizoglou .<br />
Evaluación <strong>de</strong> la Troponina I <strong>en</strong> el analizador Pathfast.<br />
REV LAB CLIN 2009;2 :131- 138. ISSN:1888-4008<br />
Jordà M, Rodríguez J, Frigola J, Peinado MA.<br />
Analysis of DNA methylation by amplification of intermethylated sites (AIMS).<br />
Methods Mol Biol 2009;507:107-16.<br />
Krallinger M, Rojas AM, Val<strong>en</strong>cia A.<br />
Creating refer<strong>en</strong>ce datasets for systems biology applications using text mining.<br />
ANN NY ACAD SCI 2009 Mar;1158:14-28<br />
IF: 2,670<br />
Luisa María Villar Guimerans, Juan José Rodríguez Molina, Cándido Juárez Rubio, Grupo <strong>de</strong> Trabajo <strong>de</strong> Inmunoquímica (Eva Mª<br />
Martínez Cáceres) <strong>de</strong>l Taller SEI 2005, y Julia Sequí Navarro<br />
Análisis interlaboratorio <strong>de</strong> parámetros inmunoquímicos, paraproteínas y bandas oligoclonales. Informe técnico <strong>de</strong>l IV Taller <strong>de</strong><br />
Inmunoquímica <strong>de</strong> la Sociedad Española <strong>de</strong> Inmunología<br />
Inmunología 2009 Abril-Junio; Vol. 28, Núm 2: 79-95<br />
Lundin, M; Szymas, J; Lin<strong>de</strong>r, E; Beck, H; <strong>de</strong> Wil<strong>de</strong>, P; van Kriek<strong>en</strong>, H; Rojo, MG; Mor<strong>en</strong>o, I; Ariza, A; Tuzlali, S; Dervisoglu, S; Helin,<br />
Pàgina 50 <strong>de</strong> 67
H; Lehto, VP; Lundin, J<br />
A European network for virtual microscopy-<strong>de</strong>sign, implem<strong>en</strong>tation and evaluation of performance<br />
VIRCHOWS ARCH 2009-APR; 454 (4): 421-429<br />
IF: 2,305<br />
Molto, J; Font, R; Galez, A; Conesa, JA<br />
Pyrolysis and combustion of electronic wastes<br />
J ANAL APPL PYROL 2009; 84:68-78<br />
IF: 2,311<br />
N. Ortega Castillo, J Barallat Martínez <strong>de</strong> Osaba, Y. Alba Macias, C. Morales Indiano, M Dola<strong>de</strong> Botias, ML Granada Ybern.<br />
Estabilidad <strong>de</strong> las conc<strong>en</strong>traciones <strong>de</strong> factor <strong>de</strong> crecimi<strong>en</strong>to similar a la insulina tipo 1, gastrina y androst<strong>en</strong>diona <strong>en</strong> suero.<br />
REV LAB CLIN 2009;2:161-8. ISSN: 1888-4008<br />
Rosales, M; Ra<strong>de</strong>va, P; Rodriguez-Leor, O; Gil, D<br />
Mo<strong>de</strong>lling of image-catheter motion for 3-D IVUS<br />
MED IMAGE ANAL 2009-FEB; 13 (1): 91-104<br />
IF: 3,093<br />
Zhang, JX; Pilette, MA; Cuevas, F; Charp<strong>en</strong>tier, T; Mauri, F; Latroche, M<br />
X-ray Diffraction and NMR Studies of Na3-nLinAlH6 (n=0, 1, 2) Alanates Synthesized by High-Pressure Reactive Ball Milling<br />
J PHYS CHEM C 2009; 113:21242-21252<br />
IF: 4,224<br />
INVESTIGACIÓ CLÍNICA<br />
Bussadori, C; Moreo, A; Di Donato, M; De Chiara, B; Negura, D; Dall'Aglio, E; Lobiati, E; Chessa, M; Arcidiacono, C; Dua, JS; Mauri,<br />
F; Carminati, M<br />
A new 2D-based method for myocardial velocity strain and strain rate quantification in a normal adult and paediatric population:<br />
assessm<strong>en</strong>t of refer<strong>en</strong>ce values<br />
Cardiovasc Ultrasound 2009; 7:8<br />
Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, García-Olivé I, Lacoma A, Ausina V, Domínguez J.<br />
Evaluation of interferon-gamma release assays in the diagnosis of rec<strong>en</strong>t tuberculosis infection in health care workers.<br />
PLOS ONE 2009 Aug 24;4(8):e6686.<br />
IF: 4,351<br />
Castano, C; Ser<strong>en</strong>a, J; Davalos, A<br />
Use of the New Solitaire (TM) AB Device for Mechanical Thrombectomy wh<strong>en</strong> Merci Clot Retriever Has Failed to Remove the Clot<br />
A Case Report<br />
INTERV NEURORADIOL 2009-JUN; 15 (2): 209-214<br />
IF: 0,128<br />
Cobo E, Seca<strong>de</strong>s JJ, Miras F, Antonio González J, Saver JL, Corchero C, Rius R, Dàvalos A.<br />
Boosting The Chances To Improve Stroke Treatm<strong>en</strong>t<br />
STROKE 2009 Dec 24.<br />
IF: 7,041<br />
Hernán<strong>de</strong>z A, Matas L, Ausina V<br />
Limpieza, <strong>de</strong>sinfección y esterilización <strong>en</strong> la prev<strong>en</strong>ción <strong>de</strong> las infecciones<br />
Medicina interna 2009; cap. 254, sección 17<br />
M.Solá, A.Mariscal, M.Fraile, S.Vizcaya, J.Julián, V.Vallejos, E.Castellà, J. Fuster, M.Milà,<br />
Radiogui<strong>de</strong>d localization of non-palpable breast cáncer lesions. A randomized comparison with wire localization in pati<strong>en</strong>ts<br />
un<strong>de</strong>rgoing conservative surgery and s<strong>en</strong>tinel no<strong>de</strong> biopsy.<br />
EUR J NUCL MED MOL I 2009, 36 (suppl 2): S281-S496.<br />
IF: 4,531<br />
Mariscal A, Solà M, Pérez A, Julián JF, Fraile M, Vizcaya S, Fernán<strong>de</strong>z J.<br />
Radiogui<strong>de</strong>d Localization of Nonpalpable Breast Cancer Lesions: Randomized Comparison With Wire Localization in Pati<strong>en</strong>ts<br />
Un<strong>de</strong>rgoing Conservative Surgery and S<strong>en</strong>tinel No<strong>de</strong> Biopsy.<br />
Pàgina 51 <strong>de</strong> 67
AM J ROENTGENOL 2009; 193:1001-1009<br />
IF: 2,951<br />
Martro, E; Garcia-Sierra, N; Gonzalez, V; Salu<strong>de</strong>s, V; Matas, L; Ausina, V<br />
Evaluation of an Automated Nucleic Acid Extractor for Hepatitis C Virus Load Quantification<br />
J CLIN MICROBIOL 2009-MAR; 47 (3): 811-813<br />
IF: 4,126<br />
Navarro JT., Hernán<strong>de</strong>z A., Rodríguez-Manzano J., Mate JL., Grau J., Morga<strong>de</strong>s M., Martró E., Tural C., Ribera JM., Matas L.<br />
Plasma Epstein-Barr viral load measurem<strong>en</strong>t as a diagnostic marker of lymphola in HIB-infected pati<strong>en</strong>ts.<br />
AIDS 2009; accepted<br />
IF: 4,909<br />
Plow EB, Carey JR, Nudo RJ, Pascual-Leone A.<br />
A lnvasive cortical stimulation to promote recovery of function after stroke: a critica1 appraisal.<br />
STROKE 2009 May;40(5).<br />
IF: 7,041<br />
Santos-Garcia, D; Blanco, M; Ser<strong>en</strong>a, J; Arias, S; Millan, M; Rodriguez-Yanez, M; Leira, R; Davalos, A; Castillo, J<br />
Brachial arterial flow mediated dilation in acute ischemic stroke<br />
EUR J NEUROL 2009-JUN; 16 (6): 684-690<br />
IF: 2,510<br />
Tutor-Crespo, MJ; Hermida, J; Romero, R; Tutor, JC<br />
Two sampling time profiles for the abbreviated estimation of mycoph<strong>en</strong>olic acid area un<strong>de</strong>r the curve in adult r<strong>en</strong>al transplant<br />
recipi<strong>en</strong>ts treated with mycoph<strong>en</strong>olate mofetil and concomitant tacrolimus<br />
J CLIN PHARM THER 2009; 34:531-537<br />
IF: 1,671<br />
INVESTIGACIÓ TRASLACIONAL<br />
B<strong>en</strong>ito P<strong>en</strong>alva J, Opisso E, Medina J, Corrons M, Kumru H, Vidal J, Valls-Solé J.<br />
H reflex modulation by transcranial magnetic stimulation in spinal cord injury subjects affer gait training with electromechanical<br />
systems<br />
SPINAL CORD 2009 Nov 24<br />
IF: 1,783<br />
Blanco, S; Forne, M; Lacoma, A; Prat, C; Cuesta, MA; Fu<strong>en</strong>zalida, L; Viver, JM; Dominguez, J<br />
Evaluation of a latex agglutination test (PYLOGEN) for the <strong>de</strong>tection of Helicobacter pylori in stool specim<strong>en</strong>s<br />
DIAGN MICR INFEC DIS 2009-APR; 63 (4): 349-353<br />
IF: 2,451<br />
Cardona, PJ; As<strong>en</strong>sio, JG; Arbues, A; Otal, I; Lafoz, C; Gil, O; Caceres, N; Ausina, V; Gicquel, B; Martin, C<br />
Ext<strong>en</strong><strong>de</strong>d safety studies of the att<strong>en</strong>uated live tuberculosis vaccine SO2 based on phoP mutant<br />
VACCINE 2009-APR 21; 27 (18): 2499-2505<br />
IF: 3,616<br />
Fu<strong>en</strong>zalida L, Blanco S, Prat C, Vivancos M, Dominguez MJ, Mòdol JM, Rodrigo C, Ausina V.<br />
Utility of the rapid antig<strong>en</strong> <strong>de</strong>tection BinaxNOW A&B test for <strong>de</strong>tection of novel influ<strong>en</strong>za A (H1N1) virus.<br />
CLIN MICROBIOL INFEC 2009 Dec 29. [Epub ahead of print]<br />
IF: 4,014<br />
Garcia-Sierra, N; Martro, E; Castella, E; Llatjos, M; Tarrats, A; Bascunana, E; Diaz, R; Carrasco, M; Sirera, G; Matas, L; Ausina, V<br />
Evaluation of an Array-Based Method for Human Papillomavirus Detection and G<strong>en</strong>otyping in Comparison with Conv<strong>en</strong>tional<br />
Methods Used in Cervical Cancer Scre<strong>en</strong>ing<br />
J CLIN MICROBIOL 2009-JUL; 47 (7): 2165-2169<br />
IF: 4,126<br />
Gatta, C; Pujol, O; Rodriguez-Leor O; Mauri J; Ra<strong>de</strong>va P<br />
Fast Rigid Registration of Vascular Structures in IVUS Sequ<strong>en</strong>ces<br />
IEEE T INF TECHNOL B 2009 NOV;13:1006-1011<br />
Pàgina 52 <strong>de</strong> 67
IF: 1,694<br />
Hernan<strong>de</strong>z-Sabate, A; Gil, D; Fernan<strong>de</strong>z-Nofrerias, E; Ra<strong>de</strong>va, P; Marti, E<br />
Approaching Artery Rigid Dynamics in IVUS<br />
IEEE T MED IMAGING 2009 NOV;28:1670-1680<br />
IF: 3,540<br />
Jafari, C; Thijs<strong>en</strong>, S; Sotgiu, G; Goletti, D; Dominguez J; Losi, M; Eberhardt, R; Kirst<strong>en</strong>, D; Kalsdorf, B; Bossink, A; Latorre, I; Migliori,<br />
GB; Strassburg, A; Winteroll, S; Greinert, U; Richeldi, L; Ernst, M; Lange, C<br />
Bronchoalveolar Lavage Enzyme-linked Immunospot for a Rapid Diagnosis of Tuberculosis A Tuberculosis Network European<br />
Trialsgroup Study<br />
AM J RESP CRIT CARE 2009-oct-01; 180 (7): 666-673<br />
IF: 10,689<br />
Laur<strong>en</strong>cin, D; Gervais, C; Wong, A; Coelho, C; Mauri, F; Massiot, D; Smith, ME; Bonhomme, C<br />
Implem<strong>en</strong>tation of High Resolution Ca-43 Solid State NMR Spectroscopy: Toward the Elucidation of Calcium Sites in Biological<br />
Materials<br />
J AM CHEM SOC 2009; 131:13430-13440<br />
IF: 8,580<br />
Moreo, A; Ambrosio, G; De Chiara, B; Pu, M; Tran, T; Mauri, F; Raman, SV<br />
Influ<strong>en</strong>ce of Myocardial Fibrosis on Left V<strong>en</strong>tricular Diastolic Function Noninvasive Assessm<strong>en</strong>t by Cardiac Magnetic Resonance<br />
and Echo Circulation-cardiovascular imaging 2009; 2:437-443<br />
Quesada MD, Giménez M, Molinos S et al<br />
Performance of VITEK-2 compact and overnight microscan panels for direct id<strong>en</strong>tificaction and susceptibility testing of<br />
gramnegative bacilli from positive FAN BacT/AlerT blood culture bottles<br />
CLIN MICROBIOL INFEC 2009.<br />
IF: 4,014<br />
Projectes<br />
INVESTIGACIÓ TRASLACIONAL<br />
GASSULL DURO, MIQUEL ANGEL - DIRECCIÓ CIENTÍFICA<br />
CIDEM - Núm. Exp.: VALCON08-2-0008<br />
Avaluació <strong>de</strong> la cartera <strong>de</strong> projectes <strong>de</strong> l'IGTP.<br />
Durada: 1 anys - (2009-2010)<br />
Import Concedit: 14.700 €<br />
JULIAN IBAÑEZ, JUAN FRANCISCO - CIRURGIA GENERAL I DIGESTIVA<br />
CIDEM - Núm. Exp.: VALTEC09-2-0098<br />
Ús <strong>de</strong> gel <strong>de</strong> plaquetes per a la cirurgia restitutiva <strong>de</strong> volum <strong>de</strong> la mama (PRP)<br />
Durada: 2 anys - (2009-2011)<br />
Import Concedit: 79.360 €<br />
MAURI FERRE, JOSEPA - CARDIOLOGIA<br />
FIS - Núm. Exp.: PI060957<br />
Caracterización <strong>de</strong> la placa mediante análisis por visión artificial a partir <strong>de</strong> imág<strong>en</strong>es <strong>de</strong> ecografía intracoronaria.<br />
Durada: 3 anys - (2006-2009)<br />
Import Concedit: 77.440 €<br />
RODRIGUEZ LEOR, ORIOL - CARDIOLOGIA<br />
FIS - Núm. Exp.: PI070454<br />
Valoración semicuantitativa <strong>de</strong> la perfusión miocárdica <strong>en</strong> el infarto agudo <strong>de</strong> miocardio a partir <strong>de</strong>l análisis angiográfico. Valor<br />
pronóstico <strong>en</strong> paci<strong>en</strong>tes tratados con angioplastia primaria.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 56.000 €<br />
Pàgina 53 <strong>de</strong> 67
INNOVACIÓN CLÍNICO-<br />
TERAPÉUTICA Y<br />
SERVICIOS SANITARIOS<br />
Publicacions<br />
INVESTIGACIÓ BÀSICA<br />
Fernan<strong>de</strong>z-Cancio, M; Audi, L; Carrascosa, A; Toran, N; Andaluz, P; Esteban, C; Granada, ML<br />
Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis g<strong>en</strong>e expression in human fetal<br />
epiphyseal chondrocytes<br />
GROWTH HORM IGF RES 2009-JUN; 19 (3): 232-237<br />
IF: 2,352<br />
García-Molina A, Enseñat-Cantallops A, Tirapu-Ustárroz J, Roig-Rovira T.<br />
Maturation of the prefrontal cortex and <strong>de</strong>velopm<strong>en</strong>t of the executive functions during the first five years of life.<br />
REV NEUROLOGIA 2009 Apr 16-30; 48(8):435-40.<br />
IF: 1,234<br />
Luc<strong>en</strong>a, MI; Crespo, E; Ulzurrun, E; Ruiz-Cabello, F; Borraz, Y; Cueto, R; Robles, M; Fernan<strong>de</strong>z, MC; Romero-Gomez, M; Costa, J;<br />
Barriocanal, A; Planas, R; Guarner, C; Andra<strong>de</strong>, RJ<br />
Role of polymorphic bile salt export pump (bsep, abcb11) and multidrug-resistance-associated protein 2 (mrp2, abcc2)<br />
transporters in drug-induced liver injury<br />
BASIC CLIN PHARMACOL 2009-AUG; 105: 76-77<br />
IF: 2,308<br />
Ricós C., Perich C., Álvarez V., Biosca C., Doménech MV., Jiménez CV., Minchinela J., Simón M., Cava F., Garcia Lario JV., Fernán<strong>de</strong>z<br />
P.<br />
Aplicación <strong>de</strong>l mo<strong>de</strong>lo Seis-Sigma <strong>en</strong> la mejora <strong>de</strong> la calidad analítica <strong>de</strong>l laboratorio clínico<br />
REV LAB CLIN 2009;2:2-7.<br />
INVESTIGACIÓ CLÍNICA<br />
A.Carreres<br />
El punt <strong>de</strong> vista d’una metgessa assist<strong>en</strong>cial d’hospital.<br />
REV R ACAD MED CATALUNYA 2009; 24: 53-56<br />
Andreo F, Ruiz-Manzano J, Prat C, Lores L, Blanco S, Malet A, Gallardo X, Domínguez J.<br />
Utility of pneumococcal urinary antig<strong>en</strong> <strong>de</strong>tection in diagnosing exacerbations in COPD pati<strong>en</strong>ts.<br />
RESP MED 2009 Nov 4. [Epub ahead of print]<br />
IF: 2,331<br />
Andreo, F; Prat, C; Ruiz-Manzano, J; Lores, L; Blanco, S; Cuesta, MA; Gim<strong>en</strong>ez, M; Dominguez, J<br />
Persist<strong>en</strong>ce of Streptococcus pneumoniae urinary antig<strong>en</strong> excretion after pneumococcal pneumonia<br />
EUR J CLIN MICROBIOL 2009-FEB; 28 (2): 197-201<br />
IF: 2,605<br />
Angi M, Romano V, Vall<strong>de</strong>peras X, Romano F, Romano MR<br />
Macular s<strong>en</strong>sitivity changes for <strong>de</strong>tection of chloroquine toxicity in asymptomatic pati<strong>en</strong>t<br />
Int Ophthalmol Enero 2009<br />
Arcelus, JI; Cairols, M; Granero, X; Jim<strong>en</strong>ez, D; Llau, JV; Monreal, M; Vic<strong>en</strong>te, V<br />
New oral anticoagulants: A multidisciplinary approach<br />
MED CLIN-BARCELONA 2009 oct-10;133:508-512<br />
Pàgina 54 <strong>de</strong> 67
IF: 1,231<br />
Ardèvol M, Valera M, Hidalgo JA, Codina C, Alvarez L, Castillo I<br />
Impacto <strong>de</strong> la at<strong>en</strong>ción farmacéutica regulada sobre la respuesta virológica <strong>en</strong> HCC y la perman<strong>en</strong>cia al tratami<strong>en</strong>to con<br />
peginterferón alfa 2a y ribavirina<br />
FARMACIA 2009; 33(suppl):11-2.<br />
IF: 0,144<br />
Arditi C, Gonvers JJ, Burnand B, Minoli G, Oertli D, Lacaine F, Dubois RW, Va<strong>de</strong>r JP, Schusselé Filliettaz S, Peytremann-Bri<strong>de</strong>vaux I,<br />
Pittet V, Juillerat P, Froehlich F; EPAGE II Study Group.<br />
Appropriat<strong>en</strong>ess of colonoscopy in Europe (EPAGE II). Surveillance after polypectomy and after resection of colorectal cancer.<br />
ENDOSCOPY 2009 Mar;41(3):209-17. Epub 2009 Mar 11.<br />
IF: 5,545<br />
Arditi C, Peytremann-Bri<strong>de</strong>vaux I, Burnand B, Eckardt VF, Bytzer P, Agréus L, Dubois RW, Va<strong>de</strong>r JP, Froehlich F, Pittet V, Schusselé<br />
Filliettaz S, Juillerat P, Gonvers JJ; EPAGE II Study Group.<br />
Appropriat<strong>en</strong>ess of colonoscopy in Europe (EPAGE II). Scre<strong>en</strong>ing for colorectal cancer.<br />
ENDOSCOPY 2009 Mar;41(3):200-8. Epub 2009 Mar 11.<br />
IF: 5,545<br />
Arméstar F, Mesalles E, Font A, Arellano A, Roca J, Klamburg J, Fernán<strong>de</strong>z-Llamazares J<br />
Complicaciones postoperatorias tras esofaguectomía <strong>en</strong> el carcinoma esofágico<br />
MEDICINA INTENSIVA 2009;33: 224-32<br />
Arméstar F, Mesalles E, Manciño, Matas L<br />
SDRA secundario a Fiebre Botonosa Mediterránea<br />
MEDICINA INTENSIVA 2009;33:306<br />
Arzoz-Fabregas M, Ibarz-Servio L, Blasco-Casares FJ, Ramón-Dalmau M, Ruiz -Marcellán F.J.<br />
Can infundibular height predict the clear<strong>en</strong>ce of lower pole calyceal Stone after extracorporeal shockwave lithotripsy.<br />
INT J UROL 2009 Mar-Apr;35(2):140-9; discussion 149-50.<br />
IF: 1,158<br />
Barba, R; Bisbe, J; Pedrajas, JNA; Toril, J; Monte, R; Munoz-Torrero, JFS; Monreal, M<br />
Body mass in<strong>de</strong>x and outcome in pati<strong>en</strong>ts with coronary, cerebrovascular, or peripheral artery disease: findings from the FRENA<br />
registry<br />
EUR J CARDIOV PREV R 2009-AUG; 16 (4): 457-463<br />
IF: 2,511<br />
Baz, JA; Albarran, A; Pinar, E; Mauri, J<br />
Spanish Cardiac Catheterization and Coronary Interv<strong>en</strong>tion Registry. 18(th) Official Report of the Spanish Society of Cardiology<br />
Working Group on Cardiac Catheterization and Interv<strong>en</strong>tional Cardiology (1990-2008)<br />
REV ESP CARDIOL 2009; 62:1418-1434<br />
IF: 2,746<br />
Bernabeu M, Demirtas-Tatlie<strong>de</strong> A, Opisso E, Lopez R, Tormos JM, Pascual-Leone A.<br />
Abnormal corticospinal excitability in traumatic diffuse axonal braininjury.<br />
J NEUROTRAUM 2009 Dec;26(12):2185-93<br />
IF: 4,252<br />
Bernabeu M, Laxe S, Lopez R, Stucki G, Ward A, Barnes M, Kostanjsek N, Reed G, Tate R, Whyte J, Zasler N, Cieza A.<br />
Developing core sets for persons with traumatic brain injury based on the international classification of functioning, disability, and<br />
healt<br />
NEUROREHAB NEURAL RE 2009 Jun; 23(5):464-7.<br />
IF: 5,398<br />
Blanco-Molina, A; Trujillo-Santos, J; Tirado, R; Canas, I; Riera, A; Val<strong>de</strong>s, M; Monreal, M<br />
V<strong>en</strong>ous thromboembolism in wom<strong>en</strong> using hormonal contraceptives<br />
THROMB HAEMOSTASIS 2009-MAR; 101 (3): 478-482<br />
IF: 3,619<br />
Blasco, PB; Comas, JG; Del Alcazar Munoz R<br />
Pàgina 55 <strong>de</strong> 67
Spontaneous improvem<strong>en</strong>t of a haemodynamically significant v<strong>en</strong>tricular septal <strong>de</strong>fect produced by blunt chest trauma in a child<br />
CARDIOL YOUNG 2009-FEB; 19 (1): 109-110<br />
IF: 1,804<br />
Boada A, Carrascosa J, Leal L, Ferrándiz C.<br />
G<strong>en</strong>eralized cutaneous drug eruption due to strontium ranelate<br />
J EUR ACAD DERMATOL 2009:23:321-22 (A)<br />
IF: 2,787<br />
Boix J, Lor<strong>en</strong>zo-Zúñiga V, Añaños F, Mor<strong>en</strong>o <strong>de</strong> Vega V, Planas R.<br />
A 2-rooms-per-<strong>en</strong>doscopist mo<strong>de</strong>l <strong>en</strong>hances effici<strong>en</strong>cy in GI <strong>en</strong>doscopy.<br />
GASTROINTEST ENDOSC 2009 Nov;70(5):1047-8; author reply 1048-9.<br />
IF: 6,713<br />
Boix, J; Lor<strong>en</strong>zo-Zuniga, V; <strong>de</strong> Vega, VM; Dom<strong>en</strong>ech, E; Gassull, MA<br />
Endoscopic resection of ampullary tumors: 12-year review of 21 cases<br />
SURG ENDOSC 2009-JAN; 23 (1): 45-49<br />
IF: 3,307<br />
Boix, J; Lor<strong>en</strong>zo-Zuniga, V; <strong>de</strong> Vega, VM; Planas, R<br />
Argon Plasma Coagulation Versus Endoscopic Mucosal Resection in Pati<strong>en</strong>ts with Dysplastic Barrett's Esophagus<br />
DIGEST DIS SCI 2009-AUG; 54 (8): 1808-1809<br />
IF: 1,838<br />
Bolognini N, Pascual-Leone A, Fregni<br />
Using non-invasive brain stimulation to augm<strong>en</strong>t motor training-induced plasticity.<br />
J NEUROENG REHABIL 2009 Mar 17;6:8.<br />
IF: 2,115<br />
Bonafont X, Bock A, Carter D, Brunkhorst R, Carrera F, Iskedjian M, Molemans B, Dehmel B, Robbins SA<br />
A meta-analysis of the relative doses of erythropoiesis-stimulating ag<strong>en</strong>ts in pati<strong>en</strong>ts un<strong>de</strong>rgoing dialysis<br />
NDT PLUS 2009; 2:347-53<br />
Bonafont X, Bonal J<br />
Dosificación <strong>de</strong> medicam<strong>en</strong>tos <strong>en</strong> la insufici<strong>en</strong>cia r<strong>en</strong>al<br />
SEMIN FUND ESP REUMATOL 2009;10:24-8.<br />
Bonafont, X; Perez, A; Ar<strong>de</strong>vol, M; Perez, C; Bonal, J; Romero, R<br />
Acceptance and self-administration rate of a new administration form of darbepoetin alfa (SureClick) in predialysis chronic kidney<br />
disease pati<strong>en</strong>ts<br />
PHARM WORLD SCI 2009-FEB; 31 (1): 41-41<br />
IF: 0,919<br />
Bosch M, Bonafont X<br />
Efecte <strong>de</strong> l´ ús <strong>de</strong> plantes medicinals <strong>en</strong> el perioi<strong>de</strong> perioperatori<br />
Butlletí d’Informació Terapèutica 2009;21:19-24<br />
Bosch M, Mazo V, Ar<strong>en</strong>y J, Sala F, Cardona G, Bonafont X<br />
Uso <strong>de</strong> plantas medicinales antes <strong>de</strong> la cirugía<br />
FARMACIA 2009; 33(suppl):47-8.<br />
IF: 0,144<br />
Camps, I; Armestar, F; Cuadrado, M; Mesalles, E<br />
VAC (vacuum-assisted closure) "covered" laparostomy to control abdominal compartm<strong>en</strong>tal syndrome in a case of<br />
emphysematous pancreatitis<br />
CIRUGIA ESPANOLA 2009 OCT;86:250-251<br />
Canet, J; Vila, E; Guasch, RG<br />
Comm<strong>en</strong>ts on "Anesthesia in Thoracic Surgery in Catalonia: Results of a Survey Carried Out in 2003" Reply<br />
ARCH BRONCONEUMOL 2009-AUG; 45 (8): 413-414<br />
IF: 2,166<br />
Pàgina 56 <strong>de</strong> 67
Cardona G, Bosch M, Costa J, Planas R, Bonafont X.<br />
Prescripció <strong>de</strong> fàrmacs <strong>en</strong> insuficiència hepàtica.<br />
Butlletí <strong>de</strong>l Medicam<strong>en</strong>t 2009;11(49):1-6.<br />
Cardona, G; Galan, A; Alvarez, M; Perez, C; Giner, P; Bonafont, X<br />
Do we need any alerts in electronic prescription of drugs that induce hyperkaliemia<br />
PHARM WORLD SCI 2009-APR; 31 (2): 300-300<br />
IF: 0,919<br />
Carretro A., Sanchez Planell L., Rusiñol Estragués J., Raich escursell R., Sanchez Carracedo D.<br />
Relevancia <strong>de</strong> factores <strong>de</strong> riesgo, psicopatología alim<strong>en</strong>taria, insatisfacción corporal y funcionami<strong>en</strong>to psicológico <strong>en</strong> paci<strong>en</strong>tes<br />
con TCA<br />
CLINICA Y SALUD 2009,20(2):145-157.<br />
Castaño B, B<strong>en</strong>ito J, Pires F, Ferreira S, Lopez R, Vidal J.<br />
Delirium secondary to intrathecal baclof<strong>en</strong>.<br />
SPINAL CORD 2009 Jun;47(6):477-80.<br />
IF: 1,783<br />
Castellanos, J; Garcia-Nuno, L; Cavanilles-Walker, JM; Roca, J<br />
Iatrog<strong>en</strong>ic Femoral Neck Fracture During Closed Nailing of the Femoral Shaft Fracture<br />
EUR J TRAUMA EMERG S 2009 OCT;35:479-481<br />
IF: 0,207<br />
Coh<strong>en</strong>-Solal A, Kotecha D, van Veldhuis<strong>en</strong> DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M;<br />
SENIORS Investigators. (Valle, Lupón)<br />
Efficacy and safety of nebivolol in el<strong>de</strong>rly heart failure pati<strong>en</strong>ts with impaired r<strong>en</strong>al function: insights from the SENIORS trial.<br />
EUR J HEART FAIL 2009 Sep;11(9):872-80. Epub 2009 Aug 1.<br />
IF: 3,706<br />
Comajuan, SM; Lopez-Ayerbe J; Ferrer, BR; Quer, C; Camazon, NV; Sistach, EF; Capllonch, FG; Baliarda, XR; Valle V<br />
An intracardiac ectopic thyroid mass<br />
EUR J ECHOCARDIOGR 2009-JUL; 10 (5): 704-706<br />
IF: 1,476<br />
Comisión Nacional <strong>de</strong> la Especialidad <strong>de</strong> Anestesiología y Reanimación: Navia J, Mone<strong>de</strong>ro P, Echevarría M, Canet J, Aguilera L,<br />
Herreras JI, Gómez M, Puig M, Ab<strong>en</strong>goechea JM, Hernán<strong>de</strong>z J, Romero AJ.<br />
Gui<strong>de</strong>lines on clinical rotation periods for medical resid<strong>en</strong>ts in anesthesiology and postanesthesia recovery care.<br />
Rev Esp Anestesiol Reanim 2009 Dec; 56(10):589<br />
Curós A, Ribas N, Baz J.A., Serra J., E. Fernán<strong>de</strong>z Nofrerias, O. Rodriguez, Valle V.<br />
Estrategias para reducir el tiempo <strong>de</strong> reperfusión <strong>en</strong> el tratami<strong>en</strong>to con angioplastia primaria<br />
REV ESP CARDIOL 2009;9:34C-45C<br />
IF: 2,746<br />
Dal-Re, R; Costa, J<br />
Informing participants on study results and the Declaration of Helsinki 2008<br />
MED CLIN-BARCELONA 2009-MAY 23; 132 (19): 763-764<br />
IF: 1,231<br />
Díez J, Coca A, <strong>de</strong> Teresa E, Anguita M, Castro-Beiras A, Conthe P, Cobo E, Fernán<strong>de</strong>z E; TORAFIC Investigators Group. (Lupón)<br />
TORAFIC study protocol: torasemi<strong>de</strong> prolonged release versus furosemi<strong>de</strong> in pati<strong>en</strong>ts with chronic heart failure<br />
Expert Rev Cardiovasc Ther 2009 Aug;7(8):897-904.<br />
Dom<strong>en</strong>ech J, Tormos JM, Barrios C, Pascual-Leone A.<br />
Motor cortical hyperexcitability in idiopathic scoliosis: could foca1 dystonia be a subclinical etiological factor<br />
EUR SPINE J 2009 Dec 24.<br />
IF: 1,956<br />
Domingo, M; Gil, O; Serrano, E; Guirado, E; Nofrarias, M; Grassa, M; Caceres, N; Perez, B; Vilaplana, C; Cardona, PJ<br />
Effectiv<strong>en</strong>ess and Safety of a Treatm<strong>en</strong>t Regim<strong>en</strong> Based on Isoniazid Plus Vaccination with Mycobacterium tuberculosis cells'<br />
Pàgina 57 <strong>de</strong> 67
Fragm<strong>en</strong>ts: Field-Study with Naturally Mycobacterium caprae-Infected Goats<br />
SCAND J IMMUNOL 2009; 69:500-507<br />
IF: 2,108<br />
E. Amestoy, A. Segura, H. Guardiola, A. Carreres.<br />
Síndrome <strong>de</strong> hiperestimulación ovárica <strong>en</strong> una mujer <strong>de</strong> 19 años.<br />
MED CLIN-BARCELONA 2009<br />
IF: 1,231<br />
Evangelista, A; Padilla, F; Lopez-Ayerbe, J; Calvo, F; Lopez-Perez, JM; Sanchez, V; Moris, C; Fernan<strong>de</strong>z-Tarrio, R; Roman,<br />
JAS; Saura, D; Nistal, F; Alegret, JM; Gallego, P; Aguilar, R<br />
Spanish Acute Aortic Syndrome Study (RESA). Better Diagnosis Is Not Reflected in Reduced Mortality<br />
REV ESP CARDIOL 2009-MAR; 62 (3): 255-262<br />
IF: 2,746<br />
Ferrer A, Estrada MD, Borràs A, Espallargues M.<br />
Guía para la indicación <strong>de</strong> la d<strong>en</strong>sitometría ósea <strong>en</strong> la valoración <strong>de</strong>l riesgo <strong>de</strong> fractura y el control evolutivo <strong>de</strong> la osteoporosis.<br />
MED CLIN-BARCELONA 2009; 132(11): 428-436.<br />
IF: 1,231<br />
Filliettaz, SS; Gonvers, JJ; Peytremann-Bri<strong>de</strong>vaux, I; Arditi, C; Delvaux, M; Numans, ME; Lor<strong>en</strong>zo-Zuniga, V; Dubois, RW; Juillerat, P;<br />
Burnand, B; Pittet, V; Va<strong>de</strong>r, JP; Froehlich, F<br />
Functional bowel disor<strong>de</strong>rs: pain, constipation and bloating<br />
ENDOSCOPY 2009-MAR; 41 (3): 234-239<br />
IF: 5,545<br />
Fiz, JA; Prat, JM; Jane, R<br />
Treatm<strong>en</strong>t of Pati<strong>en</strong>ts With Simple Snoring<br />
ARCH BRONCONEUMOL 2009 OCT;45:508-515<br />
IF: 2,166<br />
Friguls B, Coroleu W, <strong>de</strong>l Alcazar R, Hilbert P, Van Mal<strong>de</strong>rgem L, Pintos-Morell G.<br />
Severe cardiac ph<strong>en</strong>otype of Berardinelli-Seip cong<strong>en</strong>ital lipodystrophy in an infant with homozygous E189X BSCL2 mutation.<br />
EUR J MED GENET 2009 Jan-Feb;52(1):14-6. Epub 2008 Nov 12.<br />
IF: 1,568<br />
Fuster D, Torr<strong>en</strong>s M, Tor J, Muga R<br />
Paci<strong>en</strong>te con abuso <strong>de</strong> alcohol, infección por el VIH y hepatitis crónica C<br />
Trastornos adictivos 2009;11(3):173-9<br />
Galanaud JP, Qu<strong>en</strong>et S, Rivron-Guillot K, Quere I, Sanchez Muñoz-Torrero JF, Tolosa C, Monreal M; RIETE INVESTIGATORS.<br />
Comparison of the clinical history of symptomatic isolated distal <strong>de</strong>ep-vein thrombosis vs. proximal <strong>de</strong>ep vein thrombosis in 11<br />
086 pati<strong>en</strong>ts.<br />
J THROMB HAEMOST 2009 Dec;7(12):2028-34. Epub 2009 Sep 28.PMID: 19793188<br />
IF: 6,069<br />
Garcia M, Morillas RM,Miquel M, Rodriguez O, Cirera I, Vergara M,Masnou H, Gim<strong>en</strong>ez MD, Cañete N, Gallach M, Ardèvol M,<br />
Alvarez MA, Montoliu S, Romero M, Planas R, Solá R.<br />
Analysis of causes of response failure in naive pati<strong>en</strong>ts with chronic hepatitis C receiving peginterferon plus ribavirin<br />
HEPATOLOGY 2009, 50(supll):A896<br />
IF: 10,840<br />
García-Melchor E<br />
Problemas <strong>de</strong> los resid<strong>en</strong>tes: ¿cómo po<strong>de</strong>mos solucionarlos)<br />
SEMIN FUN ESP REUMATOL 2009; 10 (3): 100-103.<br />
Garcia-Olive, I; Forcada, EV; Garcia, FA; Sanz-Santos, J; Castella, E; Llatjos, M; Astudillo, J; Monso, E<br />
Linear Endobronchial Ultrasound as the Initial Diagnostic Tool in Pati<strong>en</strong>ts With Indications of Mediastinal Disease<br />
ARCH BRONCONEUMOL 2009-JUN; 45 (6): 266-270<br />
IF: 2,166<br />
Pàgina 58 <strong>de</strong> 67
Garcia-Pagan, JC; Villanueva, C; Albillos, A; Banares, R; Morillas, R; Abral<strong>de</strong>s, JG; Bosch, J<br />
Nadolol plus isosorbi<strong>de</strong> mononitrate alone or associated with band ligation in the prev<strong>en</strong>tion of recurr<strong>en</strong>t bleeding: a multic<strong>en</strong>tre<br />
randomised controlled trial<br />
GUT 2009-AUG; 58 (8): 1144-1150<br />
IF: 9,357<br />
Gayol MC,Font A,Casas I,Estrada O, Domínguez MJ, Pedro-Botet ML<br />
Utilidad <strong>de</strong> la escala <strong>de</strong> MASCC <strong>en</strong> el tratami<strong>en</strong>to <strong>de</strong> la neutrop<strong>en</strong>ia febril inducida por quimioterapia <strong>en</strong> paci<strong>en</strong>tes con neopasia<br />
sólida<br />
MED CLIN-BARCELONA 2009;133(8):296–299<br />
IF: 1,231<br />
Gomar Sancho C, Montero Matamala A, Puig Riera <strong>de</strong> Conias M, Sabaté Pes A, Fábregas Juliá N, Valero Castell R, Dalmau Llitjos A,<br />
Rull Bartomeu M, García Guasch R, Fita Rodríguez G, Rovira Canudas I, Gallart Gallego L, Samsó Sabé E, Villalonga Va<strong>de</strong>ll R,<br />
Vilanova Card<strong>en</strong>a F, Koo Gómez M, Roigé Solé J, <strong>de</strong> Nadal Clanchet M, Añez Simón C, Villalonga, Morales A, Roldán Osuna J, Díaz<br />
Meco FX.<br />
A proposal for compet<strong>en</strong>cies in anethesiology, int<strong>en</strong>sive recovery care, and pain therapy: the cons<strong>en</strong>sus of university faculty<br />
members in Catalonia regarding expectations for medical school graduates.<br />
Rev Esp Anestesiol Reanim 2009 Aug-Sep;56(7):436-44.<br />
Gonzalez Well<strong>en</strong>s N, Minguez S,Lozano M,Olivé A<br />
Neuripatía <strong>de</strong>l trigémino y <strong>de</strong>rmatomiositis<br />
MED CLIN-BARCELONA 2009; Jun 9. pmid: 19520399<br />
IF: 1,231<br />
Grau J, Formiga F, Jordana R, Urrutia A, Arias JL, Salvador J<br />
Etiología y tratami<strong>en</strong>to <strong>de</strong> la anemia <strong>en</strong> la insufici<strong>en</strong>cia cardíaca. Estudio GESAIC.<br />
MED CLIN-BARCELONA 2009;132:447-53<br />
IF: 1,231<br />
Heras, E; Salas, RM; Cap<strong>de</strong>vila, JA<br />
A pati<strong>en</strong>t from Maghreb with dysphagia<br />
MED CLIN-BARCELONA 2009-SEP 19; 133 (10): 397-401<br />
IF: 1,231<br />
Hernán<strong>de</strong>z C, Serra J.<br />
Acalasia: ¿Tratami<strong>en</strong>to <strong>de</strong>finitivo o retratami<strong>en</strong>to seguro<br />
ANN MED 2009; 92:S1-89.<br />
IF: 4,246<br />
Ibarz L; Fabregas, MA; Dominguez, JMR; Massana, MB; Sanz, JLM; Roig, JMS<br />
Primary lymphoma of p<strong>en</strong>is<br />
ACTAS UROLOGICAS ESPANOLAS 2009-JUL-AUG; 33 (7): 826-829<br />
Ibarz Servio L, Ruiz Domínguez J, Cannata Ortiz P, Olazabal Zudaire A.<br />
Oncocitoma r<strong>en</strong>al gigante.<br />
MED CLIN-BARCELONA 2009; 132: 527.<br />
IF: 1,231<br />
Jim<strong>en</strong>ez, D; Uresandi, F; Otero, R; Lobo, JL; Monreal, M; Marti, D; Zamora, J; Muriel, A; Aujesky, D; Yus<strong>en</strong>, RD<br />
Troponin-Based Risk Stratification of Pati<strong>en</strong>ts With Acute Nonmassive Pulmonary Embolism Systematic Review and Metaanalysis<br />
CHEST 2009 OCT;136:974-982<br />
IF: 6,360<br />
Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, H<strong>en</strong>driksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U,<br />
Tincheva R, Wraith JE; HOS Investigators. (Pintos G)<br />
Mortality and cause of <strong>de</strong>ath in mucopolysaccharidosis type II-a historical review based on data from the Hunter<br />
Outcome Survey (HOS).<br />
J INHERIT METAB DIS 2009 Aug;32(4):534-43. Epub 2009 Jul 14.<br />
IF: 3,598<br />
Just S, Torraba<strong>de</strong>lla P, Campos A, Fabra M<br />
Pàgina 59 <strong>de</strong> 67
Cirugía cardiaca <strong>en</strong> octog<strong>en</strong>arios<br />
MED CLIN-BARCELONA 2009; 133: 76-78<br />
IF: 1,231<br />
Kofler M, Kumru H, Stetkarova 1, Rüegg S, Fuhr P, Leis AA.<br />
Cutaneous sil<strong>en</strong>t periods are not affected by the antihistaminic drug cetirizine.<br />
CLIN NEUROPHYSIOL May;120(5):1016-9.<br />
IF: 3,122<br />
Kolb, S; W<strong>en</strong>g<strong>en</strong>roth, L; Hege, I; Praml, G; Nowak, D; Cantineau, J; Cantineau, A; Gonzalez, M; Monso, E; Pauncu, EA; Vellore, AD;<br />
Godnic-Cvar, J; Radon, K<br />
Case Based e-Learning in Occupational Medicine-A European Approach<br />
J OCCUP ENVIRON MED 2009; 51:647-653<br />
IF: 1,882<br />
Kumru H, Kofler M, Valls-Solé J, Portell E, Vidal J.<br />
Brainstem reflexes are <strong>en</strong>hanced following severe spinal cord injury and reduced by continuous intrathecal baclof<strong>en</strong>.<br />
NEUROREHAB NEURAL RE 2009 Nov;23(9):921-7.<br />
IF: 5,398<br />
Kumru H, Opisso E, Valls-Solé J, Kofler M.<br />
The effect of a prepulse stimulus on the EMG rebound following the cutaneous sil<strong>en</strong>t period.<br />
J PHYSIOL-LONDON 2009 Feb 1 ;587(Pt 3):587-95.<br />
IF: 4,764<br />
Kumru H, Vidal J, Perez M, Schestatsky P, Valls-Solé J.<br />
Sympathetic skin responses evoked by differ<strong>en</strong>t stimuli modalities in spinal cord injury pati<strong>en</strong>ts.<br />
NEUROREHAB NEURAL RE 2009 Ju1;23(6):553-8<br />
IF: 5,398<br />
Kuna, P; Bachert, C; Nowacki, Z; van Cauw<strong>en</strong>berge, P; Agache, I; Fouquert, L; Roger, A; Sologur<strong>en</strong>, A; Vali<strong>en</strong>te, R<br />
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatm<strong>en</strong>t of<br />
seasonal allergic rhinitis: a randomized, double-blind, parallel-group study<br />
CLIN EXP ALLERGY 2009-SEP; 39 (9): 1338-1347<br />
IF: 4,084<br />
Lobo JL, Zorrilla V, Aizpuru F, Grau E, Jiménez D, Palareti G, Monreal M; RIETE Investigators.<br />
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry.<br />
J THROMB HAEMOST 2009 Nov;7(11):1795-801. Epub 2009 Aug 19.PMID: 19691481<br />
IF: 6,069<br />
Lor<strong>en</strong>zo-Zuniga, V; De Vega, VM; Dom<strong>en</strong>ech, E; Boix, J<br />
Diagnosis and treatm<strong>en</strong>t of ampullary tumors<br />
Gastro<strong>en</strong>terologia y hepatologia 2009-FEB; 32 (2): 101-108<br />
Lor<strong>en</strong>zo-Zuniga, V; <strong>de</strong> Vega, VM; Mor<strong>en</strong>o, P; Muchard, J; Boix, J<br />
Endoscopic placem<strong>en</strong>t of postpyloric naso<strong>en</strong>teric feeding tubes: The importance of the gui<strong>de</strong>wire used<br />
CLIN NUTR 2009-JUN; 28 (3): 355-356<br />
IF: 3,274<br />
Lor<strong>en</strong>zo-Zúñiga V, <strong>de</strong> Vega VM, Doménech E, Mañosa M, Planas R, Boix J.<br />
Endoscopist experi<strong>en</strong>ce as a risk factor for colonoscopic complications<br />
COLORECTAL DIS 2009 Nov 23. [Epub ahead of print]<br />
IF: 2,410<br />
Lor<strong>en</strong>zo-Zúñiga V, V.Mor<strong>en</strong>o <strong>de</strong> Vega, E.Domènech, J.Boix.<br />
Diagnóstico y tratami<strong>en</strong>to <strong>de</strong> los tumores <strong>de</strong> papila <strong>de</strong> Vater.<br />
Gastro<strong>en</strong>terol Hepatol 2009; 32: 101-108.<br />
Loscos-Ar<strong>en</strong>as J, De-La-Cámara J.<br />
Blindness in the works of E. Sábato: information on the blind.<br />
Pàgina 60 <strong>de</strong> 67
Arch Soc Esp Oftalmol 2009 Mar;84(3):163-4. Spanish.<br />
Lucas-Martin AM<br />
Postpartum thyroiditis: Must we do sre<strong>en</strong>ning<br />
MED CLIN-BARCELONA 2009-APR 25; 132 (15): 585-586<br />
IF: 1,231<br />
Luc<strong>en</strong>a MI, Andra<strong>de</strong> RJ, Kaplowitz N, García-Cortes M, Fernán<strong>de</strong>z MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M,<br />
Rodriguez-González JF, Navarro JM, Salmeron J, Martinez-Odriozola P, Pérez-Alvarez R, Borraz Y, Hidalgo R; Spanish Group for the<br />
Study of Drug-Induced Liver Disease.<br />
Ph<strong>en</strong>otypic characterization of idiosyncratic drug-induced liver injury: the influ<strong>en</strong>ce of age and sex.<br />
HEPATOLOGY 2009 Jun;49(6):2001-9.<br />
IF: 10,840<br />
Martin PI, Naeser MA, Ho M, Doron KW, Kurland J, Kaplan J, Wang Y, Nicholas M, Baker EH, Fregni F, Pascual-Leone<br />
Overt naming fMRl preand post-TMS: Two nonflu<strong>en</strong>t aphasia pati<strong>en</strong>ts, with and without improved naming post-TMS<br />
BRAIN LANG 2009 Oct; 1 1 l(1)<br />
IF: 2,973<br />
Martinez, SJ; Torraba<strong>de</strong>lla <strong>de</strong> Reynoso P; Radua, ACGF<br />
Octog<strong>en</strong>arians un<strong>de</strong>rgoing cardiac surgery<br />
MED CLIN-BARCELONA 2009-juny-13; 133 (2): 76-76<br />
IF: 1,231<br />
Mateo L, Olivé A, Garcia-Casares E, Garcia-Melchor E, Holgado S, T<strong>en</strong>a X<br />
Artritis séptica politópica: análisis <strong>de</strong> 19 casos.<br />
Reumatología Clínica 2009; 5 (1): 18-22<br />
Mehta A, Beck M, Elliott P, Giugliani R, Linhart A, Sun<strong>de</strong>r-Plassmann G, Schiffmann R, Barbey F, Ries M, Clarke JT; Fabry Outcome<br />
Survey investigators.<br />
Enzyme replacem<strong>en</strong>t therapy with agalsidase alfa in pati<strong>en</strong>ts with Fabry's disease: an analysis of registry data.<br />
LANCET 2009 Dec 12;374(9706):1986-96.<br />
IF: 30,758<br />
Moltó A, Holgado S, Mateo L, Olivé A<br />
Osteoporosis transitoria <strong>de</strong> la ca<strong>de</strong>ra y embarazo<br />
MED CLIN-BARCELONA 2009 Oct 21. pmid: 19853264<br />
IF: 1,231<br />
Monreal, M<br />
Towards a better prev<strong>en</strong>tion of v<strong>en</strong>ous thromboembolism<br />
MED CLIN-BARCELONA 2009-juny-06; 133 (1): 21-22<br />
IF: 1,231<br />
Montané E, Andreu A, Barriocanal AM, Bonafont X.<br />
Ina<strong>de</strong>quate information in the medication or<strong>de</strong>rs of hospital inpati<strong>en</strong>ts.<br />
MED CLIN-BARCELONA 2009 Jul 29<br />
IF: 1,231<br />
Montane, E; Barriocanal, A; Isern, I; Parajon, T; Costa, J<br />
Multiple drug interactions - induced serotonin syndrome: a case report<br />
J CLIN PHARM THER 2009-AUG; 34 (4): 485-487<br />
IF: 1,671<br />
Morillas RM, Cirera I, García Retortillo Mª, Masnou H, Miquel M, Ardèvol M, Coll S, Bory F, Planas R, Solà R<br />
Eficacia <strong>de</strong> l’a<strong>de</strong>fovir <strong>en</strong> l’hepatitis B HbeAg <strong>en</strong> la pràctica clìnica<br />
ANN MED 2009; 92 (Suppl 1)<br />
IF: 4,246<br />
Negredo, E; Puig, J; Al<strong>de</strong>a, D; Medina, M; Estany, C; Perez-Alvarez, N; Rodriguez-Fumaz, C; Munoz-Mor<strong>en</strong>o, JA; Higueras, C;<br />
Gonzalez-Mestre, V; Clotet, B<br />
Four-Year Safety with Polyacrylami<strong>de</strong> Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy<br />
Pàgina 61 <strong>de</strong> 67
AIDS RES HUM RETROV 2009; 25:451-455<br />
IF: 2,178<br />
Nitsche MA, Boggio PS, Fregni F, Pascual-Leone A.<br />
A. Treatm<strong>en</strong>t of <strong>de</strong>pression with transcranial direct curr<strong>en</strong>t stimulation (tDCS)<br />
EXP NEUROL 2009<br />
Sep;219(1).<br />
IF: 3,914<br />
Olivé A<br />
El gran mom<strong>en</strong>to <strong>de</strong> la Reumatología Española<br />
Reumatología Clínica 2009; 5: 187-188<br />
Olivé A, Garcia Melchor E<br />
A propósito <strong>de</strong>l f<strong>en</strong>óm<strong>en</strong>o <strong>de</strong> Raynaud<br />
MED CLIN-BARCELONA 2009 Dec 16. PMID: 20022066<br />
IF: 1,231<br />
Olivé A, Lisabeth K, Pereira da Silva JA<br />
El nuevo currículo europeo <strong>de</strong> reumatología.<br />
SEMIN FUN ESP REUMATOL 2009; 10 (3): 75.<br />
Olivé A.<br />
Who is afraid of the MIR system<br />
MED CLIN-BARCELONA 2009-juny-06; 133 (1): 36-36<br />
IF: 1,231<br />
Peyró R, Aguilera L, Bartur<strong>en</strong> F, Canet J, Ginesta V, Gómez-Herreras JI, Mone<strong>de</strong>ro P, Navia J, Sánchez C.<br />
Merging the specialty of anesthesiology and postanesthesia recovery care medicine with int<strong>en</strong>sive care medicine.<br />
Rev Esp Anestesiol Reanim 2009 Dec;56(10):628-31.<br />
Peytremann-Bri<strong>de</strong>vaux I, Arditi C, Froehlich F, O'Malley J, Fairclough P, Le Moine O, Dubois RW, Gonvers JJ, Schusselé Filliettaz S,<br />
Va<strong>de</strong>r JP, Juillerat P, Pittet V, Burnand B; EPAGE II Study Group.<br />
Appropriat<strong>en</strong>ess of colonoscopy in Europe (EPAGE II). Iron-<strong>de</strong>fici<strong>en</strong>cy anemia and hematochezia.<br />
ENDOSCOPY 2009 Mar;41(3):227-33. Epub 2009 Mar 11.<br />
IF: 5,545<br />
Pimi<strong>en</strong>ta M, Olivé A.<br />
El f<strong>en</strong>óm<strong>en</strong>o <strong>de</strong> la patergia<br />
SEMIN FUN ESP REUMATOL 2009; 10 (3): 87-90.<br />
Pinar, E; Albarran, A; Baz, JA; Mauri, J<br />
Update on Interv<strong>en</strong>tional Cardiology<br />
REV ESP CARDIOL 2009-; 62: 101-116<br />
IF: 2,746<br />
Pintos-Morell G, Beck M.<br />
Fabry disease in childr<strong>en</strong> and the effects of <strong>en</strong>zyme replacem<strong>en</strong>t treatm<strong>en</strong>t.<br />
EUR J PEDIATR 2009 Nov;168(11):1355-63. Epub 2009 Feb 26.<br />
IF: 1,634<br />
Planas R, Morillas RM, Sala M.<br />
Prescripció <strong>de</strong> fàrmacs <strong>en</strong> la insufici<strong>en</strong>cia hepàtica.<br />
Butlletí d’Informació Terapèutica 2009; 21 (núm 5)<br />
Plauth, M; Cabre, E; Campillo, B; Kondrup, J; Marchesini, G; Schutz, T; Sh<strong>en</strong>kin, A; W<strong>en</strong>don, J<br />
ESPEN Gui<strong>de</strong>lines on Par<strong>en</strong>teral Nutrition: Hepatology<br />
CLIN NUTR 2009-AUG; 28 (4): 436-444<br />
IF: 3,274<br />
Podlekareva D., J. Reekie, A. Rakhmanova, A. Horban, I. Karpov, P. Domingo, M. Losso, A.Mocroft, J. Lundgr<strong>en</strong>, O. Kirk, and the<br />
EuroSIDA study group<br />
Pàgina 62 <strong>de</strong> 67
Differ<strong>en</strong>ces in Health Care of HIV-infected pati<strong>en</strong>ts across Europe.<br />
PLOS MED 2009<br />
IF: 13,050<br />
Puyalto P, Arméstar F, Cuadras P, Mor<strong>en</strong>o JA<br />
Isquemia aguda <strong>de</strong>l territorio <strong>de</strong> la arteria basilar<br />
MED CLIN-BARCELONA 2009; 1333: 268<br />
IF: 1,231<br />
Ripoll, C; Groszmann, RJ; Garcia-Tsao, G; Bosch, J; Grace, N; Burroughs, A; Planas, R; Escorsell, A; Garcia-Pagan, JC; Makuch, R;<br />
Patch, D; Matloff, DS<br />
Hepatic v<strong>en</strong>ous pressure gradi<strong>en</strong>t predicts <strong>de</strong>velopm<strong>en</strong>t of hepatocellular carcinoma in<strong>de</strong>p<strong>en</strong>d<strong>en</strong>tly of severity of cirrhosis<br />
J HEPATOL 2009-MAY; 50 (5): 923-928<br />
IF: 7,818<br />
Rivas, I; Latorre, I; Sanvis<strong>en</strong>s, A; Dominguez, J; Tor, J; Prat, C; Rey-Joly, C; Muga, R<br />
Prospective evaluation of lat<strong>en</strong>t tuberculosis with interferon-gamma release assays in drug and alcohol abusers<br />
EPIDEMIOL INFECT 2009-SEP; 137 (9): 1342-1347<br />
IF: 2,365<br />
Roa L, Monreal M, Carmona JA, Aguilar E, Coll R, Suárez C; <strong>en</strong> repres<strong>en</strong>tación <strong>de</strong>l Grupo FRENA.<br />
Treatm<strong>en</strong>t inertia in secondary prev<strong>en</strong>tion of cardiovascular disease. Fr<strong>en</strong>a registry.<br />
MED CLIN-BARCELONA 2009 Nov 11. [Epub ahead of print] Spanish. PMID: 19913259<br />
IF: 1,231<br />
Roldan, V; Lecumberri, R; Munoz-Torrero, JFS; Vic<strong>en</strong>te, V; Rocha, E; Br<strong>en</strong>ner, B; Monreal, M<br />
Thrombophilia testing in pati<strong>en</strong>ts with v<strong>en</strong>ous thromboembolism. Findings from the RIETE registry<br />
THROMB RES 2009-JUN; 124 (2): 174-177<br />
IF: 2,406<br />
Rosset-Llobet J, Candia V, Fabregas I Molas S, Dolors Rosinés 1, Cubells D, Pascual-Leone A.<br />
The chall<strong>en</strong>ge of diagnosing foca1 hand dystonia in musicians.<br />
EUR J NEUROL 2009 Jul;16(7):864-9<br />
IF: 2,510<br />
Ruiz-Almazan, I; Caceres, C; Plano, J; Cobo-Gomez, JV<br />
Neuropsychological profile in el<strong>de</strong>rly people's musical hallucinations<br />
REV NEUROLOGIA 2009-MAY 1; 48 (9): 500-501<br />
IF: 1,234<br />
Sabate, S; Gomar, C; Huguet, J; Castillo, J; Canet, J; Villalonga, A<br />
Anesthesia for urological surgery in a European region with 6.7 million inhabitants (Catalonia, Spain)<br />
J CLIN ANESTH 2009-FEB; 21 (1): 30-37<br />
IF: 1,324<br />
Sánchez P, Tomasa TM, Catalán B, Martínez-Vega S, G<strong>en</strong>er J y Klamburg J<br />
“Hematoma epidural cervicotorácico espontáneo agudo”<br />
MEDICINA INTENSIVA 2009;33:54-7.<br />
Schusselé Filliettaz S, Gonvers JJ, Peytremann-Bri<strong>de</strong>vaux I, Arditi C, Delvaux M, Numans ME, Lor<strong>en</strong>zo-Zúñiga V, Dubois RW,<br />
Juillerat P, Burnand B, Pittet V, Va<strong>de</strong>r JP, Froehlich F; EPAGE II Study Group.<br />
Appropriat<strong>en</strong>ess of colonoscopy in Europe (EPAGE II). Functional bowel disor<strong>de</strong>rs: pain, constipation and bloating.<br />
ENDOSCOPY 2009 Mar;41(3):234-9. Epub 2009 Mar 11.<br />
IF: 5,545<br />
Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada JR.<br />
Impaired intestinal gas propulsion in manometrically prov<strong>en</strong> dysmotility and in irritable bowel syndrome.<br />
NEUROGASTROENT MOTIL 2009 Dec 28. [Epub ahead of print]<br />
IF: 3,568<br />
Solà R, Morillas RM, García Retortillo M, Cirera I, Vergara M, Masnou H, Jiménez MD, Gallach M, Ardèvol M, Álvarez MA, Montoliu<br />
S, Planas R<br />
Pàgina 63 <strong>de</strong> 67
Motius <strong>de</strong>l fracàs <strong>de</strong>l tractam<strong>en</strong>t <strong>de</strong> l’hepatitis C amb interferó pegilat i ribavirina<br />
ANN MED 2009; 92 (Suppl 1): S1-80<br />
IF: 4,246<br />
Soler X, Sell R, Maestre J, Ruiz-Manzano J<br />
Bronchial rupture by an unusual mechanism of thoracic hyperext<strong>en</strong>sion.<br />
J EMERG MED 2009 Apr 28. [Epub ahead of print]<br />
IF: 1,265<br />
Terré R, Mearin F.<br />
Resolution of tracheal aspiration afier the acute phase of stroke-related oropharyngeal Dysphagia.<br />
AM J GASTROENTEROL 2009 Apr; 1 04(4):923-32.<br />
IF: 6,012<br />
Terré R, Mearin F.<br />
Evolution of tracheal aspiration in severe traumatic brain injury-related oropharyngeal dysphagia: 1-year longitudinal follow-up<br />
study.<br />
NEUROGASTROENT MOTIL 2009 Apr;21(4):361-9.<br />
IF: 3,568<br />
Toro, R; Perez-Isla, L; Doxastaquis, G; Barba, MA; Gallego, AR; Pintos, G; Barbados, FJ; Mangas, A; Zamorano, JL<br />
Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy<br />
INT J CARDIOL 2009-feb-06; 132 (1): 38-44<br />
IF: 3,469<br />
Trujillo-Santos J, Ruiz-Gamietea A, Luque JM, Samperiz AL, Garcia-Bragado F, Todoli JA, Monreal M; RIETE Investigators.<br />
Predicting recurr<strong>en</strong>ces or major bleeding in wom<strong>en</strong> with cancer and v<strong>en</strong>ous thromboembolism. Findings from the RIETE<br />
Registry.<br />
THROMB RES 2009; 123 Suppl 2:S10-5.PMID: 19217463<br />
IF: 2,406<br />
Tural C, Tor J, Sanvis<strong>en</strong>s A, Pérez-Alvarez N, Martínez E, Ojangur<strong>en</strong> I, García-Samaniego J, Rockstroh J, Barlu<strong>en</strong>ga E, Muga<br />
R, Planas R, Sirera G, Rey-Joly C, Clotet B.<br />
Accuracy of simple biochemical tests in id<strong>en</strong>tifying liver fibrosis in pati<strong>en</strong>ts co-infected with human immuno<strong>de</strong>fici<strong>en</strong>cy<br />
virus and hepatitis C virus.<br />
CLIN GASTROENTEROL H 2009 Mar;7(3):339-45. Epub 2008 Dec 3<br />
IF: 5,642<br />
Valles M, Rodríguez A, Borau A, Mearin F.<br />
Effect of sacra1 anterior root stimulator on bowel dysfunctíon in pati<strong>en</strong>ts with spinal cord injury.<br />
DIS COLON RECTUM 2009 May;52(5):986-92.<br />
IF: 2,536<br />
Van Gossum, A; Cabre, E; Hebuterne, X; Jeppes<strong>en</strong>, P; Krznaric, Z; Messing, B; Powell-Tuck, J; Staun, M; Nightingale, J<br />
ESPEN Gui<strong>de</strong>lines on Par<strong>en</strong>teral Nutrition: Gastro<strong>en</strong>terology<br />
CLIN NUTR 2009-AUG; 28 (4): 415-427<br />
IF: 3,274<br />
Vasco, B; Villalba, JC; Lopez-Jim<strong>en</strong>ez, L; Falga, C; Montes, J; Trujillo-Santos, J; Monreal, M<br />
V<strong>en</strong>ous thromboembolism in nonag<strong>en</strong>arians Findings from the RIETE Registry<br />
THROMB HAEMOSTASIS 2009-JUN; 101 (6): 1112-1118<br />
IF: 3,619<br />
Vilaplana C, Montané E, Pinto S, Barriocanal AM, Dom<strong>en</strong>ech G, Torres F, Cardona PJ, Costa J.<br />
Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTIâ.<br />
VACCINE 2009 Oct 22.<br />
IF: 3,616<br />
Vilaplana C., Cardona PJ<br />
Tuberculin immunotherapy: its history and lessons to be learned.<br />
MICROBES INFECT 2009; 1e7<br />
IF: 2,757<br />
Pàgina 64 <strong>de</strong> 67
INVESTIGACIÓ TRASLACIONAL<br />
Alvarez, J; Dominguez, A; Sabria, M; Ruiz, L; Torner, N; Cayla, J; Barrabeig, I; Sala, MR; Godoy, P; Camps, N; Minguell, S<br />
Impact of the Legionella urinary antig<strong>en</strong> test on epi<strong>de</strong>miological tr<strong>en</strong>ds in community outbreaks of legionellosis in<br />
Catalonia, Spain, 1990-2004<br />
INT J INFECT DIS 2009; 13:E365-E370<br />
IF: 2,167<br />
Gieselmann V, Pintos-Morell G.<br />
Disease pathog<strong>en</strong>esis--basic sci<strong>en</strong>ce.<br />
INT J CLIN PHARM TH 2009;47 Suppl 1:S7-8.<br />
IF: 1,381<br />
Lopez, R; Poy, R; Pastor, MC; Segarra, P; Molto, J<br />
Cardiac <strong>de</strong>f<strong>en</strong>se response as a predictor of fear learning<br />
INT J PSYCHOPHYSIOL 2009; 74:229-235<br />
IF: 4,906<br />
Richard E, Jorge-Finnigan A, Garcia-Villoria J, Merinero B, Desviat LR, Gort L, Briones P, Leal F, Pérez-Cerdá C, Ribes A, Ugarte M,<br />
Pérez B; MMACHC Working Group. (Pintos G)<br />
G<strong>en</strong>etic and cellular studies of oxidative stress in methylmalonic aciduria (MMA) cobalamin <strong>de</strong>fici<strong>en</strong>cy type C (cblC) with<br />
homocystinuria (MMACHC).<br />
HUM MUTAT 2009 Nov;30(11):1558-66.<br />
IF: 6,887<br />
Santin, S; Garcia-Maset, R; Ruiz, P; Gim<strong>en</strong>ez, I; Zamora, I; P<strong>en</strong>a, A; Madrid, A; Camacho, JA; Fraga, G; Sanchez-Mor<strong>en</strong>o, A; Cobo,<br />
MA; Bernis, C; Ortiz, A; <strong>de</strong> Pablos, AL; Pintos, G; Justa, ML; Hidalgo-Barquero, E; Fernan<strong>de</strong>z-Llama, P; Ballarin, J; Ars, E; Torra,<br />
RFSGS Spanish Study Grp<br />
Nephrin mutations cause childhood- and adult-onset focal segm<strong>en</strong>tal glomerulosclerosis<br />
KIDNEY INT 2009 DEC;76:1268-1276<br />
IF: 6,193<br />
V<strong>en</strong>tura Orriols E., Biosca Adzet C., Bayés G<strong>en</strong>ís B., Holgado Pérez S., Lauzurica Val<strong>de</strong>moros R., Corominas Vilar<strong>de</strong>ll A.<br />
Utilidad <strong>de</strong>l propéptido amino-terminal <strong>de</strong>l procolág<strong>en</strong>o tipo 1 (P1NP) como marcador <strong>de</strong> remo<strong>de</strong>lado óseo <strong>en</strong> el paci<strong>en</strong>te<br />
sometido a trasplante r<strong>en</strong>al<br />
REV LAB CLIN 2009; 2:80-86.<br />
Projectes<br />
INVESTIGACIÓ BÀSICA<br />
MOLTO MARHUENDA, JOSE - FUNDACIÓ LLUITA CONTRA LA SIDA<br />
Ministerio <strong>de</strong> Sanidad y Politica Social - Núm. Exp.: TRA-084<br />
Interacciones farmacológicas <strong>en</strong>tre Echinacea Purpurea y Darunavir/Ritonavir.<br />
Durada: 1 anys - (2009-2010)<br />
Import Concedit: 31.365 €<br />
INVESTIGACIÓ CLÍNICA<br />
ANDREO GARCIA, FELIPE CRISTOBAL - PNEUMOLOGIA<br />
FIS - Núm. Exp.: PI070170<br />
R<strong>en</strong>tabilidad diagnóstica <strong>de</strong> la ultrasonografía <strong>en</strong>dobronquial <strong>en</strong> el diagnóstico y estadificación <strong>de</strong>l carcinoma pulmonar no<br />
microcítico.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 35.000 €<br />
COSTA PAGES, JOAN - FARMACOLOGIA CLÍNICA<br />
Pàgina 65 <strong>de</strong> 67
FIS - Núm. Exp.: EC08/00266<br />
Estudio prospectivo multicéntrico <strong>de</strong> la incid<strong>en</strong>cia, relevancia clínica, factores <strong>de</strong> riesgo y prev<strong>en</strong>tibilidad <strong>de</strong>l ingreso hospitalario<br />
por fracaso r<strong>en</strong>al agudo asociado al uso <strong>de</strong> fármacos inhibidores <strong>de</strong>l sistema r<strong>en</strong>ina-angiot<strong>en</strong>sina.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 35.800 €<br />
ESTEBAN OLIVA, DOLORS - PEDIATRIA<br />
Fundación Santiago DEXEUS Font - Núm. Exp.:<br />
Estudio <strong>de</strong>l patrón proteómico urinario <strong>en</strong> recién nacidos con anomalías nefro-urológicas <strong>de</strong> <strong>de</strong>tección pr<strong>en</strong>atal: búsqueda <strong>de</strong><br />
biomarcadores predictores <strong>de</strong> la evolución.<br />
Durada: 2 anys - (2008-2010)<br />
Import Concedit: 6.000 €<br />
FERRA COLL, CHRISTELLA MARIE - HEMATOLOGIA I HEMOTERÀPIA<br />
FIS - Núm. Exp.: PI070444<br />
Relación <strong>de</strong> los valores séricos <strong>de</strong> la procalcitonina (PCT) y otros reactantes <strong>de</strong> fase aguda con las complicaciones y superviv<strong>en</strong>cia<br />
<strong>de</strong> paci<strong>en</strong>tes con hemopatías malignas que requier<strong>en</strong> ingreso <strong>en</strong> Unidad <strong>de</strong> Cuidados Int<strong>en</strong>sivos.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 28.850 €<br />
FERRER LASALA, MARIA JOSE - MEDICINA INTERNA - VIH<br />
FIPSE - Núm. Exp.: 24673/07<br />
Elaboración y validación <strong>de</strong> un instrum<strong>en</strong>to breve para la evaluación <strong>de</strong>l funcionami<strong>en</strong>to neurocognitivo y motor <strong>en</strong> paci<strong>en</strong>tes<br />
infectados por el VIH.<br />
Durada: 2 anys - (2007-2009)<br />
Import Concedit: 15.400 €<br />
IBARZ SERVIO, LUIS - UROLOGIA<br />
Asociación Española <strong>de</strong> Urología - Núm. Exp.: --<br />
El estrés crónico como factor etiológico <strong>de</strong> la litiasis r<strong>en</strong>al oxalocálcica. Estudio <strong>de</strong> sus implicaciones psicológicas y posibles<br />
interacciones bioquímicas.<br />
Durada: 2 anys - (2008-2010)<br />
Import Concedit: 10.700 €<br />
MILLAN TORNE, MONICA - NEUROLOGIA<br />
FIS - Núm. Exp.: EC07/90325<br />
Estudio doble ciego, aleatorizado, controlado con placebo <strong>de</strong> dosis escaladas <strong>de</strong> <strong>de</strong>feroxamina intrav<strong>en</strong>osa <strong>en</strong> paci<strong>en</strong>tes con ictus<br />
isquémico agudo tratado con activador tisular <strong>de</strong>l plasminóg<strong>en</strong>o.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 33.500 €<br />
MONREAL BOSCH, MANEL - MEDICINA INTERNA - HOSPITALITZACIÓ<br />
FIS - Núm. Exp.: PI080902<br />
Predicción <strong>de</strong> la muerte por embolia pulmonar <strong>en</strong> España.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 30.900 €<br />
MONSO MOLAS, EDUARD - PNEUMOLOGIA<br />
COMISSIÓ EUROPEA - Núm. Exp.: 135281-LLP-2007-1-DE-KA4MP<br />
NetWoRM-Net 3, Teaching in Work-Related Medicine.<br />
Durada: 2 anys - (2007-2009)<br />
Import Concedit: 16.690 €<br />
MONTANÉ ESTEVA, EVA - FARMACOLOGIA CLÍNICA<br />
FIS - Núm. Exp.: EC07/90318<br />
Estudio <strong>de</strong> utilización <strong>de</strong> antifúngicos sistémicos <strong>en</strong> los hospitales españoles.<br />
Durada: 2 anys - (2007-2009)<br />
Import Concedit: 15.000 €<br />
MORILLAS CUNILL, ROSA MARIA - APARELL DIGESTIU<br />
FIS - Núm. Exp.: EC08/00259<br />
Estudio multicéntrico, aleatorizado, doble-ciego, controlado con placebo, sobre la eficacia <strong>de</strong>l tratami<strong>en</strong>to con beta-bloqueantes<br />
Pàgina 66 <strong>de</strong> 67
(nadolol o carvedilol según respuesta hemodinámica) para la prev<strong>en</strong>ción <strong>de</strong> la <strong>de</strong>scomp<strong>en</strong>sación <strong>en</strong> paci<strong>en</strong>tes con cirrosis<br />
comp<strong>en</strong>sada y gradi<strong>en</strong>te <strong>de</strong> presión portal superior a 10 mmHg.<br />
Durada: 3 anys - (2008-2011)<br />
Import Concedit: 82.200 €<br />
RAMO TELLO, CRISTINA - NEUROLOGIA<br />
FIS - Núm. Exp.: EC07/90278<br />
Ensayo clínico, multicéntrico, con asignación aleatoria y doble ciego, para comparar la eficacia clínica y radiológica <strong>de</strong> dosis<br />
equival<strong>en</strong>tes <strong>de</strong> metilprednisolona administradas por vía oral o vía intrav<strong>en</strong>osa <strong>en</strong> paci<strong>en</strong>tes <strong>en</strong> brote <strong>de</strong> esclerosis múltiple.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 81.940 €<br />
INVESTIGACIÓ TRASLACIONAL<br />
COLL CANTI, JAUME - NEUROLOGIA<br />
Fundació La Marató <strong>de</strong> TV3 - Núm. Exp.: 061510<br />
Paràlisi <strong>de</strong>l malalt crític: Estudi Clínic, electrofisiològic, bioquímic i patològic.<br />
Durada: 3 anys - (2007-2010)<br />
Import Concedit: 45.629 €<br />
Pàgina 67 <strong>de</strong> 67